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Abstract
Elmer-Dixon, Margaret M. Ph. D., Summer 2018

Biochemistry & Biophysics

Elucidation of the Physical and Chemical Properties of Cytochrome c - Cardiolipin Interactions
Chairperson: Bruce E. Bowler
Recently, the electron transport protein Cytochrome c (Cytc) was shown to interact with the
mitochondrial lipid cardiolipin (CL) during the initial stages of the intrinsic apoptotic pathway.
This interaction is characterized by the protein binding and oxidation of cardiolipin on the
concave surface of the outer leaflet of the inner mitochondrial membrane. To date, this
interaction has been studied with a variety of methods and techniques reporting varied and often
conflicting findings characterizing the nature and extent of the protein-lipid interaction. Cytc has
been hypothesized to interact with cardiolipin electrostatically, hydrophobically and through
hydrogen bonding and is thought to partially to completely unfold and imbed in the membrane
during the interaction or remain folded on the membrane surface. This thesis aims to (1)
quantitatively assess the electrostatic protein-lipid interaction, (2) characterize the cationic amino
acid constituents that comprise the electrostatic protein binding site, (3) address the impact of
membrane curvature on (a) lipid packing and (b) protein binding. Here, we present a complete
analysis of electrostatic Cytc-CL binding to both yeast and human variants of the protein. Using
a new technique for lipid quantification, we characterize the interaction of the protein with
membrane surfaces with high reproducibility. Our findings strongly suggest a biphasic response
of the protein when exposed to CL with attenuated unfolding of the human variant with respect
to the yeast variant. Alanine scanning was used to elucidate the electrostatic constituents of the
anionic site. Lysines 72, 73, 86 and 87 were shown to be involved in CL binding but do not
completely characterize electrostatic binding site. We also show that CL preferentially partitions
to concave surfaces and that this preferential localization attenuates the interaction of Cytc with
the outer leaflet of mixed lipid vesicles. Lastly, we demonstrate the role of membrane curvature
for electrostatically bound Cytc. Here, Cytc conformational rearrangements are attenuated on
concave CL surfaces. The nature of the binding is intrinsically different with a concerted
structural rearrangement observed on concave surfaces as opposed to the biphasic
electrostatically-driven conformational rearrangement seen on convex outer leaflets.
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CHAPTER 1: Introduction
1.1. Cytochrome c Biological Role in the Cell.
Cytochrome c (Cytc) is a small globular heme protein found in high concentrations in the
intermembrane space of mitochondria where it shuttles electrons between complex III and
complex IV of the electron transport chain (Figure 1.1).1–3 Peroxidase activity associated with
energy harvesting in electron transport has been isolated to the heme active site at the center of
the protein.1 Structural analysis, in coordination with mutagenesis and stopped-flow4,5, has
shown that access to the heme active site is regulated by the flexible Ω-loop-D (residues 70-85,
Figure 1.2). Further, loop opening, and thus heme access, is directly linked to enhanced
peroxidase activity.

Figure 1.1. Cartoon of electron transport chain showing Cytochrome c’s role transporting
electrons from complex III to complex IV on the surface of the inner mitochondrial membrane
(IMM).1

1

Figure 1.2. Cartoon of iso-1-yeast Cytc corresponding to PDB 2YCC6 produced using
MacPymol. Heme center (Black sticks), tethered to protein by His18 (Yellow) and Met80
(Magenta). The flexible Ω-loop-D (residues 70-85, Dark Grey) controls direct access to the

heme. The A site (Red) flanks Ω-loop-D above the heme while the L site (Green) sits below the

heme. The C site (Orange) is hydrophobically buried adjacent to the heme. The N site (Blue) sits
behind the heme toward the back of the heme crevice.

2

1.2.Cytochrome c’s Role in Apoptosis.
Recently, Cytc was shown to have an additional role in the precursory steps of the intrinsic
apoptotic pathway.7–12 During apoptotic initiation, Cytc binds and oxidizes the non-bilayerforming lipid cardiolipin (CL) on the surface of the outer leaflet of the inner mitochondrial
membrane in the cristae of the mitochondrion (Figure 1.3).12,13 After oxidation, the protein loses
affinity for the CL surface and dissociates from the membrane and exits the mitochondrion. 10–12
The exact mechanism for protein efflux from the mitochondrion is not clearly understood with
several potential mechanisms of escape hypothesized. 10–12 Interestingly, CL is found in
appreciable concentrations on the outer membrane of the mitochondrion suggesting a migration
pathway may exist.12
The nature of the protein-lipid interaction between cationic Cytc (+8 net charge) and CL (-2
headgroup charge) is not clearly understood and several conflicting models have been postulated
to characterize the involvement of residues and regions on the protein, the structural orientation
of the protein-lipid interaction, and the extent of protein interaction with the lipid and the
membrane.13–28

3

Figure 1.3. Composite three-dimensional model of chick cerebellum mitochondrion imaged
using electron tomography. Outer membrane shown in blue and cristae, including both leaflets of
the inner mitochondrial membrane, is displayed in yellow. 29

1.3. Cardiolipin Binding Sites of Cytochrome c.
Four major regions of the protein have been hypothesized to function as binding sites during
CL interaction. The anionic site, site A, resides on the flexible Ω-loop-D above the heme where it
potentially regulates access to the heme loop crevice, the known site of peroxidation during

electron transport (Figure 1.2).14,23,30–32 This site is minimally characterized as electrostatically
interacting with one lysine at residue 72.14,23,30,31 Lysines at residues 7314,23,30,31 and potentially
86 and 87 may also be constituents of this site.32 The C site, comprised of a hydrophobically
buried asparagine at residue 52, could potentially hydrophobically interact with buried CL acyl
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chains (Figure 1.2).14 The lipid-interacting or L site comprises the region below the heme and
consists of histidines at positions 26 and 33 and lysines at positions 22, 25 and 27.33 The L site is
thought to interact with CL via both hydrogen bonding and electrostatic interactions (Figure
1.2).33 Recently, a fourth site, the N site, has been characterized as Phe36, Gly37, Thr58, Trp59
and Lys60 (Figure 1.2).34
These four sites are not completely conserved across eukaryotes. Lysine at position 25,
Thr58, as well as Lys60 are absent in yeast variants and may produce a varied response to lipid
binding at the L site and N sites, respectively, when compared with higher order variants.6,33,34

1.4. Conformational Binding Models of Cytochrome c.
Two major conformations have been hypothesized to characterize protein structure during
lipid interaction. The compact folded structure maintains the native Cytc conformation, docking
lipid headgroups at the exterior binding sites (A and L (See Figure 1.2)) while promoting acyl
chain invagination into the heme loop crevice by maintaining a highly structured hydrophobic
pocket around the heme.15,21,34,35 The C site could further stabilize infiltration of acyl chains into
the protein core through hydrophobic interaction.14,21,31,36,37 Direct experimental evidence also
supports a partially unfolded or extended conformer.18,19,23–25,38 In this conformation, Ω-loop-D

opens, promoting access to the heme active site. 18,19,23–25 Further structural rearrangement may
encourage more contact between sites N, C and L with the membrane. Partial unfolding of the
structure may also allow for partial burial of the protein into the hydrophobic region of the
membrane.38
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1.5. Environmental Contributions to Cytochrome c-Cardiolipin Binding.
To study this interaction, a wide variety of mimetic systems have been employed. Lipid
composition has varied from pure cardiolipin systems 39 to mixed cardiolipin/neutral lipid
systems18,19 at varying concentrations. Further complicating the problem, a range of pHs from
7.0-8.0 are used.14,18,19,33,35,39 Cytc has a pH dependent conformer that further convolutes binding
analyses. To complicate the matter further, hydrogen bonding is attributed to the L site due to the
presence of histidines at the site, suggesting the site’s involvement is a pH dependent
phenomenon.18,33 This variation in experimental design may be partially responsible for the
diverse and conflicting results that have led to the characterization of four binding sites and two
potential conformational models.

1.6. The Complexity and Consequences of In Vitro Experimental Design on Cytochrome cCardiolipin Binding.
The diverse array of model systems used to investigate Cytc-CL binding makes direct
comparison of experimental findings difficult at best. To investigate the intrinsic nature of the
protein-lipid interaction, the true interaction of Cytc with CL is necessary. Further, a systematic
approach to experimental design is essential to make meaningful comparison of findings across a
breadth of experiments possible.
Complex experimental design, multiple binding site involvement and multiple protein
conformations have made extracting binding constants from lipid titrations nontrivial. Further,
reported binding constants are often conflicting due to lack of analytical lipid quantification
among other concerns. A simplified approach including reproducible, analytical analysis of sitespecific involvement in lipid binding is needed to meaningfully analyze the Cytc-CL system.
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1.7. Cardiolipin’s Structure Dictates Membrane Location and Functionality.
Cardiolipin is a large non-membrane-forming phospholipid consisting of two negatively
charged phosphate headgroups and four acyl chains.40 Tetraoleylcardiolipin (1’,3’-bis[1,2dioleoyl-sn-glycero-3-phospho]-glycerol) is the most stable form of cardiolipin, and the one
generally used in vitro. It has four 18-carbon mono-unsaturated acyl chains (Figure
1.4).7,12,19,39,41 Many variations of the lipid exist but are hard to work with and generally not used.
The four unsaturated acyl chains have a larger cross-sectional area than the lipid’s headgroup
giving the bulk structure of the molecule a conic geometric shape and making it a non-membrane
forming lipid.40,42 Non-membrane forming lipids with smaller headgroups than tail cross sections
can generally be found on the concave leaflet of curved membranes. 40,42,43 Cardiolipin is known
to reside in high concentrations on the outer leaflet of the inner mitochondrial membrane.7,13,41
This surface is concave in accordance with the preferred membrane surface dictated by the
lipid’s structure (Figure 1.3).
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Figure 1.4. The most commonly researched form of Cardiolipin, Tetraoleylcardiolipin (1’,3’bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol), imaged using ChemBioDraw courtesy of
Avanti Polar Lipids (https://avantilipids.com/product/710335).

1.8. Experimental Considerations Ignore Cardiolipin’s Preferred Membrane Location.
The majority of studies investigating Cytc-CL interactions utilize mixed membrane systems
generally consisting of CL and dioleoylphosphocholine (1,2-dioleoyl-sn-glycero-3phoshocholine or DOPC)13,15,17,21,22,24,25,27,44–46 (and occasionally other formulations14,16,21,22,25,35).
Because CL’s structure suggests a strong preference for the lipid to partition to the concave
surface of membranes, careful consideration is needed when designing experiments with mixed
lipid systems. Either the system designed needs to be characterized to verify the lipid of interest
is in the location where the interaction is being studied or experimentation needs to occur on
concave surfaces. DOPC is a well known, cylindrical membrane forming lipid with no preferred
curvature-dependent localization.40,47,48 Experiments using DOPC/CL formulations generally
assume that both lipids mix homogeneously throughout the membrane without verifying lipid
location. This basic assumption gives rise to concerns that Cytc binding to these mixed systems
may not truly be an investigation of CL binding. It should be noted that findings corresponding
8

to these mixed systems are often conflicting and difficult to compare. An analysis of CL location
in mimetic systems would facilitate a better understanding of previously reported findings using
mixed lipid membranes.
1.9. Experimental Considerations Ignore Cytochrome c’s Location in the Mitochondria and
the Role of Membrane Curvature in Protein-Lipid Binding.
Cytc is known to reside in high concentrations in the inner mitochondrial space surrounded
by the cardiolipin rich, concave, outer leaflet of the inner mitochondrial membrane. The
physiological environment where Cytc-CL binding occurs32 (the concave outer leaflet) and CL’s
hypothesized propensity for negatively curved surfaces strongly suggests that the true nature of
the protein-lipid interaction is membrane curvature dependent. To date, one group has considered
the membrane structural dependence on this interaction.34 All other investigations of Cytc-CL
binding ignore membrane curvature, assume homogeneous lipid mixing and study protein
binding to convex surfaces of memetic membranes.13,14,26,27,32,35,44–46,49,50,15–17,21–25 While these
studies are valuable for their isolation of regional contributions by the protein to lipid interaction,
they do not begin to study the interaction in a physiologically relevant manner making their
findings interesting but not necessarily meaningful. A comprehensive, analytical approach to
protein binding to concave surfaces is needed to elucidate the complex physical and chemical
interactions that govern Cytc-CL binding.
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GOALS
Goal 1: Create Method for Rapid Quantification of Lipids.
In an effort to quantitatively approach lipid-protein binding, a technique for rapid lipid
quantification was developed to be used immediately before experimentation to ensure accurate
analytical assessment of CL’s involvement in binding. In Chapter 2, Mie scattering theory is
used to derive a computational method to determine lipid concentration from scattering
measurements acquired using a UV-Visible spectrophotometer for pure lipid and mixed lipid
systems.

Goal 2: Investigate Species-dependent Electrostatic Binding of Cytochrome c to
Cardiolipin.
Cytochrome c is highly conserved across eukaryotes yet its function varies from yeast, where
it serves only in electron transport, to higher order organisms like mammals, where it is integral
to both the electron transport chain and apoptotic pathway initiation. Further, the primary lysine
attributed to the anionic site, site A, on Cytc is completely conserved in all organisms.51 Chapter
3 investigates the role of the primary A-site lysine at position 72 in both yeast and human
variants of the protein during CL binding.

Goal 3: Characterize the Electrostatic Constituents of the Anionic Site on Cytochrome c.
With the varied approaches to study the Cytc-CL interaction, it is unsurprising that a
complete characterization of the anionic binding site of Cytc has not been undertaken. In chapter
4, we quantitatively evaluate the electrostatic contributions by lysines in and around the anionic

10

site of model protein, yeast iso-1-Cytc in an attempt to (1) characterize the binding site
constituents and (2) elucidate the physical nature of the binding event.

Goal 4: Evaluate Cardiolipin’s Preferred Location on Curved Surfaces with Variable Lipid
Composition.
Cardiolipin is found in high concentrations on the concave surface that comprises the
outer leaflet of the inner mitochondrial membrane in eukaryotes. Further, the structure of CL
suggests that the lipid readily preferentially localizes on the concave leaflet of membranes. Yet,
when investigating the Cytc-CL interaction, most experiments assume homogenous mixing of
DOPC and CL containing membranes between the inner (concave) and outer (convex) leaflets of
vesicles when investigating protein-lipid binding on the convex surface of a mimetic membrane
such as a vesicle. Chapter 5 investigates the preferred location of CL in membranes in a
concentration dependent manner.

Goal 5: Investigate the Role of Cardiolipin Partitioning in Mixed Lipid Systems During
Convex, Electrostatic, Cytochrome c Binding.
Using analytical techniques for evaluating electrostatic protein-lipid binding on
membrane surfaces established in chapters 2 and 3, chapter 5 investigates the role of lipid
partitioning in mixed lipid membranes on protein binding to convex surfaces.

11

Goal 6: Investigate the Role of Membrane Curvature on Electrostatic Cytochrome c –
Cardiolipin Binding.
Cytc-CL binding occurs on the concave surface of the inner mitochondrial membrane.
Chapter 6 evaluates the physiological relevance of membrane surface curvature on protein-lipid
binding.
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CHAPTER 2: Lipid Quantification

2.1. Rapid Quantification of Cardiolipin Lipid and Vesicle Concentration.
2.1.1. INTRODUCTION
Vesicles are made and used in a variety of biologically relevant experiments to elucidate and
characterize membrane associated interactions. Existing methods for vesicle quantification are
time consuming and costly. Commercially available particle-counting equipment can enumerate
vesicles as small as 10 nm, but these devices are expensive. Phosphate analysis assays and
inductively coupled plasma atomic emission spectroscopy (ICP) can measure phosphate
headgroup concentration but are time consuming and destroy large amounts of sample 1–3 and
thus are impractical for routine use. Because of these limitations, measurement of
protein/membrane binding affinities via analytical vesicle titrations is expensive. Due to lipid
oxidation in solution and membrane stability 4,5, it is essential that lipid and vesicle concentration
be measured expeditiously. Here, we report a rapid and reliable method for vesicle
quantification.
This quantification technique can be performed immediately before vesicle titrations of
protein samples and does not destroy any of the vesicle stock solution. After initial validation,
this technique requires only 15 minutes to quantify vesicles and lipids and uses common
laboratory equipment and software. In this report, we apply the method to measurement of the
concentration of 100% 18:1 cardiolipin (1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-snglycerol) vesicles of known radii, we then use existing physical parameters to extend this method
to DOPC analysis demonstrating that the method is readily adapted for use with vesicles
composed of any lipid with appropriate validation or calibration.
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2.1.2. THEORETICAL CALCULATIONS
Quantifying lipids is difficult because they have no absorbance signature in a convenient
region of the UV-Visible spectrum (Figure 2.1.1.). While lipids, themselves, do not
characteristically absorb visible light, supramolecular structures like lipid vesicles scatter light in
a size, wavelength, concentration and media dependent manner known as Mie scattering 6. A
UV-Vis spectrophotometer can be used to evaluate Mie Scattering as a function of wavelength.
Knowing particle size, the wavelength and angle of exposure, as well as the refractive index of
the medium, the concentration of particles in solution can be calculated. Methods for using Mie
scattering theory to measure nanoparticle concentration 6,7 have been modified for application to
cardiolipin and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) vesicles so that vesicle and
lipid concentration can be determined.
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Figure 2.1.1. Scattering measurement of 136.6 nm extruded cardiolipin vesicles prepared at a
concentration of 535 M lipid (based on reported mass from manufacturer) in 20 mM TES Buffer,
0.1 mM EDTA, pH 8. The scattering curve demonstrates no intrinsic absorbance in the UV-Visible
region of the electromagnetic spectrum for cardiolipin.

This method involves calculating the scattering cross section of vesicles of known size at an
appropriate wavelength using Mie scattering theory, measuring the absorbance of the vesicle
with a UV-Vis spectrophotometer and solving Beer’s law for the particle concentration. Matlab
code is provided in Appendix I.1 for the required calculations. To accurately calculate scattering
due to vesicles, vesicle size, angle and wavelength of absorbance and the index of refraction of
the medium are required. Furthermore, with appropriate validation or calibration, the number of
lipids per vesicle can be determined, allowing total lipid concentration to be calculated.
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To relate absorbance to the calculated scattering off of a non-absorbing vesicle, Beer’s law
must be expressed in terms of the scattering extinction coefficient, C ext 6,7;
𝐴(𝜆) = 𝑑 ∑𝑖 𝑁𝑖 𝐶𝑒𝑥𝑡,𝑖 (𝜆)

Eqn. 2.1.1

where d is sample path length, N is the number of scattering centers and A is the total absorbance
measured at a specific wavelength, .
The scattering extinction coefficient is expressed as 6,7
𝜆2

𝐶𝑒𝑥𝑡 = 2𝜋 ∑∞
𝑛=1(2𝑛 + 1) 𝑅𝑒{𝑎𝑛 + 𝑏𝑛 }

Eqn. 2.1.2

where an and bn are the differential expressions of Bessel functions
𝑎𝑛 =

′ (𝑥)−𝜓 (𝑥)𝜓′ (𝑚𝑥)
𝑚𝜓𝑛 (𝑚𝑥)𝜓𝑛
𝑛
𝑛
′ (𝑚𝑥)
𝑚𝜓𝑛 (𝑚𝑥)𝜉𝑛′ (𝑥)−𝜉𝑛 (𝑥)𝜓𝑛

𝑏𝑛 =

′ (𝑥)−𝑚𝜓 (𝑥)𝜓′ (𝑚𝑥)
𝜓𝑛 (𝑚𝑥)𝜓𝑛
𝑛
𝑛
′ (𝑚𝑥)
𝜓𝑛 (𝑚𝑥)𝜉𝑛′ (𝑥)−𝑚𝜉𝑛 (𝑥)𝜓𝑛

Eqn. 2.1.3a

Eqn. 2.1.3b

where ψn, is the Ricatti-Bessel Function, j(n), of the first kind, and ξ n, is the Hankel function,
h(n), of the first kind. The value, x is the size parameter relating vesicle radius, R, to wavelength;
𝑥=

2𝜋𝑅𝑒(𝑚)𝑅

Eqn. 2.1.4

𝜆

where wavelength, , is reported in the same units as the vesicle radius. The value m is the
relative refractive index represented by the real, nRe, and complex, nIm, parts of the refractive
index of the lipid and water.
𝑛𝑅𝑒,𝑙𝑖𝑝𝑖𝑑+𝑛𝐼𝑚,𝑙𝑖𝑝𝑖𝑑

𝑚=𝑛

Eqn. 2.1.5

𝑅𝑒,𝑤𝑎𝑡𝑒𝑟 +𝑛𝐼𝑚,𝑤𝑎𝑡𝑒𝑟
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For cardiolipin. nRe,lipid was set to 1.46 8, while nIm,lipid was approximated as nIm,water at 200 nm
(1x10-7, 9). The wavelength dependence of nRe,water was calculated with Eqn. 2.1.6 10,
6.662

𝑛𝑅𝑒,𝑤𝑎𝑡𝑒𝑟 (𝜆) = 1.31848 + 𝜆−129.2

Eqn. 2.1.6

while nIm,water was approximated using the value at 200 nm reported above. Equations 2.1.2-2.1.6
were programmed into Matlab to solve Eqn. 2.1.1 for N, allowing calculation of vesicle
concentration. Absorbance measurements taken with a Beckman Coulter DU 800 UV-Visible
spectrophotometer were used in the calculation. Wavelengths were selected such that the value
of x in Equation 2.1.4 was between 1 and 10. Wavelengths of 300-400 nm are ideal for
measuring vesicle scattering off of 100-200 nm diameter vesicles.

2.1.3. EXPERIMENTAL METHODS
2.1.3.1. Fluorescein Vesicle Preparation.
Vesicles of cardiolipin (TOCL, Avanti Polar Lipids) were formed in the presence of high
concentrations (~mM) of fluorescein dye in 20 mM TES, 0.1 mM EDTA at pH 8. Lipids were
purchased in chloroform from Avanti. Lipids were initially dried under a steady stream of Argon
for 2 hours to remove chloroform. The dried sample was reconstituted into the above specified
buffer and vortexed for 1 minute. Lipid solutions then underwent a freeze/thaw/vortex cycle that
was repeated 5 times. Lipids were then extruded with an Avanti Mini-extruder fitted with 200
nm membranes to form vesicles. Vesicle diameter was measured by DLS and found to be 136.6
nm. Fluorescein-filled vesicles were buffer exchanged to remove unencapsulated dye from the
buffer using a 10,000 MWCO Amicon centrifugal ultrafiltration device. Samples were buffer
exchanged multiple times until the flow through showed no detectable fluorescein (𝜀495 = 76,000
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M-1 cm-1) by UV-Vis spectroscopy. Vesicle size did not change during buffer exchange from that
observed immediately after extrusion, as determined by DLS. The spectra of vesicle samples
were collected at a series of dilutions. Total fluorescein concentration in the vesicle stock
solution was calculated after adjusting for dilution. Vesicle inner volume was approximated by
using the lipid size to estimate bilayer thickness, so that the measured vesicle diameter could be
corrected for bilayer thickness (estimated as ~3.9 nm from the combined acyl chain and
headgroup length of cardiolipin determined with MacPymol software, Schrödinger, Inc.). This
estimation corresponds closely with recently published experimental data for cardiolipin bilayers
(bilayer thickness ~3.7 nm11). Using inner volume per vesicle derived in this manner, the total
initial solution volume and the fraction of absorbance remaining after buffer exchange, the
vesicle concentration was calculated (Table 2.1.1.).

2.1.3.2. NBD Vesicle Preparation.
To calibrate lipid concentration to vesicle concentration, vesicles were doped with 5% NBDlabelled DOPC lipid (Avanti Polar Lipids), (for NBD, 𝜀 485 = 19,500 M-1 cm-1).

Cardiolipin(TOCL)/NBD-labelled DOPC vesicles were formed under the same conditions as
stated above using Cardiolipin that was mixed with 5% mole ratio NBD-labelled DOPC lipid in
chloroform. The resultant mixture was dried to remove chloroform before reconstitution in 20
mM TES buffer in 0.1 mM EDTA at pH 8.
Cardiolipin(TOCL)/NBD-DOPC mixtures were extruded using an Avanti mini extruder and
their size was measured using DLS. NBD-DOPC lipid was assumed to fully incorporate into
cardiolipin vesicles at a 5% mole ratio. The membranes of the extruder were colorless after
vesicle extrusion, consistent with this assumption. The scattering and absorbance spectrum of the
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NBD doped cardiolipin vesicles was measured from 200-800 nm at a series of dilutions (Figure
2.1.2.). The absorbance spectrum of free NBD in solution was also measured (Figure 2.1.2.).
NBD absorbance was evaluated from the UV-Vis spectrum of vesicles (Figure 2.1.2.) and used
to determine cardiolipin concentration. Cardiolipin concentration from three independently
prepared samples is reported in Table 2.1.2. Lipid concentration was also evaluated from the
scattering portion of the UV-Vis spectrum (Figure 2.1.2.) using vesicle concentration obtained
from Mie scattering and the lipid density evaluated from the relative surface area of cardiolipin
(129.8 Å2, [1]) and the vesicle.
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Figure 2.1.2. CL vesicles were prepared at 5% NBD mole ratio. Total absorbance was measured
(red) and the NBD signal (blue, dashed) was subtracted to produce scattering due to vesicles
(yellow). Scattering data were fit using equations 1-6 for wavelengths between 300-400 nm.
Vesicles were measured to be 136 nm using DLS and lipid concentration per vesicle was
approximated to be 1.75x105 lipids/vesicle based on ICP measurements.

2.1.3.3. ICP Sample Analysis to Measure Lipid Concentration.
Cardiolipin (TOCL, Avanti Polar Lipids) vesicles were prepared in 20 mM TES, 0.1 mM
EDTA at pH 8 by extrusion through two 200 nm pore membranes using an Avanti Mini-extruder
using the same lipid preparation as stated previously. Scattering and R g (DLS) were measured for
each sample before submission for ICP phosphorous analysis.
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DOPC (Avanti Polar Lipids) vesicles were prepared in 20 mM TES, 0.1 mM EDTA at pH 8
by extrusion through two 100 nm pore membranes using an Avanti Mini-extruder using the same
lipid preparation method as stated previously. Scattering and R g (DLS) were measured for each
sample before submission for ICP phosphorous analysis.
DLS was performed on extruded vesicles to measure particle size and vesicle concentration
of the stock was calculated using the Matlab vesicle concentration calculator. Samples were then
made from the stock at various concentrations. The corresponding vesicle concentration for each
sample was calculated using the Matlab vesicle concentration calculator before submission for
ICP phosphorous analysis. A cold digest (concentrated nitric acid, 12 hours) was used to remove
both phosphorous atoms from the cardiolipin headgroup2 and samples were analyzed on a Perkin
Elmer 5300 DV ICP-OES using the 178.2 nm emission of phosphorous.

2.1.3.4. Method Validation.
Initial validation or calibration measurements are required before the Matlab vesicle
concentration calculator (MVCC) can be used simply with absorbance data as input. Strong
absorbing dyes were used to estimate vesicle and lipid concentration and relate these
measurements to scattering measurements. All experiments were performed on a Beckman
Coulter DU 800 UV-Visible spectrophotometer where the spectral range from 200 to 800 nm
was monitored. A Malvern Zetasizer Dynamic Light Scattering (DLS) instrument was used to
monitor vesicle size throughout the validation process. If a DLS instrument is not available,
particle size can be measured with a UV-Vis spectrophotometer7.
To validate the MVCC, vesicles were first quantified by labelling their interior with a
strongly absorbing dye and measuring dye content after external dye was removed by extensive
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washing. Knowing vesicle size (and thus internal volume) and initial dye concentration, vesicle
concentration could be calculated from the decrease in dye absorbance after the wash step.
Vesicles were formed in the presence of fluorescein (a strongly absorbing dye) to determine
vesicle concentration. External fluorescein was removed from extruded vesicles by buffer
exchange and the residual fluorescein concentration was calculated. This fluorescein
concentration was related to inner volume of a vesicle to determine the total number of vesicles
required to produce the fluorescein absorbance (Table 2.1.1.).
Next, the vesicle concentration was found using Mie scattering theory. To extract scattering
data from spectra taken of fluorescein-filled vesicles, the fluorescein absorbance was subtracted
from spectra collected after buffer exchange (Figure 2.1.3.). Scattering absorbance data between
300-400 nm were input into the Matlab vesicle concentration calculator because this spectral
region has minimal fluorescein absorbance (Figure 2.1.3.) The vesicle concentration obtained is
reported in Table 1. The vesicle concentration found using fluorescein is within an error of less
than 8% of the vesicle found using Mie Scattering theory in three independent trials. Taking into
account the error in approximating inner vesicle volume and extracting scattering absorbance
from the raw absorbance data, the agreement is good, validating the use Mie scattering theory to
calculate vesicle concentration.
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Table 2.1.1.
Comparison of vesicle concentration calculated using fluorescein filled vesicles with
that obtained from Mie scattering for the same vesicles.
Vesicle Concentration from
Vesicle Concentration from
% Error
Fluorescein Absorbance
Mie scattering
4.8 ± 0.1 x1017

5.15 ± .01 x1017

6.8

5.0 ± 0.1 x1017

5.16 ± .01 x1017

3.1

4.8 ± 0.1 x1017

5.16 ± .01 x1017

7.0

Concentrations reported in vesicles per L. Vesicle concentration measurements and
calculations found for three independent trials. Error reported reflects error in
absorbance measurements.
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Figure 2.1.3. Fluorescein filled vesicle scattering and absorbance data of extruded vesicles
measuring 136.6 nm in diameter using DLS (blue). Fluorescein intrinsic absorbance spectrum
shown for diluted fluorescein stock used during vesicle preparation (dotted red). Scattering off
vesicles after subtracting out absorbance due to fluorescein inside vesicles.

Having established that the number of vesicles per sample could be calculated, we carried out
a second, independent set of experiments so that the MVCC could be calibrated to incorporate
lipid density per vesicle to permit lipid concentration determination. In these experiments, lipid
concentration per vesicle was measured using fluorescently labelled lipid to correlate vesicle
concentration to lipid concentration. NBD-labelled DOPC lipid was used to dope Cardiolipin
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vesicles and determine lipid concentration. Associated scattering data from absorbance
measurements was used to calculate vesicle concentration and relate that to lipid concentration
using Cardiolipin headgroup size as reported by Pan et al.11 The lipid concentrations obtained
from NBD absorbance and from Mie scattering theory from three independent trials are within
5% (Table 2.1.2.), confirming the validity of the surface area used for cardiolipin.

Table 2.1.2.
Comparison of lipid concentration calculated using NBD doped vesicles with that
obtained from Mie scattering for the same vesicles.
Lipid Concentration from
Lipid Concentration from Mie
% Error
NBD Absorbance, M
scattering, M
8.5 ± 0.3 ×10-4

8.41 ± .04 ×10-4

1.1

8.4 ± 0.2 ×10-4

8.20 ± .03 ×10-4

2.4

8.5 ± 0.2 ×10-4

8.16 ± .02 ×10-4

4.4

Error evaluated as standard deviation of multiple spectra collected for each trial.

As an independent external method for lipid concentration calibration, ICP was used to
measure phosphorous content of samples of pure cardiolipin vesicles. Samples were prepared for
ICP as outlined in Supplementary Information. The correspondence between cardiolipin
concentration obtained by phosphorous analysis and cardiolipin concentration calculated with the
MVCC using the experimental value for cardiolipin surface area11 to evaluate lipid density was
consistently within <5% (Table A.1.).
To demonstrate the versatility of the MVCC, samples of DOPC were also submitted for ICP
analysis and compared to MVCC calculated concentrations (TableA.1.). DOPC bilayer
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thickness, headgroup surface area 11 and index of refraction 12 were used to calculate DOPC lipid
concentration from scattering. Error between the MVCC and ICP was within <3% demonstrating
the calculator’s ability to accurately measure lipid concentration given the corresponding lipid
physical parameters.
Lipid concentration, as determined using the reported manufacturer concentration, was
compared to MVCC findings to analyze the necessity of a vesicle calculator in quantitative
experiments. Significant deviations in concentration based on manufacturer specified lipid mass
or concentration and ICP analysis are reported for all DOPC and TOCL samples in Table A.2.
Error in concentration based on starting material and final ICP measurements were as high as
28%, whereas the correspondence between the ICP and MVCC values was always <5% (Table
A.1.). Because of the vesicle formation process used, lipid had the potential of being lost in
several steps demonstrating that concentration based on manufacturer reported lipid mass does
not necessarily reflect final experimental concentration. This finding supports the use of the
MVCC in reliably determining lipid concentration for quantitative experiments.

2.1.4. CONCLUSION
The Mie scattering-based method for vesicle quantification was designed to provide a quick,
reliable, and cost effective analytical method, which after initial validation by absorbance and/or
phosphorous analysis, can be implemented immediately before any experiment involving use of
extruded vesicles. The method allows vesicle concentration to be accurately measured simply
using UV- Vis measurements. Knowing the surface area of the lipid (validated or calibrated by
absorbance or by phosphorous analysis), lipid concentration can also be obtained with the
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MVCC. Due to the simplicity of the experimental setup, vesicle and lipid concentrations may be
calculated quickly and without sample destruction, providing a reliable alternative for more timeconsuming methods.
The wavelength measurement range is only limited by the size of the vesicle (thus size
parameter, x (See Eq. 1.4)) and constraints of the detection device. When using extruded vesicles
or vesicles with a well-defined radius, as was done here, DLS measurements are not necessary
once vesicle size is established, although occasional spot- checking of the consistency of the
extrusion process is recommended. While the region of 300-400 nm was used to measure vesicle
scattering and calculate concentration, any convenient wavelength in the UV-Visible spectrum
may be used provided the constraints on size parameter, x, are met from Eqn. (2.1.4). This
technique uses the mean vesicle radius to determine Cext for a scattering center. Table A.3.
provides wavelength ranges for testing dependent on vesicle size for various vesicle
compositions. It should be noted that for samples with large standard deviations in vesicle radius,
theoretical vesicle calculations may have higher error.
The technique may be adopted for any pure lipid system. The above outlined technique
should also work for mixed lipid systems, provided the refractive index of the mixed lipid vesicle
is available. Finally, any buffer that does not appreciably change the index of refraction may be
used provided it does not absorb significantly at the wavelength of detection. Modifications may
be made to incorporate the adjusted index of refraction of the buffering media if needed.
A simplified version of the MVCC written in .m file format can be found in Appendix I.1
with associated instructions on the installation and running of the file. This version uses reported
index of refraction, headgroup size and bilayer thickness to calculate lipid concentration for
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TOCL, DOPC, POPC (1- palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPG (1palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1’-rac-glycerol)).8,11–15
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2. 2. Rapid quantification of vesicle concentration for DOPG/DOPC and
Cardiolipin/DOPC mixed lipid systems of variable composition.

2.2.1. INTRODUCTION
Lipid bilayers in the form of micelles, vesicles and liposomes are important for studies of
membrane associated biological interactions. More recently, they have been utilized for vaccine
delivery.16 Both fields use a diverse array of lipid compositions to form biologically relevant
membranes.16,17 To date, basic characterization of lipid systems has been time consuming and
expensive.
Recent work by Elmer-Dixon and Bowler (See Chapter 2.1.)18 described and validated a
rapid, label-free, and non-destructive method to determine vesicle number and to generate lipid
concentration in pure lipid systems composed of either 1,2-dioleoyl-sn-glycero-3phosphocholine (DOPC) or cardiolipin (1’,3’-bis[1,2-dioleoyl-sn-glycero-3-phospho]-snglycerol, TOCL). Using Mie scattering theory, Beer’s law was applied to scattering, nonabsorbing vesicles to calculate the number of vesicles scattering light.6,18 A standard UV-Visible
spectrophotometer was used to acquire absorbance measurements of the pure lipid vesicles.
Knowing vesicle size and the refractive index of the lipid, vesicle concentration was calculated
using a Matlab Vesicle Concentration Calculator (MVCC, code found in Appendix I.1).18 Lipid
concentration measurements using standard methods were used to calibrate the number of lipids
per vesicle allowing the MVCC also to derive lipid concentration from the absorbance data. This
paper extends the MVCC to allow calculation of vesicle number and lipid concentration for
mixed lipid systems.
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2.2.2. THEORETICAL CALCULATIONS
As previously noted,18 quantification of lipids is difficult because they lack a characteristic
absorbance in the UV-Visible spectrum. However, it is possible to quantify lipid-containing
vesicles based on their light scattering properties, using Mie scattering theory. Knowing the lipid
number per vesicle, a total lipid concentration can be calculated. Our previous work applied this
approach to quantify vesicle and lipid concentrations for pure lipid systems of Cardiolipin and
DOPC.18 Simple modifications in the calculation of vesicle concentration from UV-Visible
spectrophotometer scattering measurements can be implemented to extend the technique to
mixed lipid systems.
The pure lipid vesicle quantification method of Elmer-Dixon and Bowler (see Chapter 2.1.)18
requires that the physical characteristics of the pure lipid are known. Specifically, the MVCC
requires that the lipid headgroup surface area, lipid bilayer thickness and refractive index of the
lipid are known. Headgroup surface area and bilayer thickness are used to determine total vesicle
surface area and approximate lipid packing in the membrane allowing calculation of the total
number of lipids per vesicle given a known vesicle diameter. Refractive index is required as it
dictates how light interacts with the non-absorbing vesicle surface leading to a deviation from its
initial trajectory. Cardiolipin (TOCL) and DOPC have significantly different refractive indices
(1.468 and 1.375,12 respectively) resulting in differences in the absorbance due to scattering when
the same number of vesicles for each pure lipid are scanned with a UV-Visible
spectrophotometer. Refractive index prediction for heterogeneous systems from individual
component refractive indices is well established for bulk liquid mixtures. 19 That said, the lipids
comprising the system are constrained to the lipid bilayer at the surface of the vesicle. At the
time of this publication, the authors are unaware of existing models to predict refractive index
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from component refractive indices for mixed lipids on surfaces. To extend the MVCC to mixed
lipid systems, we have developed and validated a model for approximating the refractive index
of lipid mixtures.
The quantification of mixed lipid vesicles requires the use of a bilayer refractive index
dependent on the composition of the mixed lipid system. Assuming that lipids readily
incorporate into heterogeneous vesicles, a corresponding refractive index can be calculated based
on the mole fraction of membrane constituents, the headgroup surface area of each lipid and the
corresponding refractive index for that lipid. The mole fraction of each constituent lipid in the
membrane only partially dictates the surface composition of a heterogeneous lipid membrane
because the surface area of the headgroup of each constituent lipid can vary considerably. The
mole fraction, xi, of a lipid, ℓi, in a system of mixed composition is

[ℓ ]

𝑥𝑖 = ∑ [ℓ𝑖 ] .
𝑖

Eqn. 2.2.1

𝑖

We define effective lipid headgroup surface area, HDSAeff, as the mole fraction weighted sum of
the actual surface areas of the constituent lipids, HDSAi,

𝐻𝐷𝑆𝐴𝑒𝑓𝑓 = ∑𝑖 𝑥𝑖 ∗ 𝐻𝐷𝑆𝐴𝑖

Eqn. 2.2.2

Using HDSAeff, the fractional surface area, Pi, for each lipid constituent is the mole fraction
weighted surface area of each divided by HDSAeff:
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𝐻𝐷𝑆𝐴𝑖

𝑃𝑖 = 𝑥𝑖 ∗ 𝐻𝐷𝑆𝐴

𝑒𝑓𝑓

.

Eqn. 2.2.3

Because the refractive index is expected to be proportional to fractional contribution of each lipid
to lipid surface area, the effective refractive index of a mixed lipid system is the sum of
refractive indices (RIi) of the constituent lipids weighted by Pi:

𝑅𝐼 = ∑𝑖 𝑅𝐼𝑖 ∗ 𝑃𝑖 .

Eqn. 2.2.4

Equations 1-4 have been used to modify the previously published Matlab code (Appendix I.2)18
to incorporate the mixed lipid refractive index. The updated Matlab code, which we refer to as
the Mixed Lipid Calculator (MLC), incorporates this method of evaluating RI for a mixed lipid
vesicle, and is provided in supplementary information. Like the MVCC for pure lipid vesicles,
the MLC requires absorbance measurements of scattering off of vesicles of known approximate
size to calculate particle and lipid concentration using Beer’s law. 6,18

2.2.3. EXTERNAL VALIDATION.
To validate the above method for evaluating refractive index in mixed lipid systems, vesicle
and lipid concentration calculations with the MLC were compared with direct measurements of
lipid content using phosphorous analysis. Samples analyzed with the MLC were prepared and
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sent for independent lipid concentration analysis using Inductively Coupled Plasma Atomic
Emission Spectroscopy (ICP) to determine phosphorous content.
The previously reported MVCC was not tested and validated with pure DOPG vesicles using
the known physical parameters of the lipid (Refractive index, headgroup surface area, bilayer
thickness). Thus, before modifying the MVCC for use with mixed lipid systems containing
DOPG, the MVCC was validated for pure DOPG vesicles using a headgroup surface area of
0.694 nm2,20 a bilayer thickness of 3.63 nm20 and a refractive index of 1.359.12
Known amounts of DOPG (Avanti Polar Lipids, Inc), based on the manufacturer reported
mass, were dried under a constant flow of compressed nitrogen to remove excess chloroform.
Samples were then reconstituted in 20 mM TES buffer, 0.1 mM EDTA, pH 8 to yield a
concentration based on the manufacturer reported mass (see Table A.4.). Samples were extruded
to 100 nm diameter using an Avanti Mini-extruder. Vesicle diameter was verified with dynamic
light scattering (DLS) measurements using a Malvern Zetasizer. A Beckman-Coulter DU 800
spectrophotometer was used to measure Mie scattering in standard absorbance mode for each
sample at multiple wavelengths between 300 and 400 nm. The vesicle diameter and the Mie
Scattering data were used to evaluate lipid concentration using the MVCC.18 Samples were then
submitted for independent ICP analysis. Table 2.2.1. compares the results for the two methods.
The agreement between ICP and the MVCC is excellent.
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Table 2.2.1.
Comparison of DOPG lipid concentration in 100 nm pure DOPG vesicles found
using ICP and calculated from Mie scattering data using the MVCC.
DOPG lipid concentration
DOPG lipid concentration from
% Error‡
*
†
measured using ICP, mM
Mie scattering (MVCC), mM
1.16

1.14 ± 0.02

1.7%

0.94

0.89 ± 0.05

5.3%

0.20

0.21 ± 0.01

5.0%

*Based

on phosphorous content obtained from ICP measurements (see Table A.4) after a cold digest
to release phosphorous (see ref. [3])
†Error is the standard deviation from scattering measurements at different wavelengths
‡
% Error for Mie scattering data versus ICP data

Samples of mixed lipid composition were then prepared to test the validity of the method of
evaluating RI for mixed lipid vesicles implemented in the MLC. Known masses of DOPC were
mixed with known masses of either Cardiolipin (CL) or DOPG (Avanti Polar Lipids, Inc) based
on their manufacturer reported concentrations, and dried under a constant flow of compressed
nitrogen to remove excess chloroform. Samples were then reconstituted in 20 mM TES buffer,
0.1 mM EDTA, pH 8 to yield a concentration based on the manufacturer reported mass (see
Table A.5.). Concentrations for reconstitution were well above the known critical micelle
concentration (CMC) for constituents of the mixture to ensure heterogeneous incorporation of
lipids into vesicles.21 Samples were extruded to 100 nm diameter using an Avanti Mini-extruder.
Vesicle diameter was verified using DLS (Malvern Zetasizer). Mie scattering was measured with
a Beckman-Coulter DU 800 spectrophotometer operating in standard absorbance mode. For each
sample, multiple wavelengths between 300-475 nm were used to evaluate Mie scattering.
Samples were then submitted for independent ICP analysis.
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Table 2.2.2. reports lipid concentration and compares calculated total lipid concentration
using Mie scattering to total concentration obtained by ICP measurements of phosphorous
content. The average percent error between the values obtained by ICP and those calculated from
Mie scattering with the MLC is 4.3%, providing a strong validation of our method for evaluating
refractive index in mixed lipid systems. The concentrations from Mie scattering measurements
are also mostly within one standard deviation of the concentrations obtained by phosphorous
analysis (Table 2.2.2.). The method of evaluating RI for mixed lipid systems provides close
agreement between ICP measurements and calculations from Mie scattering data with the MLC
across a broad range of mixing ratios, indicating that the method of evaluating RI is general.
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Table 2.2.2.
Comparison of total lipid concentrations of 100 nm DOPC:CL or DOPC:DOPG mixed
lipid vesicles found using ICP and calculated with the MLC.
Mixed lipid
vesicle
content*

Total lipid
concentration
by ICP, mM†

20% CL

0.93

Total lipid
concentration
from Mie
scattering (MLC),
mM‡
0.95 ± 0.03

20% CL

1.26

20% CL

Calculated
DOPC
concentration
(MLC), mM

Calculated CL
or DOPG
concentration
(MLC), mM

%
Error§

0.76

0.19

2.30

1.37 ± 0.04

1.09

0.27

8.66

2.28

2.47 ± 0.08

1.97

0.49

7.96

50% CL

0.58

0.54 ± 0.03

0.27

0.27

6.22

50% CL

0.35

0.35 ± 0.03

0.17

0.17

1.86

20% DOPG

1.07

1.09± 0.01

0.87

0.22

2.29

20% DOPG

0.38

0.37± 0.01

0.30

0.07

3.26

20% DOPG

0.75

0.79± 0.03

0.63

0.16

4.37

50% DOPG

1.06

1.08± 0.02

0.54

0.54

1.86

*

Mole percent, the remainder being DOPC.
Based on phosphorous content obtained from ICP measurements (see Table A.4) after a cold digest to
release phosphorous (see ref. [3]).
‡
Error is the standard deviation from scattering measurements at multiple wavelengths.
§
% Error for Mie scattering data versus ICP data.
†

Due to the physical nature of the lipids investigated here, it is impossible to obtain scattering
measurements based on specific lipids in a mixed lipid system using absorbance spectroscopy in
the visible range of the electromagnetic spectrum. That being said, knowing the mole fraction of
each constituent lipid from the mass of lipid used to prepare the vesicles, the concentration of
each lipid can be calculated from the total lipid concentration. This indirect measurement permits
quantification of individual lipid populations in mixed lipid systems using the MLC (see Table
2.2.2.). The close correlation between the lipid concentrations obtained by Mie scattering and
ICP also indicates that the manufacturer-provided masses are fairly accurate and that losses of
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material during extrusion (average percent error is 11.9 % for mixed lipid systems relative to
ICP, see Table A.5) do not affect the mole fractions of lipids in the vesicles used to evaluate RI.

2.2.4. CONCLUSION
The modification of the MVCC to produce the MLC for mixed lipid systems provides a
rapid, reliable, non-destructive quantification method for timely experimental characterization of
lipid vesicles across a broad range of mixed lipid compositions. The method provides accurate
lipid concentrations using a standard UV-Vis spectrophotometer making the technique accessible
and affordable.
As discussed in our earlier report,18 the optimal wavelength region for Mie scattering
measurements depends on vesicle size. Further, with vesicle extrusion, DLS is not necessary
once vesicle size is characterized for the system. The MLC has been validated for DOPC:DOPG
and DOPC:CL mixed lipid vesicles, but can be extended to any other lipid if the headgroup
surface area, the bilayer thickness and the refractive index of the lipid of interest is known.
Finally, all lipid mixtures in this work were prepared well above the CMC. 21 If sample
preparation for vesicle formation is near the transition temperature for a specific lipid or the
CMC, the resultant vesicles may not be heterogeneous. In this case, the MLC may fail to
accurately measure lipid concentration.
Matlab code for the MLC along with installation and user instructions can be found in
Appendix I.2.
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CHAPTER 3: Site A-mediated Partial Unfolding of Cytochrome c on
Cardiolipin Vesicles Is Species Dependent and Does Not Require Lys72

3.1. INTRODUCTION
Cytochrome c (Cytc) is well known to function as an electron transporter during respiration.1
More recently, Cytc was shown to be involved in the initiating steps of apoptosis.2-4 This
involvement requires the protein to dissociate from the inner mitochondrial membrane and exit
mitochondria.2-4 Before any of these steps can happen, the protein must oxidize cardiolipin
(CL).4, 5 Thus, the nature of Cytc-CL binding, CL oxidation by Cytc and subsequent dissociation
of Cytc from CL recently has been the subject of intense investigation.6, 7 Cytc-membrane
interactions have been studied in vitro with a variety of memetic membrane systems using
primarily mammalian Cytc,8-21 and in some cases, yeast iso-1-Cytc.22, 23 These studies use
differing compositions of mixed lipid systems, salt and solution concentrations and detection
techniques. These variations make direct comparison of protein response to lipid exposure
between and among different studies difficult, if not impossible. Four binding sites, A (Figure
3.1, anionic site; lysines 72, 73, 86 and 87; electrostatic),13, 14, 21 C (cardiolipin site; Asn52;
hydrophobic),13, 14 L (lysines 22 and 27, histidines 26 and 33; membrane fusion)24 and N (novel
site; Phe36, Gly37, Thr58, Trp59, Lys60)25 have been characterized. However, few studies have
attempted to analyze the binding at these sites in isolation or via mutagenesis methods.26, 27
Similarly, few studies exist that directly compare binding behavior for Cytc from different
species.22, 23
Comparison of the binding of yeast iso-1-Cytc versus human Cytc to cardiolipin vesicles has
the potential to provide important insight into how this interaction has evolved to optimize the
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Cytc-mediated switch that initiates the intrinsic pathway of apoptosis through peroxidation of
cardiolipin. Yeast, while capable of releasing Cytc from mitochondria under solution conditions
that mimic apoptosis,28 lacks many components of the intrinsic pathway of apoptosis, including
the ability to interact with Apaf-1 to form a functional apoptosome.32-34 Yeast iso-1-Cytc has
been free of the necessity of evolving to bind to Apaf-1, which has led to some changes in
sequence that affect the charge distribution around site A. Mutating Glu62 to the yeast residue,
Asn, in horse Cytc leads to a 10-fold decrease in caspase activation.34
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Figure 3.1. Overlay of yeast iso-1-Cytc (PDB entry 2YCC;29 light gray and salmon) and human
Cytc (PDB entry 3ZCF;30 dark gray and red) aligned using Pymol.31 Lys72 (trimethyllysine in
yeast, tmK72), Lys73, Lys86 and Lys87, which have been implicated as constituents of site A,
are show in light gray and dark gray stick models for yeast iso-1-Cytc and human Cytc,
respectively. Ω-Loop-D (residues 70 – 85), which positions the Met80 heme ligand, is shown in
salmon and red for yeast iso-1-Cytc and human Cytc, respectively. Trp59, seen behind the heme,
is shown as a blue stick model. The heme and its ligands, Met80 and His18, are shown as light
gray and dark gray stick models for yeast iso-1-Cytc and human Cytc, respectively.
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Figure 3.2. Surface electrostatics of site A in
yeast iso-1-Cytc versus human Cytc. (A)
yeast iso-1-Cytc (PDB entry 2YCC),29 (B)
chain A of human Cytc (PDB entry 3ZCF)30
and (C) chain A of human K72A Cytc (PDB
entry 5TY3).35 Electrostatic surface was
generated with PyMol.31 Positive, neutral and
negative electrostatic surfaces are indicated
by blue, white and red surfaces, respectively.
Lysine and glutamate residues in or near site
A are labelled.
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This mutation contributes to a significant change in the continuity of the positive surface
charge around site A (Figure 3.2), along with the additional mutation from Thr69 in yeast to
Glu69 in mammals. The re-ordering of the cluster of charged residues at positions 86 – 90 that
follow

-loop D (KKEKD in yeast iso-1-Cytc and KKKEE in human Cytc) also changes the

charge distribution around site A (Figure 3.2A versus 2B) and has implications for ATP
inhibition of CL binding.23 Studies on the salt dependence of yeast iso-1-Cytc versus horse Cytc
binding to 100% CL vesicles indicate that the electrostatic interaction with CL is much stronger
for yeast iso-1-Cytc,23 indicating that these evolutionary changes significantly impact the
Cytc/CL interaction. However, this study was carried out at pH 7 and showed strong increases in
light scattering when 100% CL vesicles were mixed with yeast iso-1-Cytc and horse Cytc. This
behavior indicates that significant binding through site L, which leads to membrane fusion, was
occurring under these conditions and thus the results do not report exclusively on site A binding.
To address the evolution of Cytc/CL binding specifically through site A, solution conditions to
quantitatively investigate site A, in the absence of other binding sites, have been developed. CL
vesicle binding to wild type human Cytc (HuWT) and wild type yeast iso-1-Cytc (yWT), using
Escherichia coli-expressed iso-1-Cytc, which lacks the native post-translational modification at
K72 (𝜀-NH2 is trimethylated in yeast36), has been characterized. The results show that site A
binding to 100% CL vesicles is both similar and different for yeast iso-1-Cytc and human Cytc.
Recent studies on horse Cytc variants have also indicated that Lys72 is a predominate
contributor to CL/Cytc binding at pH 7.26, 27 The structure of human Cytc carrying a K72A
mutation shows the expected truncation of the charge surface usually assigned to site A (Figure
3.2B versus 3.2C). Thus, significant effects on site A binding might be expected. Recent work
indicates that K72A mutations to yeast iso-1-Cytc37 and human Cytc35 can promote
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conformational fluctuations that enhance the intrinsic peroxidase activity of these proteins. Thus,
it is of interest to evaluate whether the enhanced conformational flexibility produced by the
K72A mutation also affects binding through site A. The site A specific binding conditions
developed here are also applied to K72A variants of yeast iso-1-Cytc and human Cytc (yK72A
and HuK72A, respectively). Our results indicate that other nearby lysines can compensate for the
loss of Lys72 from site A.

3.2. EXPERIMENTAL METHODS
3.2.1. Mutagenesis.
The yeast WT iso-1-cytochrome c was made using the QuikChange Lightning Site-Directed
Mutagenesis kit (Agilent Technologies, Inc.) to mutate Ala72 to lysine (A72→K72) (primers:
CATGTCAGAGTACTTGACTAACCCAAAGAAATATATTCCTGGTACCAGATGG and its
reverse complement, from Invitrogen Life Technologies) in the pRbs_BTR1 plasmid38 carrying
the gene for the K72A variant of iso-1-Cytc.37 The pRbs_BTR1 plasmid38 is a derivative of
pBTR136, 39 with an optimized ribosomal binding sequence. pRbs_BTR1 co-expresses the iso-1cytochrome c gene, CYC1, and the yeast heme lyase gene, CYC3, allowing covalent attachment
of the heme in the cytoplasm during expression. After mutagenesis, mutant DNA was
transformed into XL-10 Gold Competent Escherichia coli cells (Agilent Technologies). Cultures
(5 mL) of individual clones were grown and the DNA extracted using a Wizard Genomic DNA
Purification Kit (Promega Corp). Extracted DNA was submitted to the Murdock DNA
Sequencing Facility (University of Montana, Missoula) for sequencing to confirm successful
mutagenesis.
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3.2.2. Protein Preparation.
The yeast iso-1-cytochrome c variants yWT and yK72A37 were expressed from the
pRbs_BTR1 plasmid. Human Cytc variants, HuWT and HuK72A,35 were expressed from the
pBTR(HumanCc) plasmid, obtained from the Pielak laboratory at the University of North
Carolina.40 DNA plasmids for all mutants were transformed into E. coli BL21 competent cells
(EdgeBio, Gaithersburg, MD). The yeast and human variants were expressed and purified using
previously reported methods.41-44 Final purification was by HPLC cation exchange (Uno S6,
BioRad) using a previously described gradient.41 Purified protein in the reduced state was
oxidized using a 5-fold excess by weight of potassium ferricyanide followed by size exclusion
chromatography using a Sephadex G-25 (GE Healthcare Life Sciences) column to separate
oxidized Cytc from ferricyanide. Protein concentration prior to experiments was determined by
UV-Vis spectroscopy (Beckman Coulter DU 800 spectrophotometer) using the previously
reported extinction coefficients of Cytc at 339, 526.5, 541.75 and 550 nm.45

3.2.3. Lipid and Vesicle Preparation.
Cardiolipin (1’,3’-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol, TOCL) was
purchased from Avanti Polar Lipids, Inc., Alabaster, AL and used in vesicle formation without
further purification. Lipids were dried under Argon to remove chloroform before being
reconstituted in 20 mM TES Buffer, 0.1 mM EDTA, pH 7 or pH 8, as specified. Lipids and
buffer were vortexed for 1 minute then set in a warm bath for 9 minutes. This vortex/warm bath
cycle was repeated 10 times. To form vesicles, the lipid solution underwent a freeze/thaw/vortex
cycle five times. The vesicle solution was then extruded to the desired vesicle size using an
Avanti mini-extruder with two 100 nm membranes. The size of the extruded vesicles was
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measured using a Malvern Dynamic Light Scattering (DLS) instrument and found to be 102 ± 9
nm. Scattering measurements were performed using a Beckman Coulter DU 800 with a 10 mm
pathlength Hellma micro-cuvette. Scattering measurements were used in coordination with DLS
measurements to determine vesicle and lipid concentration using a previously reported technique
based on Mie scattering.46 Vesicles were used immediately after preparation to avoid issues
related to vesicle stability. DLS measurements following experiments indicated no change in
vesicle size.

3.2.4. Titration of Cytc with Cardiolipin Vesicles.
Titrations were performed using a batch procedure. The main stock of freshly prepared
vesicles was then used to make a set of dilutions at 2-fold the concentration required for each
vesicle concentration in the titration curve. A 2-fold concentration protein stock was added to 2fold concentration lipid for each titration point in a 1:1 ratio resulting in a solution at the desired
protein and lipid concentrations. Samples were gently mixed by hand and incubated for 30
minutes before spectroscopic measurements. Experiments were performed in triplicate and each
sample at each concentration point was prepared independently.

3.2.5. Absorption Spectroscopy.
A Beckman Coulter DU800 spectrophotometer was used to measure the UV-Vis
spectrum during titrations of Cytc with CL vesicles. A 10 mm pathlength Hellma micro-cuvette
was used to measure absorption between 200 and 800 nm at a 1 nm step and 400 nm/min scan
rate with a 5 nm bandwidth.
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3.2.6. Circular Dichroism Spectroscopy.
An Applied Photophysics Chirascan circular dichroism (CD) spectrophotometer was used for
Soret CD measurements. Spectral regions from 350-450 nm were measured with a Hellma 4x10
mm quartz cuvette utilizing the 4 mm pathlength. CD data were acquired using a 1 nm
descending step, 1.8 nm bandwidth and a 3 second acquisition time at 25 C. Three independent
titrations were carried out for each protein. All spectra were smoothed using a 6th order SavitskyGolay filter smoothing technique. The data points in Figure 3.7 of the Results are the average
and standard deviation of the three independent trails for each of the four proteins studied.

3.2.7. Fluorescence Spectroscopy.
An Applied Photophysics Chirascan CD spectrophotometer was adapted for scanning
fluorescence measurements. Tryptophan excitation was performed at 295 nm with a 5 nm
bandwidth. A Helma 5x5 mm fluorescence cuvette was used during data acquisition. Excitation
bleed-through was filtered using a 305 nm cutoff filter (Newport Corp.) and data were acquired
using the scanning emission monochromator provided by Applied Photophysics. Emission
spectra were measured from 320 - 500 nm using a 1 nm step and a 2.5 nm bandwidth with an
acquisition time of 0.5 sec per step. A minimum of three independent trials were acquired for
each Cytc variant. Each trial was smoothed using a 6 th order Savitsky-Golay filter smoothing
technique before averaging data points from the three independent trials (See Figure 3.14,
Results).
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3.2.8. Data Fitting.
CD and fluorescence data for all Cytc variants were fit to the simplest suitable model, a one
site cooperative Langmuir-type equation (eq 3.1), where the spectroscopic value,
𝑠(𝑥) =

𝑥

𝑠𝑜 +𝑠1 (𝐾 (app))
𝑑
𝑥

1+(𝐾 (app))
𝑑

𝑛

𝑛

(eq 3.1)

s(x), corresponds to the amplitude measured at the lipid to protein ratio, x, in the titration and s 0
and s1 are the amplitudes of the initial and final states, respectively. In eq 3.1, Kd(app) is the
apparent dissociation constant corresponding to the lipid concentration or lipid to protein ratio
(LPR) required to induce half occupancy of the conformation associated with site A binding to
CL and n is the associated Hill coefficient.

3.2.9. Guanidine Hydrochloride Induced Protein Unfolding Monitored by Fluorescence.
An Applied Photophysics Chirascan CD spectrophotometer adapted for scanning
fluorescence monochromator measurements and coupled with a Hamilton Microlab 500 series
auto-titrator was used to perform guanidine hydrochloride (GdnHCl) titrations monitored using
Trp59 fluorescence. Tryptophan excitation was performed at 295 nm with a 5 nm bandwidth. A
Hellma 4 mm x 10 mm quartz cuvette was used with excitation along the 4 mm pathlength and
acquisition along the 10 mm pathlength. This cuvette accommodates a stir bar to ensure
complete mixing during the titration. Excitation bleed-through was filtered as described for
vesicle titrations. Emission spectra were measured from 320 - 500 nm as described for vesicle
titrations. The autotitrator was setup to increase GdnHCl concentration variably in 0.05 to 0.1 M
increments. Two protein stock solutions were prepared at 10 µM protein concentration in 1) 20
mM Tris Buffer, 40 mM NaCl, at pH 7 as well as 2) 6 M GdnHCl, 20 mM Tris Buffer, 40 mM
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NaCl, at pH 7 and were stored at 4 C until experimentation when the solutions were equilibrated
to 25 C. Protein stock with GdnHCl was auto-titrated into protein stock with no GdnHCl. After
each increment of GdnHCl, the sample was stirred in the cuvette for 10 seconds and then left to
rest for 100 seconds before data acquisition. Three independent trials were acquired for yWT iso1-Cytc.

3.3. RESULTS
3.3.1. Site A-specific Binding Conditions.
To create a simplified, controlled environment to investigate site A-specific CL binding, we
optimized experimental conditions. Site A sits on the Ω-loop covering heme crevice access1 and
has been characterized as being comprised of Lys72 and Lys73,13, 16 and sometimes lysines 86
and 87 (see Figures 3.1 and 3.2).6, 21 Therefore, electrostatic interactions dominate. Both sites C
and L diminish in importance above neutral pH.14, 24 To isolate site A, binding studies were
carried out in 20 mM TES buffer, 0.1 mM EDTA at pH 8. To further simplify binding, 100% CL
vesicles formed with 1’,3’-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol (TOCL) were
used.
To demonstrate that binding at site A is dominant at pH 8, we compared binding to 100%
TOCL vesicles monitored by UV-Vis spectroscopy at pH 7 versus pH 8 using yWT iso-1-Cytc
and HuWT Cytc. At pH 7, titrations of yWT iso-1-Cytc with CL led to a substantial increase in
light scattering as CL concentration increased (Figure 3.3A), as observed previously.23 Similar
observations are made with HuWT Cytc at pH 7 (Figure 3.4A), although, the degree of light
scattering is less pronounced. Thus, at pH 7, Cytc-CL interactions produce large structures that
generate scattering. This finding corresponds directly with Kawai et al.24 who attributed
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formation of large structures to vesicle fusion mediated by simultaneous binding to both sites A
and L of Cytc.
Deprotonation of ionizable residues contributing to site L eliminates this site above pH 7 in
the membrane system used in this earlier study.24 For 100% CL vesicles, titration of yWT iso-1Cytc and HuWT Cytc at pH 8 led to no significant light scattering, indicating that site L no
longer plays a role in binding at this pH (Figure 3.3B, Figure 3.4B). Thus, CL vesicle titrations at
pH 8 should report on site A binding. While light scattering does not report directly on site C, pH
dependent binding data for site C indicate that binding is almost completely eliminated when pH
is raised to 7.

Figure 3.3. (A) UV-Vis absorbance of yWT iso-1-Cytc in the presence of various
concentrations of 100% CL lipid vesicles at pH 7, 25 C. (B) UV-Vis absorbance of yWT iso-1Cytc in presence of various concentrations of 100% CL lipid vesicles at pH 8, 25 C. Panel A
shows signal shifted well above 0 A.U (absorbance units). across the spectrum for each titration
point above 0 M CL total lipid concentration, indicative of scattering due to large lipid vesicles.
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Figure 3.4. (A) UV-Vis absorbance of 97% oxidized HuWT Cytc in the presence of various
concentrations of 100% CL lipid vesicles at pH 7, 25 C. (B) UV-Vis absorbance of HuWT
Cytc in presence of various concentrations of 100% CL lipid vesicles at pH 8, 25 C. Panel A
shows signal shifted well above 0 A.U. across the spectrum for each titration point above 0 M
CL total lipid concentration indicative of scattering due to enlarged lipid vesicles.

3.3.2. Site A Binding Monitored by Heme Soret CD.

To assess Cytc-CL binding analytically, 100 nm pure TOCL vesicles were formed by
extrusion and vesicle and lipid concentrations were quantified utilizing a previously
reported method for rapid lipid quantification.46 We monitored the Soret region of Cytc
during titrations using CD spectroscopy, which probes the environment near the heme.
Soret CD band signal shifts are indicative of heme crevice rearrangement due to binding
at site A.
Soret CD from 350-450 nm demonstrates intrinsically different spectral signatures for
human and yeast variants (Figure 3.5) at pH 8. HuWT shows a pronounced negative
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trough at 418 nm while yeast has less obvious negative ellipticity at pH 8. At lower pH,
the negative trough is prominent for yeast iso-1-Cytc.22 Previous studies on the Soret CD
of the alkaline state of horse Cytc47 indicate that the reduced negative trough for yWT is
consistent with population of the alkaline conformer at this pH (pKapp = 8 for the alkaline
transition of yWT).36, 38 The negative trough is more pronounced for yK72A than for
yWT (compare black spectra in Figure 3.6 for yWT and yK72A), consistent with the
higher pKapp of 8.6 for yK72A.36 Furthermore, peaks and troughs do not occur at exactly
the same wavelengths: the HuWT positive peak is at 405 nm while for yWT it is at 407
nm and HuWT shows a negative trough at 418 nm whereas for yWT it is at 422 nm.

Figure 3.5. yWT iso-1-Cytc (solid line) and HuWT Cytc (dashed line) at 10 µM concentration in
20 mM TES buffer, 0.1 mM EDTA, pH 8. Spectra were acquired at 25 oC.
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The Soret CD signal response to increased CL vesicle concentration also differs for
human versus yeast iso-1-Cytc (Figure 3.6). The negative trough near 420 nm initially
decreases in magnitude for both yWT and HuWT. At higher CL concentrations, the
negative trough re-emerges for yWT, leading to an isodichroic point (Figure 3.6). Neither
the reemergence of the negative trough nor the isodichroic point are observed for HuWT.
For yWT, the isodichroic point is not present for the first few data points, indicating a
distinct process from that which occurs after the isodichroic point forms. This early phase
is likely initial intermolecular binding and only modestly affects the Soret CD spectrum.
This observation suggests that initial intermolecular binding does not strongly perturb the
structure of the heme crevice, consistent with some previous reports. 11, 25 The binding
process leading to the isodichroic point would then correspond to an intramolecular
structural rearrangement on the surface of the vesicle. Structural rearrangements are
expected to depend on available space on the membrane surface. For this reason, we
analyze our data in terms of lipid to protein ratio (LPR). Only lipid available on the outer
leaflet of the vesicle is used to calculate LPR, i.e. exposed LPR. Because the dissociation
constants extracted from our data are due to structural rearrangements on the membrane
surface rather than intermolecular association, they will be referred to as apparent
dissociation constants, Kd(app).
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Figure 3.6. CD spectra as a function of the concentration of 100 nm CL vesicles for (A)
yWT and (B) yK72A iso-1-Cytc and (C) HuWT and (D) HuK72A Cytc. Protein
concentration was 10 µM. Black arrow denotes direction of signal shift of the positive
peak during titrations. 0 M exposed lipid concentration corresponds to the black curve for
each mutant. Maximum exposed (outer leaflet) lipid concentration was 200 μM and
corresponds to the blue spectrum for each protein.
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For human Cytc, the magnitude of the Soret CD at the wavelength of the positive
maximum in the 0 M CL spectrum was used to track CL binding. Because of the reemergence of the negative trough in the Soret CD peak for yeast iso-1-Cytc, the response
of the Soret CD signal versus exposed LPR was quantified by subtracting the magnitude
of the Soret CD at the wavelength of the negative trough from the magnitude of the Soret
CD at the wavelength of the positive peak in 0 M CL.
Figure 3.7 shows binding isotherms monitored by Soret CD for yWT and yK72A iso1-Cytc (Figure 3.7A) and for HuWT and HuK72A Cytc (Figure 3.7B) plotted versus
exposed LPR. The mutations affect the amplitude of the change in the Soret CD as
observed for CL binding of Lys→Asn variants of horse Cytc.26 We fit the data to the
simplest possible model, a single site Langmuir-type binding isotherm allowing for
cooperativity (eq 3.1, Experimental procedures). 16, 18 The resultant parameters (Table
3.1), Kd(app), and the cooperativity, n, were used to plot percent bound protein versus
exposed LPR for each variant (Figure 3.8). It is evident from these plots and the
parameters in Table 3.1 that the K72A mutation causes no significant change in the
Kd(app) of CL for yeast iso-1-Cytc and human Cytc and perhaps a small decrease in the
cooperativity.
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Figure 3.7. Yeast iso-1-Cytc and human Cytc Soret CD signal response to cardiolipin.
(A) yWT (black) and yK72A (red) iso-1-Cytc Soret CD signal as a function of exposed
(outer leaflet) LPR. Data points at each LPR are the difference between the CD signal at
the wavelength of the positive maximum and the wavelength of the negative minimum in
the Soret region of the CD spectrum of iso-1-Cytc in the absence of vesicles. (B) HuWT
(black) and HuK72A (red) Cytc Soret CD signal as a function of exposed LPR. Data
points at each LPR are the CD signal at the wavelength of the positive maximum in the
Soret region of the CD spectrum of human Cytc in the absence of vesicles. All titrations
were carried out at 25 °C and pH 8 using 100% CL vesicles extruded through a 100 nm
membrane. Error bars are the standard deviations of the average values from three
independent trials. Solid curves are fits to eq 3.1.
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Figure 3.8. (A) Plots of fraction protein bound versus exposed (outer leaflet) lipid to protein
ratio (LPR) for yWT (black) and yK72A (red) iso-1-Cytc using the parameters extracted from a
fit to eq 3.1. (B) Plots of fraction protein bound versus exposed LPR for HuWT (black) and Hu
K72A (red) Cytc using the parameters extracted from a fit to eq 3.1. Fraction bound = (s(x)s0)/(s1-s0) in these plots.

Table 3.1. Thermodynamic Parameters for Cytc Site A Binding to 100% CL Vesicles
CDa,b
Fluorescencea,c
Kd(app) (LPR,
Kd(app) (LPR,
variant
µM)
n
µM)
n
yWT
10.2 ± 0.3
2.2 ± 0.1
23.4 ± 0.8
2.3 ± 0.2
(102 ± 3)
(117 ± 4)
yK72A
9.8 ± 0.2
2.01 ± 0.07
26.2 ± 0.8
2.3 ± 0.1
(98 ± 2)
(131 ± 4)
HuWT
8.6± 0.7
1.27 ± .09
36.0 ± 3.6
2.2 ± 0.2
(86 ± 7)
(180 ± 18)
HuK72A
8.4 ± 1.2
1.1 ± 0.1
40.5 ± 3.0
1.9 ± 0.1
(84 ± 12)
(203 ± 15)
a
Reported in exposed (outer leaflet) lipid to protein ratio (LPR) and in brackets in
µM exposed lipid concentration. Error corresponds to the standard error in the fit of
the parameter. bCytc concentration was 10 µM. c Cytc concentration was 5 µM.
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3.3.3. Site A Binding Monitored by Trp59 Fluorescence.
Trp59 fluorescence also was used to track binding for yWT and yK72A iso-1-Cytc
and for HuWT and HuK72A Cytc. Trp59 fluorescence enhancement results from loss of
Cytc tertiary structure (unfolding) as Trp59 moves away from the heme.48 Growth in the
intensity of emission was seen for all four proteins in titrations of 5 µM solutions of each
Cytc (Figure 3.9). All variants show a shift in the peak emission wavelength from ~330
nm to ~340 (Figure 3.10), consistent with Trp59 moving from a buried to a surfaceexposed site in contact with ordered but not bulk water.49 The Trp59 environment is not
as polar as for guanidine hydrochloride unfolded Cytc, where the emission maximum
shifts to ~350 nm (Figs. 3.11 – 3.13).
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Figure 3.9. Fluorescence spectra as a function of the concentration of 100 nm CL vesicles
for (A) yWT and (B) yK72A iso-1-Cytc and (C) HuWT and (D) HuK72A Cytc. Protein
concentration was 5 μM. Black arrow denotes direction of signal shift during the titration.
0 M exposed lipid concentration corresponds to the dark red signal for each Cytc variant.
Maximum exposed lipid concentration (250 µM) corresponds to the blue spectrum for
each variant.
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Figure 3.10. (A) yWT (black) and yK72A (red) iso-1-Cytc fluorescence emission peak location
versus exposed (outer leaflet) LPR. (B) HuWT (gray) and HuK72A (red) Cytc fluorescence
emission peak location versus exposed LPR.
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Figure 3.11. Trp59 fluorescence spectra of 10 μM yWT iso-1-Cytc at pH 7, 25 oC, in 20
mM Tris, 40 mM NaCl over a titration from 0 M (black) to 3 M (blue) GdnHCl
concentration. Fluorescence measured in arbitrary units (A.U.). Black arrow indicates
direction of increase in fluorescence intensity with increasing GdnHCl concentration.
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Figure 3.12. Trp59 fluorescence intensity (350 nm) progression of 10 μM yWT iso-1-Cytc at pH
7, 25 oC, in 20 mM Tris, 40 mM NaCl over 3 independent GdnHCl titrations from 0 M to 5 M.
Fluorescence measured in arbitrary units (A.U.).

Figure 3.13. Trp59 fluorescence peak shift monitored for 3 trials over GdnHCl titrations
from 0 M to 5 M GdnHCl for yWT iso-1-Cytc.
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Titrations were monitored at the wavelength corresponding to the emission peak at the
highest CL vesicle concentration for each Cytc variant studied. Figure 3.14 shows the
increase in Trp59 fluorescence for both yeast iso-1-Cytc and human Cytc variants as
exposed LPR increases, consistent with significant disruption of tertiary structure.
Previous work on horse Cytc has shown similar effects on Trp59 fluorescence during
titrations with CL-containing vesicles.16, 17 The overall increase in fluorescence is larger
for human Cytc than for yeast iso-1-Cytc. Human Cytc also requires higher LPR to
complete the CL titration. The fluorescence-monitored titration data were fit to a singlesite Langmuir-type binding model allowing for cooperativity (eq 3.1, Experimental
procedures). Parameters from these fits (Table 3.1) were used to plot fraction of bound
protein versus exposed LPR (Figure 3.15). Attenuation of apparent binding by the K72A
mutation is more evident when monitored by fluorescence versus Soret CD. For both
human and yeast iso-1-Cytc, Kd(app) in terms of exposed LPR is significantly larger than
observed when titrations with CL vesicles are monitored by Soret CD (Table 3.1).
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Figure 3.14. (A) yWT (black) and yK72A (red) iso-1-Cytc fluorescence intensity as a
function of exposed LPR. (B) HuWT (black) and K72A (red) Cytc fluorescence intensity
as a function of exposed LPR. All titrations were carried out at 5 μM protein
concentration using 100 nm 100% CL lipid vesicles at pH 8 and 25 °C. Fluorescence
intensity was followed at the wavelength of maximum intensity in the fluorescence
emission spectrum of Cytc at the highest lipid concentration. Solid curves are fits to eq
3.1.
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Figure 3.15. (A) Fraction protein bound versus exposed (outer leaflet) LPR for yK72 (black) and
yK72A (red) iso-1-Cytc using parameters in Table 3.1. (B) Fraction protein bound versus
exposed LPR for HuK72 (black) and HuK72A (red) Cytc using parameters in Table 3.1. Fraction
bound = (s(x)-s0)/(s1-s0).

3.4. DISCUSSION
3.4.1. Similarities and Differences between Site A Binding to CL Vesicles for Yeast
Iso-1-Cytc and Human Cytc.
The primary similarity between the interaction of yeast iso-1-Cytc and human Cytc
with CL vesicles is that both proteins show two binding phases. Based on the initial low
amplitude phase that occurs prior to formation of the isodichroic point with the yeast
protein, we assume that both binding phases are intramolecular structural rearr angements
of Cytc on the membrane surface. The first phase, which occurs at lower exposed LPR, is
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observable with Soret CD and thus involves rearrangement of the local heme
environment. The presence of a positive/negative couplet in the Soret CD spectrum of the
native state of Cytc has been attributed to the presence of Met80 ligation to the heme 50
and of Phe82 near the heme,51 although the exact nature of the interaction that produces
the couplet may be more complex.52 The loss of this couplet is observed when human
Cytc binds to CL and initially for iso-1-Cytc binding to CL (Fig. 3.6). Loss of the couplet
is also observed for the alkaline conformer,47 providing some insight into the possible
nature of the small structural rearrangement that occurs at lower LPR when Cyt c binds to
CL. Structural studies of the alkaline conformer of iso-1-Cytc show that it is compact
with a rearrangement of Ω-loop D.53, 54 However, structural studies on a K72A variant of
iso-1-Cytc show that loss of Met80 ligation is possible with a very small structural
rearrangement.37 The second binding phase occurs at significantly higher exposed LPR
and leads to an increase in the Trp59 fluorescence. The increase in Trp59 fluorescence is
attributable to reduced quenching of the fluorescence by the heme due to increased Trp59
to heme distance, indicating a significant loss of tertiary structure.48 These observations
are qualitatively consistent with previous work on horse Cytc, which supports an
equilibrium between compact and extended conformers, with the extended conformer
favored at higher LPR.8, 16 While our data only inform on the heme-Trp59 distance, the
increase in the Trp59 to heme distance at higher LPR is consistent with the fluorescence
resonance energy transfer studies of Pletneva and coworkers, 8 which indicate that the 60’s
and C-terminal helices move away from the heme in the extended conformer.
The second similarity for yeast iso-1-Cytc and human Cytc interactions with CL is
that site A binding is not strongly affected by the K72A mutation. This result indicates
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that the other lysines (73, 86, 87) in site A can compensate for the loss of Lys72 for
Cytc/CL binding at pH 8.
Fitting data to eq 3.1 reveals differences in variant response to CL binding. For the
first phase, Kd(app), is similar for yWT, yK72A, HuWT and HuK72A (Table 3.1).
However, the cooperativity parameter, n, for HuWT and HuK72A Cytc is lower by ~0.9
units than for yWT and yK72A iso-1-Cytc. Despite the similar Kd(app) values, the
cooperativity suggests that site A for human Cytc may only accommodate ~1 lipid, while
yeast iso-1-Cytc interacts with ~2 lipids. This difference might be attributed to population
of the alkaline conformer for yeast iso-1-Cytc at pH 8.0. However, the pKapp of the
alkaline transition for yK72A is 8.6 (versus 8.0 for yWT)36, 38 with no significant effect on
Kd(app) or n (Table 3.1). Thus, the higher value of n for yeast iso-1-Cytc does not appear
to be specific to the degree of population of the alkaline conformer. The details of the
structural rearrangement of the heme crevice also appear to differ between yeast and
human Cytc. Yeast iso-1-Cytc shows a reemergence of the negative CD band near 420
nm, reminiscent of the shape of the native Soret CD spectrum, which is not observed with
human Cytc. This observation suggests that for iso-1-Cytc the position of Phe82 could
become more nativelike51 or that Met80 ligation is partially restored50 during this phase of
binding to CL.
Comparison of Kd(app) from CD versus fluorescence data shows significant shifts in
Kd(app) reported in terms of LPR for both yeast and human Cytc (Table 3.1). The Kd(app)
for the fluorescence detected site A interaction is 2-fold larger for yeast iso-1-Cytc than
for Soret CD detected site A interactions. A much larger 4-fold shift in Kd(app) is
observed for human Cytc. The cooperativity, n, differs for yeast versus human Cytc for
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the smaller structural rearrangement monitored by Soret CD, but is near 2 for both yeast
and human Cytc for the larger structural rearrangement monitored by fluorescence at
higher LPR. The Kd(app) values for CD and fluorescence detected interactions of 100%
CL vesicles with site A are close enough for the yeast protein that the cooperativity
parameters for the two structural rearrangements may not be fully independent. Thus, it is
possible that n for one of the phases for the yeast iso-1-Cytc interaction with CL is
inflated. The higher stability of human Cytc versus yeast iso-1-Cytc44 may be a factor in
the larger LPR needed to disrupt the tertiary structure of human versus yeast iso-1-Cytc in
the larger conformational rearrangement at higher LPR. The closer spacing of the
stabilities of the substructures of yeast iso-1-Cytc38 compared to mammalian Cytc55, 56
could be a factor, as well. The larger LPR for loss of tertiary structure of human Cytc on
the surface of a CL vesicle, as detected by Trp59 fluorescence, suggests that more
membrane surface area may be required to unfold the more stable protein. Stability
provides a compelling argument for the higher LPR required to partially unfold human
Cytc on CL vesicles. However, the surface charge pattern near site A, which differs for
human Cytc versus yeast iso-1-Cytc (see Figure 3.2), could also impact the partial
unfolding phase of Cytc on CL vesicles.
The larger increase in fluorescence for human Cytc versus yeast iso-1-Cytc (Figures
3.9 and 3.14) suggests a larger disruption of the structure of human Cytc than for yeast
iso-1-Cytc in the large structural rearrangement at higher LPR. It is known that extended
conformers of Cytc have higher peroxidase activity.8 While there is some debate about
the physiological significance of extended conformers,11 it is plausible that the higher
LPR required to produce the more extended conformer of human Cytc versus yeast iso-1-

74

Cytc, combined with the larger extent of unfolding apparent for the human versus the
yeast protein at higher LPR, demonstrate the evolution of both a more stringent and
efficient switch for the peroxidase activity of Cytc early in apoptosis.
For yeast iso-1-Cytc, the K72A mutation leads to a small increase in the Kd(app) for
the larger fluorescence-detected structural rearrangement (Table 3.1). For human Cytc,
the K72A mutation causes a small decrease in the cooperativity, n, for the larger
fluorescence-detected structural rearrangement (Table 3.1). Thus, Lys72 affects the
binding mode monitored by Trp59 fluorescence more significantly than the binding mode
monitored by Soret CD. However, when site A is isolated at pH 8, Lys72 is not necessary
for the structural rearrangements that occur when Cytc interacts with 100% CL vesicles.

3.4.2. Comparison with Previous Data for Binding of CL to Cytc.
It is of interest to compare our results to those obtained at lower pH where multiple
binding sites contribute to the interaction of Cytc with CL-containing vesicles. Previous
work by Santucci and coworkers was carried out with 100% CL vesicles at pH 7 using
yeast iso-1-Cytc22, 23 and horse Cytc.18, 26, 27 They observe biphasic binding curves with
Soret CD measurements and similar binding curves for yeast iso-1-Cytc and horse Cytc.18,
22

At pH 7, sites C, L and A will all contribute to Cytc binding to CL vesicles. Thus, more

complex binding curves are expected. The observed binding affinities,18 when corrected
to exposed lipid concentrations, are ~1x10 5 M-1 (Kd = 10 µM, n = 2) and ~5x104 M-1 (Kd =
20 µM, n =4). Two binding constants of similar magnitude were also observed with horse
Cytc by Pandiscia and Schweitzer-Stenner using 20% CL (80% DOPC) vesicles at pH
7.4, when their data are analyzed in terms of CL concentration exposed on the outer
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leaflet of the vesicle.16 Multiple binding sites should be available at pH 7.4, too. For
purposes of comparison, we provide Kd(app) in µM units in Table 3.1. The Kd values
reported at pH 7 – 7.4 are ~5-fold smaller than what we observe (Kd(app) ~ 85-100 µM),
suggesting that the availability of multiple binding sites leads to significantly higher
overall CL binding affinity. Studies by Pandiscia and Schweitzer-Stenner with 100% CL
vesicles at pH 7.4 are more difficult to compare with our data because they were analyzed
with a more complex model.17 However, the binding curves are also consistent with
considerably higher affinities than we observe under our binding conditions.
A K72N variant of horse Cytc appears not to bind to 100% CL vesicles,26 in contrast
to our results with K72A variants of human Cytc and yeast iso-1-Cytc. Alanine versus
asparagine variants may behave differently. GdnHCl titration data for Lys→Asn variants
of horse Cytc yield unusual biphasic unfolding curves, whereas the K72A variants of
yeast iso-1-Cytc57 and human Cytc35 have monophasic unfolding curves like the wild type
proteins. Thus, the Lys→Asn variants may perturb the stability of Cytc in a manner that
also affects binding to cardiolipin.

3.4.3. Conservation of Lysine at position 72 of Cytc.
Lysine at position 72 of mitochondrial Cytc is strongly, but not absolutely conserved
in all known cytochromes c.58 It is important,59 although not absolutely essential,60 for
interaction with redox partners in the electron transport chain. It is important for
formation of a strong complex with Apaf-1,32, 34, 40 although mutation to other residues
does not completely abrogate activation of caspases by the apoptosome.40, 60, 61 Truncation
of Lys72 to alanine enhances the intrinsic peroxidase activity of both yeast iso-1-Cytc37
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and human Cytc.35 Thus, Lys72 also plays some role in the peroxidase activity of Cytc,
which acts as a signaling switch in the early stages of apoptosis. Lys72 also affects the
binding of Cytc to CL-containing vesicles. However, the results presented here indicate
that, while it may be important for binding at some CL binding sites, 26, 27 it is not essential
for interactions at site A. Thus, the strong conservation of Lys at position 72 of Cytc does
not appear to be because it is essential for any one function, but because it is an important
contributor to most of the functions of Cytc.

3.5. CONCLUSION
In summary, at pH 8, we are able to isolate the site A binding site. In the absence of
the C and L binding sites, the interaction of Cytc with CL vesicles is significantly weaker.
The Kd(app) values obtained by Soret CD, in terms of exposed LPR, are similar for
human Cytc and yeast iso-1-Cytc, indicating that the initial small structural rearrangement
requires a comparable amount of space on the surface of CL vesicles. The second and
larger structural rearrangement monitored by Trp59 fluorescence occurs at significantly
higher LPR for human Cytc than for yeast iso-1-Cytc, indicating that more surface area
on CL vesicles is required to unfold the more stable human Cytc. Based on the larger
increase in Trp fluorescence for the human versus the yeast protein, the degree of
unfolding is larger, indicating a more extended conformer for the human versus the yeast
protein. This more extended conformer may yield higher peroxidase activity.8 Thus, the
signaling switch which controls peroxidase activity early in apoptosis may have evolved
to be a more stringent, but more effective, switch. Neither phase of the interaction with
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CL vesicles through site A is strongly affected by the K72A mutation indicating that other
lysines can compensate for Lys72 at site A.
.
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CHAPTER 4: Electrostatic Constituents of Cardiolipin binding to site A of Cytochrome c

4.1. INTRODUCTION
Cytochrome c is a well-used model system for studies on protein folding,1, 2 conformational
dynamics3 and long distance electron transfer in proteins and protein complexes. 4 With regard to
studies on its biological function, the emphasis of recent research has shifted from its role in the
electron transport chain5, 6 to understanding its role during apoptosis.7-9 Cytochrome c (Cytc)
abandons its function as an electron transporter in the electron transport chain during apoptosis,
oxidizes cardiolipin and is released from the inner mitochondrial membrane followed by passage
through the outer mitochondrial membrane into the cytoplasm. 10 Upon its release from the
mitochondria, Cytc binds apoptotic protease activating factor 1 (Apaf-1)11 and, in the presence of
dATP, forms the apoptosome which in turn, initiates the apoptotic pathway. 12, 13 Work has shown
that Cytc undergoes a conformational rearrangement upon binding to cardiolipin (CL). Various
model systems incorporating CL-containing membranes have been used to elucidate the true
nature of the protein-lipid interaction10, 14-28 for Cytc in the mitochondria. Several binding modes
have been proposed to describe the interactions of Cytc with these membrane mimetic systems.
However, the nature of both the structural rearrangement and the constituents of the binding sites
remain a matter of considerable debate.14-24 Thus, further characterization of the Cytc-CL
interaction is important.
Four regions of Cytc have been postulated to interact with CL. The anionic site (site A) sits
on the flexible Ω-loop D and is thought to electrostatically interact with CL.14 Lys72 and, to a
lesser extent, Lys73 have been identified as primary constituents of site A.14, 17, 29, 30 Lysines 86
and 87 have also been proposed to be constituents of site A. 31 The cardiolipin binding site, site C,
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is believed to involve hydrogen bonding of protonated cardiolipin to Asn52.14 Site C is also
believed to involve a hydrophobic component. The L site is comprised of lysines at residues 22,
25, 27 and histidines at residues 26 and 33 that interact with CL via electrostatic and hydrogen
bonding interactions at low pH.32 This site is opposite site A, allowing Cytc to bridge two
membrane surfaces, thus, promoting membrane fusion. The N site containing residues F36, G37,
T58, W59 and K60 may be yet another interaction site for CL.33
Two major protein conformations have been proposed to characterize Cytc structure upon
interaction with CL on lipid bilayer surfaces. Some results suggest a native-like folded structure
binds to the lipid membrane.15, 23, 33, 34 Site C is believed to involve insertion of one or more of
the hydrocarbon chains of the CL lipid into the hydrophobic core of Cytc. 15, 35-37 This interaction,
which has been referred to as an extended lipid anchorage, 15, 35 would seem to require a welldefined binding that would best be provided by a compact structure. The ability of Cytc to form
a well-defined binding pocket for hydrocarbons has recently been shown through a set of X-ray
structures, which show the hydrocarbon chain of detergents bind within a well-defined pocket in
domain-swapped dimers of yeast iso-1-cytochrome c (iso1-Cytc).38 However, there is also good
evidence for an equilibrium between compact and partially unfolded structures on CL-containing
membrane surfaces, with the partially unfolded structures favored when the lipid to protein ratio
(LPR) is higher.17-19, 26, 27 Peroxidase activity data indicate that this partially unfolded conformer
has higher catalytic activity.18
Previous mutagenesis studies on the constituents of site A using horse Cytc have been carried
out with 100% CL vesicles at pH 7.29, 30 Under these conditions, both sites A and C contribute to
binding.28 Recent crystallographic studies on detergents bound to a domain-swapped dimer of
yeast iso-1-Cytc show that the head group of CL may interact with the hydrophobic site C with
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acyl chain emerging near Lys73. Thus, it is possible that binding studies at pH 7 on variants with
mutate surface lysines may report on both binding at sites A and C.
We have recently shown that binding of CL to site A of both human Cytc and yeast iso-1Cytc can be accomplished without interference from other binding sites at pH 8. 39 At pH 8,
Lys72 was not essential for the binding of either the yeast or the human protein to 100% CL
liposomes.39 The work presented here aims to further clarify the relative importance of lysines
72, 73 86 and 87 to the site A binding site of Cytc for CL. Using the Soret band region of the
circular dichroism (CD) spectrum of Cytc (350-450 nm) and fluorescence from Trp59 (emission
from 320-500 nm), we have investigated A site binding. We show that charge neutralization at
residues 72, 73, 86 and 87 (Figure 4.1) in site A by alanine-scanning attenuates binding. Further,
double charge neutralization substitutions at residues 72 and 73 and at residues 86 and 87 do not
completely prevent binding. All binding titrations monitored by Soret CD demonstrate a strong
binding at an exposed (outer leaflet) lipid to protein ratio (LPR) of <12. An electrostatic binding
event at an exposed LPR of ~20 is detected by fluorescence-monitored titration data. The
binding event involves partial unfolding of the protein structure. The apparent degree of
unfolding is strongly effected by which lysines constitute site A.
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Figure 4.1. Structure of yeast iso-1-Cytc (PDB ID 2YCC)40 with Lys72 (red), Lys73 (yellow),
Lys86 (dark green), Lys87 (orange) and Trp59 (light green) shown behind heme (black) and its
ligands Met80 and His18. Red arrow measures width of postulated A site.

4.2. EXPERIMENTAL PROCEDURES
4.2.1. Preparation of Yeast Cytc Variants.
Iso-1 Cytc variants were prepared in the pRbs_BTR1 plasmid41 carrying the yeast iso-1cytochrome c gene, CYC1, with a C102S substitution to prevent disulfide dimerization. The
plasmid also carries the CYC3 gene (yeast heme lyase) permitting covalent attachment of heme
in the cytoplasm. The PCR-based QuikChange Lightning method (Agilent) was used to prepare
all variants. The starting point for mutagenesis were the previously described WT 39 and K72A42
variants of iso-1-Cytc. Primer sequences for the following mutations: K73A, K72|73A
(Lys→Ala at positions 72 and 73), K86A, K87A, K86|87A (Lys→Ala at positions 86 and 87),
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K72|73|86|87A (Lys→Ala at positions 72, 72, 86 and 87), can be found in Table A.6. For the
K72|73|86|87A variant, pRbs_BTR1 DNA carrying the K72|73A variant was used as template
and the K86|87A primer (Table A.6) was used to introduce the required mutations. Mutagenesis
reaction mixtures were transformed into in Escherichia coli XL10 Gold competent cells
(Agilent). DNA was extracted from single colonies, following overnight cultures, using the
Wizard MiniPrep DNA Purification Kit (Promega Inc). Mutated plasmids were sequenced
(Eurofins, Louisville, KY) to verify the mutations conferring the Lys→Ala substitutions.

4.2.2. Protein Expression of Yeast Iso-1-Cytochrome c Variants.
All variants were expressed and purified using previously reported methods. 43, 44 HPLC
cation exchange (Uno S6 column, BioRad) was used to purify iso-1-Cytc variants in the reduced
state.44 Immediately prior to experiments, iso-1-Cytc variants were oxidized using 5 mg of
ferricyanide per mg of protein followed by size exclusion chromatography using Sephadex G-25
resin (GE Life Sciences) equilibrated to and run with buffer appropriate to the experiment.
Protein concentration and the degree of oxidation was measured with a Beckman Coulter DU
800 spectrophotometer using previously reported extinction coefficients for Cytc at 339, 526.5,
541.75 and 550 nm.45

4.2.3. Alkaline Transition Detected by pH Titration.
The alkaline conformational transition of Cytc variants K73A, K72|73A, K86A, K87A,
K86|87A and K72|73|86|87A was measured using a Beckman Coulter DU 800 UV-Vis
spectrophotometer with a 10 mm pathlength Beckman Coulter MICRO CELL. Absorbance was
measured from 600 to 750 nm in 1 nm increments at a scan rate of 400 nm/min with a bandwidth
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of 1 nm. The absorbance at 695 nm was used as a probe for the Met80-heme ligation of the
native state of Cytc.46 Absorbance at 750 nm was used as a baseline to correct for spectrometer
drift during the titration yielding A695corr (A695corr = A695-A750). Titrations were performed at room
temperature (20 ± 1 oC) with 400 µM protein in 0.1 M NaCl. Protein samples were initially
prepared in solution at low pH (approximately pH 5 – 6) and titrations were performed by adding
equal amounts of 800 µM protein in 0.2 M NaCl and varying concentrations of NaOH (0.03 to
0.3 M) to increase the solution pH by 0.05 – 0.1 pH units. A695corr absorbance values were plotted
versus pH and fit to a modified Henderson-Hasselbalch equation incorporating both proton
linkage number, n, and the apparent pKa, pKapp, for formation of the alkaline conformer as
previously described.43

4.2.4. Global Unfolding Measured using Guanidine Hydrochloride Titration.
An Applied Photophysics (Leatherhead, UK) Chirascan circular dichroism (CD)
spectrophotometer interfaced with a Hamilton Microlab 500 series auto-titrator was used to
perform guanidine hydrochloride (GdnHCl) titrations, as previously described. 47 All titrations
were carried out at 10 µM protein concentration in 20 mM Tris Buffer, 40 mM NaCl, at pH 7
and 25 C. Three independent trials were acquired for Cytc variants K73A, K72|73A, K86A,
K87A, K86|87A, K72|73|86|87A. A corrected ellipiticity at 222 nm, θ222corr, was calculated by
subtracting ellipticity at 250 nm, θ250, as baseline from ellipticity at 222 nm, θ222, to evaluate loss
of helicity during the GdnHCl titration. θ222corr plotted versus GdnHCl were fit assuming a linear
free energy relationship between protein stability and GdnHCl concentration48 as previously
reported.49, 50
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4.2.5. Preparation of Cardiolipin vesicles.
Cardiolipin [1′,3′-bis(1,2-dioleoyl-sn-glycero-3-phospho)-sn-glycerol (TOCL)] from Avanti
Polar Lipids, Inc. (Alabaster, AL) was used to prepare pure (100%) CL vesicles by extrusion
through 100 nm membranes using an Avanti mini-extruder, as previously described.39 Vesicle
and lipid concentration were evaluated by Mie scattering using a Beckman Coulter DU 800 UVVis spectrometer, as previously described.39, 51 Vesicles were used immediately after preparation.

4.2.6. Iso-1-Cytc-CL Binding Titrations.
Cardiolipin binding experiments were performed in 20 mM TES, 0.1 mM EDTA buffer at
pH 8 using a batch procedure as previously described.39 Briefly, freshly prepared 100% CL
vesicles were mixed by hand in a 1:1 ratio with stock protein 30 minutes prior to spectroscopic
measurements. Samples were prepared independently for each concentration of lipid for each
trial. A set of vesicle solutions at twice the desired final concentration was prepared for 1:1
mixing with stock solutions of the iso-1-Cytc variants to produce the set of solutions at the
desired exposed LPR for the binding curves. Titrations were monitored by Soret CD or Trp
fluorescence using an Applied Photophysics Chirascan CD Spectrometer with the sample holder
temperature set to 25 oC. For Soret CD, spectra were measured from 350 – 450 nm using the 4
mm pathlength of a Hellma 4x10 mm quartz cuvette. Spectra were acquired using a 1 nm
descending step, 1.8 nm bandwidth, at a scan rate of 3 s/nm. Three independent titrations were
carried out for each variant. For Trp59 fluorescence, excitation was at 295 nm (5 nm bandwidth).
A Hellma 5x5 mm fluorescence cuvette was used. Excitation bleed-through was filtered using a
305 nm cutoff filter (Newport Corporation, Irvine, CA) in front of the emission monochromator.
Emission spectra were measured from 320 - 500 nm using a 1 nm step and a 2.5 nm bandwidth
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with an acquisition time of 0.5 sec per step using a scanning emission monochromator provided
by Applied Photophysics. A minimum of three independent trials were acquired for each Cytc
variant. All Soret CD and fluorescence spectra were smoothed using a 6 th order Savitsky-Golay
smoothing technique before averaging data points from the three independent trials.

4.2.7. Near UV Circular Dichroism Spectroscopy.
CD spectra in the aromatic region were acquired with an Applied Photophysics Chirascan
CD Spectrophotometer set to scan from 350 – 250 nm in 1 nm steps (1.8 nm bandwidth) at a
scan rate of 3.0 s/nm. Spectra were acquired at 25 oC in a 10x4 mm Hellma Quartz cuvette
utilizing the 4 mm path length. Stock solutions of each variant were prepared at 100 µM in 20
mM TES buffer, 0.1 mM EDTA, pH 8. Stock solutions were then mixed 1:1 with the same
buffer to produce protein at 50 µM for data collection. Samples of protein in GdnHCl were
prepared by mixing the protein stock solutions 1:1 with 6 M GdnHCl buffered with 20 mM TES
buffer, 0.1 mM EDTA, pH 8 resulting in a 50 µM protein solution in 3 M GdnHCl. Samples of
protein in the presence of CL vesicles were prepared by mixing protein stock solutions with
vesicles at 1 mM CL concentration in 20 mM TES buffer, 0.1 mM EDTA, pH 8 giving a final
solution of 50 µM protein in the presence of 500 µM CL (exposed LPR = 5). CL containing
samples were equilibrated for 30 minutes prior to acquiring spectra. Spectra of solutions of CL
vesicles were also prepared by mixing 20 mM TES buffer, 0.1 mM EDTA, pH 8 and the stock 1
mM CL in a 1:1 ratio to demonstrate that light scattering off of the vesicles did not affect the
near UV CD spectra of iso-1-Cytc bound to the CL vesicles.
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4.3. RESULTS
4.3.1. Variants of Iso-1-Cytc Used to Probe Binding of CL vesicles to Site A.
We have previously reported the effect of a K72A variant on the binding of iso-1-Cytc
through site A to CL vesicles at pH 8. Two binding phases were observed for WT (Lys72 is not
trimethylated because of expression from E. coli52) iso-1-Cytc and the K72A variant. At lower
exposed (outer leaflet) lipid to protein ratio (LPR) a CD monitored binding event occurred,
which we attributed to a local conformational rearrangement and yielded an apparent
dissociation constant, Kd(app) near 10 in units of exposed LPR. This binding phase was
unaffected by the K72A substitution. The second phase, monitored by Trp59 fluorescence,
yielded an apparent dissociation constant, Kd(app) near 23 in units of exposed LPR, which
increased modestly to an exposed LPR near 26 in the presence of the K72A substitution. These
results indicated that binding through site A at pH 8 did not depend strongly on a single lysine.
Site A binding has been attributed to electrostatic interactions with two subclusters of lysines,
Lys72/Lys7314, 17, 29, 30 and Lys86/Lys8753 that are separated by 15.4 ± 2.5 Å (𝛼-carbon to 𝛼 carbon distances, see Figure 4.1) with the closest distance being the 12.4 Å separating the 𝛼 -

carbons of Lys73 and Lys86. Thus, it is possible that elimination of a single Lys would simply
adjust the orientation of iso-1-Cytc on the membrane surface without strongly affecting Kd(app).
To evaluate the role of this cluster on the interaction between iso-1-Cytc with 100 nm pure
(100%) CL vesicles, we have prepared single substitution variants with each lysine replaced with
alanine. To probe the role of the two lysine subclusters, we have prepared Lys72|73Ala and
Lys86|87Ala double substitution variants. Finally, to determine whether or not site A mediated
binding is limited to this cluster of four lysines we have prepared the quadruple substitution
variant, Lys72|73|86|87Ala. We note that all variants were expressed from E. coli. Thus, for
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variants that contain Lys72, it will not be trimethylated52 as is the case when expression of iso-1Cytc is from the native host, Saccharomyces cerevisiae.

4.3.2. Local and Global Protein Unfolding.
Iso-1-Cytc undergoes a conformational change at mildly alkaline pH, typical of
mitochondrial cytochromes c,3, 46 from the native conformer with Met80 ligated to the sixth
coordination site of the heme iron (See Figure 4.1) to a conformer with a lysine replacing Met80.
The conformational switch for yeast iso-1-Cytc involves a change from heme ligation to Met80
to ligation by Lys72, Lys73 or Lys79.50, 52 For iso-1-Cytc expressed from S. cerevisiae, the
apparent pKa, pKapp of the alkaline transition is 8.6.54, 55 pKapp decreases to near 8.0 when Lys72
is not trimethylated.41, 52 Because we are measuring the binding of iso-1-Cytc variants to CL
vesicles at pH 8, to selectively monitor binding to site A, it is important to determine the effect of
the Lys→Ala mutation on pKapp, so we know the degree to which the alkaline conformer is
populated under our iso-1-Cytc-CL binding conditions.
Figure 4.2 shows individual pH titrations of K73A, K72|73A, K86A, K87A, K86|87A,
K72|73|86|87A variants as well as WT Cytc. pH titrations were performed in triplicate for each
mutant and individual trials were fit to a modified Henderson-Hasselbalch as outlined in
Experimental Procedures. Figure 4.2. shows that the titrations cluster into two distinct groups.
The group that has a higher pKapp, comprises the variants that lack Lys72. The resultant
thermodynamic parameters are reported in Table 4.1. The single mutant variants K73A, K86A,
K87A and double mutant K86|87A show modest shifts in pKapp to more basic pH relative to the
pKapp of WT iso-1-Cytc expressed from E. coli. The K72|73A and K72|73|86|87A variants show
a more pronounced basic shift in the pKapp of the alkaline transition to values near 8.7. The pKapp
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observed from yeast-expressed K73A iso-1-Cytc, where the alkaline state ligand is Lys79 is 8.82
± 0.02,56 consistent with Lys79 being the alkaline state ligand for the K72|73A and
K72|73|86|87A variants, as expected.

Figure 4.2. Corrected absorbance at 695 nm (A695corr = A695nm – A750nm) versus pH for WT
(black), K73A (yellow), K72|73A (grey), K86A (cyan), K87A (orange), K86|87A (green) and
o

K72|73|86|87A (lavender) iso-1-Cytc. Data were collected at 20 ± 1 C in 0.1 M NaCl with a
protein concentration of 400 μM. Solid lines are fits to a modified Henderson-Hasselbalch as
described in Experimental Procedures in the main text.
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Table 4.1. Thermodynamic parameters for local and global unfolding of iso-1-Cytc
variants by pH GdnHCl titrations, respectively.
pH Titration
GdnHCl Denaturation
ΔGuo'(H2O), m,
Cm,
Variant
pKapp
n
kcal/mol
kcal/mol•M M
WTa
8.00 ± 0.05 0.98 ± 0.01 5.05 ± 0.30 4.24 ± 0.13 1.19 ± 0.04
K72Ab
8.65 ± 0.01 1.15 ± 0.01 5.31 ± 0.08 4.39 ± 0.09 1.21 ± 0.01
K73A
8.16 ± 0.01 0.99 ± 0.00 4.87 ± 0.08 3.79 ± 0.10 1.29 ± 0.03
K72|73A
8.71 ± 0.01 1.02 ± 0.04 5.48 ± 0.04 4.05 ± 0.05 1.32 ± 0.04
K86A
8.37 ± 0.02 1.02 ± 0.06 4.87 ± 0.07 4.40 ± 0.03 1.11 ± 0.01
K87A
8.12 ± 0.04 1.04 ± 0.09 4.79 ± 0.06 4.04 ± 0.11 1.19 ± 0.02
K86|87A
8.37 ± 0.56 1.07 ± 0.02 4.60 ± 0.09 3.77 ± 0.14 1.22 ± 0.06
K72|73|86|87A 8.75 ± 0.02 0.86 ± 0.01 5.09 ± 0.07 4.12 ± 0.06 1.24 ± 0.01
a
Data from ref. 41
bData from ref. 49

Global protein unfolding was investigated using GdnHCl unfolding monitored by CD. Figure
4.3 shows individual GdnHCl unfolding titrations for the K73A, K72|73A, K86A, and K87A
variants. The thermodynamic parameters for all variants are provided in Table 4.1. Table 4.1
shows modest changes in Gibb’s free energy indicating these substitutions have small effects on
the global stability for these variants. Single Lys→Ala substitutions have very modest effects on
global stability. The double and quadruple substitution variants demonstrate compensatory and
largely additive behavior between lysines. Most notably, the K86|87A double substitution variant
decreases global stability by ~0.4 kcal/mol while the K72|73A substitution variant increases
global stability by ~0.5 kcal/mol. The compensatory effect of combining these substitution
variants to form the quadruple substitution variant K72|73|86|87A results in an additive effect on
global stability with the ∆∆G relative to WT iso-1-Cytc being only 0.1 kcal/mol.
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Figure 4.3. GdnHCl unfolding shown as corrected ellipiticity, θ222corr, versus GdnHCl
concentration for K73A (yellow), K72|73A (grey), K86A (cyan), K87A (orange) iso-1-Cytc. Data
o

were collected at 25 C, 10 μM protein, 20 mM Tris Buffer, 40 mM NaCl, at pH 7. Solid lines
show fits of the data to a two-state model assuming a linear dependence of the free energy of
unfolding on GdnHCl concentration.

4.3.3. Cardiolipin Binding Monitored by CD.
The Soret region of the CD spectrum, from 350-450 nm, was used to investigate
conformational changes in iso-1-Cytc corresponding the heme environment during CL
titrations.57, 58 Iso-1-Cytc site A variants at 10 µM protein concentration were titrated with 100
nm cardiolipin vesicles from 0-250 µM exposed lipid concentration (0-25 exposed LPR). Figure
4.4 shows Soret CD spectra for the K73A and K87A variants of iso-1-Cytc from the averaged
data of 3 independent trials where each spectrum corresponds to data averaged at a specific lipid
concentration.
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Figure 4.4. Soret CD spectra of 10 µM the K73A (left) and K87A (right) variants of yeast iso-1Cytc with 100 nm TOCL vesicles in 20 mM TES buffer, 0.1 mM EDTA at pH 8 and 25 oC. Lipid
concentration increases from 0 μM to 250 μM exposed (outer leaflet) lipid (black→red→blue).

For WT iso-1-Cytc and many of the variants, the negative CD band near 420 nm is missing,
although this is not universally true (Figure 4.5, Figure 4.6). Lack of this band likely results from
the fact that WT and many of these variants have pKapp values near 8 (see Table 4.1).
Interestingly, this negative band re-emerges at high exposed LPR (Figure 4.4). After the three
lowest exposed LPR data points, an isodichroic point is established indicating that a two state
process is occurring for the remainder of the titration (Figure 4.4). The same isodichoric point is
observed for all variants investigated (Figure 4.6).
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Figure 4.5. Soret CD spectra of WT yeast iso-1-Cytc (black), and the K72A (red) and K73A
(yellow) variants in 20 mM TES buffer, 0.1 mM EDTA at pH 8 and 25 oC.
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Figure 4.6. Soret CD spectra of 10 µM yeast iso-1-Cytc variants titrated with 100 nm CL
vesicles in 20 mM TES, 0.1 mM EDTA buffer at pH 8 and at 25 oC. Exposed (outer leaflet) CL
concentration ranges from 0→200 µM (black→red→blue).
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The Soret CD spectrum of WT iso-1-Cytc expressed from S. cerevisiae has a characteristic
positive peak at 406 nm and negative trough at 420 nm.59, 60 For WT iso-1-Cytc expressed from
E. coli, the negative trough near 420 nm is essentially eliminated (Figure 4.6). For the K73A the
perturbation to the Soret CD spectrum is similar to WT iso-1-Cytc. However, the negative
through near 420 nm is more prominent for the K72A variant. Based on the pKapp values in Table
4.1, the population of the alkaline conformer will be near 50% for WT iso-1-Cytc and the K73A
variant at pH 8. The higher pKapp of the K72A variant will lead to <20% population of the
alkaline conformer at pH 8. Thus, the diminished negative trough in buffer at pH 8 appears to be
linked to population of the alkaline conformer.
Pandiscia et al.27 showed a shift in the peak location in the Soret CD during titration with CLcontaining vesicles. They used a peak to trough amplitude defined by the initial, unbound protein
signal to characterize lipid-protein interactions. Peak wavelength shifts were observed (blue
shifted) during the titration of each variant with CL vesicles (Figures 4.4 and 4.6). Following
Pandiscia et al, relative amplitude was defined for each variant as the peak minus the trough of
the unbound protein. The peak and trough wavelength for the unbound state were used to define
amplitude throughout the titration (Figure 4.7). Monitoring the peak-trough amplitude in the
Soret region of each variant effectively tracks changes in the heme environment as the exposed
LPR increases.
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Figure 4.7. The difference in the CD signal at the peak and the trough wavelengths of the
unbound iso-1-Cytc variants, ∆∆𝜀 = ∆𝜀max- ∆𝜀 min, as 100 nm TOCL vesicles are titrated into 10
µM solutions of yeast iso-1-Cytc variants in 20 mM TES, 0.1 M EDTA buffer at pH 8 and 25 oC.
The titrations are reported in exposed LPR. WT (black), K72A (red), K73A (yellow), K72|73A
(gray), K86A (cyan), K87A (orange), and K86|87A (green) data points are fit to a one-site
cooperative binding model (eq 4.1, solid curves). The K72|73|86|87A (lavender) variant data
points are simply connected with a dashed line.

4.3.4. Fits of Soret CD Amplitudes to a One-site Cooperative Binding Model.
The amplitude, ∆∆𝜀, due to protein binding to CL liposomes varies from variant to variant
with the largest amplitude observed for the K87A, K86A and K86|87A variants and the smallest
change in amplitude over the titration demonstrated by the K72|73A variant (Figure 4.7).
Averaged Soret CD amplitude data as a function of exposed LPR for each variant were fit to a
one-site cooperative Hill equation (eq 4.1)26 to elucidate A-site specific CL binding,
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𝑛
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(4.1)

where the spectroscopic value, s(x) corresponds to the amplitude measured at the exposed LPR,
x, in the titration, so is the value of spectroscopic parameter for the initial state, s1 is the value of
spectroscopic parameter for the final state, Kd(app) is the apparent dissociation

Table 4.2. Thermodynamic parameters for binding of site A of Cytc to 100% CL vesicles.
CDa,b
Fluorescencea,c
n
Variant
Kd(app) (LPR, µM)
n
Kd(app) (LPR, µM)
WT
10.2 ± 0.2
2.2 ± 0.1
23.4 ± 0.8
2.3 ± 0.2
(102 ± 2)
(117 ± 4)
K72A
9.8 ± 0.2
2.01 ± 0.07
26.2 ± 0.8
2.31 ± 0.10
(98 ± 2)
(131 ± 4)
K73A
11.5 ± 0.8
29.8 ± 1.7
2.07 ± 0.15
1.6 ± 0.1
(115 ± 8)
(139 ± 6)
K72|73A
12.4 ± 1.2
34.0 ± 2.7
1.77 ± 0.13
1.6 ± 0.1
(124 ± 12)
(195 ± 23)
K86A
10.6 ± 0.4
22.9 ± 0.7
1.93 ± 0.08
1.85 ± 0.08
(106 ± 4)
(114 ± 4)
K87A
11.2 ± 0.3
1.92 ± 0.06
22.0 ± 0.9
1.97 ± 0.13
(112 ± 3)
(107 ± 4)
K86|87A
1.7 ± 0.1
22.2 ± 0.7
2.88 ± 0.15
11.6 ± 0.8
(109 ± 3.7)
(116 ± 8)
aReported in exposed (outer leaflet) lipid to protein ratio (LPR) and in brackets µM exposed
lipid concentration. Error corresponds to the standard error in the fit of the parameter. bCytc
concentration was 10 µM. cCytc concentration was 5 µM.
constant for the iso-1-Cytc-CL interaction at the membrane surface, and n is the associated Hill
coefficient and can be interpreted as the number of lipids binding to site A. Figure 4.7 shows the
fit to eq 4.1 overlaid with the amplitude data for each mutant. Parameters for the fits to eq 4.1 are
reported in Table 4.2.
The values of Kd(app) for the K72A and K86A variants are within error the same as for WT,
whereas there are small increases in Kd(app) for the K73A and K87A variants. Within error the
double-substitution variants, K72|73A and K86|87A, have Kd(app) values that are identical to
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those observed for the K73A and K87A variants. The modest effect on Kd(app) for the binding
event monitored by Soret CD indicates that the variation in the degree of population of the
alkaline conformer for these variants does not significantly affect the binding event observed by
Soret CD,
All variants show a decrease in their Hill coefficient, n, relative to WT, suggesting that loss
of lysines decreases the average number of lipids interacting with site A. Loss in lipid binding is
modest for both K72A and K87A (~0.2 and ~0.3 lipids). K73A and K86A demonstrate a more
pronounced loss in lipid binding through their Lys→Ala substitutions (~0.6 and ~0.35 lipids,
respectively). The double mutant, K72|73A has the same decrease in n as the K73A variant in
(~0.6 lipids), whereas the K86|87A exhibits a further decrease in lipid binding (~0.5 lipids)
indicating that both lysines of this subcluster contribute to the CL interaction.

4.3.5. Cardiolipin Binding Monitored using Trp59 Fluorescence.
Tryptophan fluorescence was used as a secondary probe to investigate environmental
changes indicative of protein structural rearrangement (partial to full unfolding) in and around
the heme crevice as a result of the iso-1-Cytc-CL interaction. Cytc has one tryptophan at position
59 in the heme crevice (Figure 4.1) that is quenched by heme when the protein is folded. The
increase in Trp59 fluorescence when Trp59 moves away from the heme has been used to monitor
loss of tertiary structure when Cytc unfolds.61 Exposure of WT and variant forms of iso-1-Cytc
to 100% CL vesicles leads to increased tryptophan fluorescence, corresponding to a distance
increase of Trp59 from the heme, which is indicative of partial or full unfolding of the protein
(Figure 4.8, Figure 4.9). A red shift of fluorescence peak location is observed for WT and all
variants (Figure 4.10), consistent with an increase in the solvent exposure of Trp59.
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Figure 4.8. Trp59 Fluorescence emission spectra of 5 µM K73A (left) and K87A (right) iso-1Cytc titrated with 100 nm TOCL vesicles in 20 mM TES, 0.1 mM EDTA buffer at pH 8 and 25
oC.

Lipid concentration increases from 0 µM to ~250 µM (outer leaflet) lipid concentration

(black→red→blue). Fluorescence is in arbitrary units (A.U).
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Figure 4.9. Trp59 fluorescence emission spectra of 5 µM yeast iso-1-cytc variants titrated with
100 nm CL vesicles in 20 mM TES. 0.1 mM EDTA buffer at pH 8 and at 25 oC. Exposed (outer
leaflet) CL concentration ranges from 0→250 µM (black→red→blue).
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Figure 4.10. Trp59 spectral peak location (in nm) from 100 nm CL vesicles titrated into 5 µM
WT(black), K72A (red), K73A (yellow), K72|73A (gray), K86A (cyan), K87A (orange), and
K86|87A (green) iso-1-Cytc in 20 mM TES. 0.1 mM EDTA buffer at pH 8 and at 25 oC.
Titrations are reported in exposed LPR.

To track progression of the iso-1-Cytc-CL interaction by fluorescence, the peak wavelength
location in the final titration spectrum of each variant (see Figure 4.10) was used. The increase in
fluorescence intensity versus exposed LPR for each variant is shown in Figure 4.11. Peak shift
and center of mass shift were also tracked over the course of the titration (Figure 4.10, Figure
4.12). Both peak shift and center of mass shift demonstrate the impact of lysine removal on
solvent exposure of Trp59. K86|87A and K87A demonstrate the greatest red shift in peak
location while K72|73A has the smallest peak shift relative to the folded protein (Figure 4.10).
K86|87A and K87A also have the largest shift in center of mass location while K72|73A center
of mass shift is minimal (Figure 4.12).
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Figure 4.11. Increase in Trp59 emission during titration of iso-1-cytc variants with 100 nm CL
vesicles in 20 mM TES, 0.1 mM EDTA buffer at pH 8 and 25 oC. The concentration of iso-1Cytc was 5 µM in all titrations. A single-site cooperative binding model is fit to titration data
(solid curves). Error bar are one standard deviation from multiple independent trials, WT(black),
K72A (red), K73A (yellow), K72|73A (gray), K86A (cyan), K87A (orange), and K8|687A
(green). The K72|73|86|87A variant (lavender data points connected by a dashed line) is shown
without a fit. Fluorescence measured in arbitrary units.
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Figure 4.12. Trp59 spectral center of mass location (in nm) for 100 nm CL vesicles titrated into
5 µM WT(black), K72A (red), K73A (yellow), K72|73A (gray), K86A (cyan), K87A (orange),
and K86|87A (green) iso-1-Cytc in 20 mM TES, 0.1 mM EDTA buffer at pH 8 and at 25 oC.
Titrations are reported in exposed LPR.

The fluorescence binding curves for each variant were fit using eq 1 (Figure 4.11). The
Kd(app) with respect to exposed LPR obtained from fluorescence data for each variant is 2- to 3fold larger than Kd(app) obtained from the Soret CD-monitored titration data. This observation
indicates that the iso-1-Cytc-CL interaction is biphasic (Figure 4.13). The magnitude of the
change in Kd(app) obtained from fluorescence data also depends on which subcluster of site A
contains the Lys→Ala substitution(s). Substitution of one or both of the lysines in the
Lys86/Lys87 subcluster of site A has minimal impact on Kd(app). By contrast, substitution of the
lysines in the Lys72/73 subcluster leads to significant increases in Kd(app), with the K72|73A
double-substitution variant increasing Kd(app) by 45%. It is also noteworthy that variants with
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substitutions in the Lys86/Lys87 subcluster all lead to significant increases in Trp59 fluorescence
relative to WT iso-1-Cytc (Figures 4.8, 4.9 and 4.11) when bound to CL at high exposed LPR.
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Figure 4.13. Soret CD signal change (ΔΔ𝜀= Δ𝜀max- Δ𝜀min) for 100 nm CL vesicles titrated into
10 µM yeast iso-1-Cytc variants in 20 mM TES, 0.1 mM EDTA buffer at pH 8 (blue) overlaid
with Trp59 emission amplitudes for 100 nm CL vesicles titrated into 5 µM yeast iso-1-Cytc
variants in 20 mM TES, 0.1 mM EDTA buffer at pH 8 (red). Titration reported as a function of
exposed LPR. A one-site cooperative binding model is fit to the titration data (solid lines). Data
were acquired at 25 oC.
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The magnitude of Kd(app) for the K86A, K87A, and K86|87A variants shows minimal
perturbation from the WT Kd(app) (decrease of 0.5 – 1.5 in units of exposed LPR, see Table 4.2).
This minimal response suggests that lysines at residues 86 and 87 do not strongly impact the
large scale structural rearrangement that occurs at high exposed LPR and causes Trp59 to move
away from the heme. Conversely, the Kd(app) for the K72A, K73A and K72|73A variants
increases more significantly relative to WT iso-1-Cytc (3 – 11 in units of exposed LPR). The
increase in required exposed lipids to induce partial unfolding indicates that Lys72 and Lys73 are
both important for partial unfolding of iso-1-Cytc on CL liposomes.
For fluorescence monitored binding phase, all variants, except K72A, demonstrate changes in
the number of lipids bound, n. The K73A diminishes n by 0.2 units and the K72|73A variants
decreases n by ~0.5 units. Thus, removal of both lysines, K72|73A, has a combined cooperativity
loss greater than expected based on the values of n for the individual variants. K86A and K87A
show decreases in n of ~0.35 and ~0.30 lipids. However, the K86|87A variants show an additive
increase in n of approximately ~0.55 lipids.

4.3.6. Trp59 Environment Monitored using Circular Dichroism.
The CD region reporting Trp59 rearrangement was investigated to determine the role of CL
in local rearrangement around the amino acid following the work of Pinheiro et al. 62 Figure 4.14.
shows near UV CD in the absence (folded protein) and presence (unfolded protein) of 3 M
GdnHCl as well as in the presence of CL vesicles at a concentration corresponding to an exposed
LPR of 5 for each variant. Each variant demonstrates minimal perturbation of the near UV CD
signal in the presence of CL under crowded conditions on the membrane surface. The sharp
minima at 282 and 289 nm are characteristic of Trp59 in the native state structure of iso-1-
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Cytc.63 This finding shows that in the region of the binding curve where the surface density of
iso-1-Cytc is expected to be high (low exposed LPR), the perturbation to the near UV CD, and
thus to the Trp59 environment, is minimal. By contrast, large changes in the near UV CD are
observed in 3 M GdnHCl where all variants are expected to fully unfolded (see Figure 4.3).
These results indicate that at low exposed LPR the environment of Trp59 is only modestly
perturbed. Previous work on horse Cytc binding to phosphatidylserine (DOPS) vesicles at a high
exposed LPR of 125 show complete loss of the near UV signal due to Trp59. 62
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Figure 4.14. Near UV CD of 50 µM yeast iso-1-Cytc variants in 20 mM TES, 0.1 mM EDTA
buffer at pH 8 (black) overlaid with 50 µM yeast iso-1-Cytc variants mixed with 500 µM 100
nm CL vesicles in 20 mM TES, 0.1 mM EDTA buffer at pH 8 (exposed LPR = 5; blue) and with
50 µM yeast iso-1-Cytc variants in 3 M GdnHCl in 20 mM TES, 0.1 mM EDTA buffer at pH 8
(red). All spectra were recorded at 25 oC.
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4.4. DISCUSSION
4.4.1. General Features of Cardiolipin Binding to Site A at pH 8.
In previous work, we established that we can isolate binding to site A at pH 8. 39 Under these
conditions, we no longer observe an increase in light scattering in the UV-Vis absorbance
spectrum that is typical of binding to site L.32 We are also above the pH regime where binding to
site C is expected to occur.14 In our previous report, we observed that an isodichroic point in the
Soret CD spectra of WT yeast iso-1-Cytc and a K72A variant begins to form at an exposed LPR
near 3.39 This result indicates that initial intermolecular binding occurs below an exposed LPR of
~3 with the remainder of the titration representing a conformational rearrangement of iso-1-Cytc
on the surface of 100% CL vesicles. A similar behavior is observed here for all of the site A
Lys→Ala variants. However, the isodichroic point does not establish until a somewhat higher
exposed LPR for the K87A (see Figure 4.4) and the K86|87A variant (Figure 4.6), suggesting
that these substitutions weaken the initial intermolecular binding to the CL vesicles. In the case
of the quadruple substitution variant, K72|73|86|87A, a separate intermolecular binding phase is
apparent in the binding isotherm (Figure 4.7), indicating that intermolecular binding is
significantly weakened for this variant.
In our previous report,39 and for all variants studied here, the majority of the amplitude signal
propagation of the Soret CD-monitored binding titration occurs after the initial intermolecular
association. The minimal effect of intermolecular association on the Soret CD at small values of
exposed LPR indicates that when the membrane surface is crowded, the structure of iso-1-Cytc is
minimally effected by binding to 100% CL vesicles. Consistent with this observation, the largest
change in the Soret CD signal occurs during the initial intermolecular association of the
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K72|73|86|87A variant for which intermolecular association is not complete until larger values of
exposed LPR. Because we are observing intramolecular rearrangements of membrane bound iso1-Cytc, which appear to be dependent on available space on the membrane surface, we report all
apparent dissociation constants, Kd(app), in terms of exposed LPR.
In our previous work, binding monitored by Trp59 fluorescence occurs at larger values of
exposed LPR than binding monitored by Soret CD.39 This observation is consistent with two
sequential structural rearrangements on the surface of the CL vesicles. The same behavior is
observed here for all site A Lys→Ala variants (Figure 4.13 and Table 4.2). The characteristic
positive/negative couplet observed for the Soret CD of the native state of Cytc has been
attributed to the presence of the heme-Met80 bond64 and is believed to report on the orientation
of Ph82 relative to the heme,59 although exact structural determinants of the splitting of the
couplet are likely more complex.65 An X-ray structure of the K72A variant of iso-1-Cytc at pH
8.8 shows that a modest structural rearrangement of iso-1-Cytc is sufficient to permit
replacement of the Met80 heme ligand by water. Quenching of Trp59 fluorescence is used to
monitor loss of tertiary structure as Trp59 moves away from the heme (see Figure 4.1). 61

For

most of the site A Lys→Ala variants, the increase in Trp59 fluorescence is small during the CDmonitored transition (Figure 4.13). Thus, the first structural rearrangement is likely a small
conformational rearrangement that alters the heme environment. The modest effect of CL
binding on the near UV CD spectrum of iso-1-Cytc at low exposed LPR (Figure 4.14) is also
consistent with this conclusion. The second conformational change, which leads to a large
increase in Trp fluorescence, is consistent with significant unfolding of iso-1-Cytc. The existence
of an equilibrium between compact and extended conformers has previously been demonstrated
for the binding of horse Cytc to CL vesicles.18, 26 These features of CL binding to site A of yeast
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iso-1-Cytc qualitatively remain unaltered even by complete elimination of the four lysines
(K72|73|86|87A variant) most commonly considered to define the boundaries of site A (Figure
4.13). This observation indicates that site A may be a more extensive binding site than
previously thought.

4.4.2. Effect of Lys→Ala Substitutions in Site A on the Structure of Iso-1-Cytc bound to CL
Vesicles.
For CL vesicle binding to the cluster of positive charges that comprise site A, the degree of
perturbation to the structure of iso-1-Cytc, as detected by either Soret CD or Trp59 fluorescence,
depends on whether the substitution is in the Lys72/73 or the Lys86/87 charge subcluster. The
K86A, K87A and K86|87A variants all show a larger change in both the Soret CD signal
(Figures 4.4, 4.6 and 4.7) and a greater increase in the Trp59 fluorescence (Figures 4.8, 4.9 and
4.11) compared to the binding of WT iso-1-Cytc to CL vesicles. Thus, elimination of the Lys86
and/or Lys87 charges leads to a larger perturbation of the heme environment for binding to CL
vesicles at low exposed LPR (crowded vesicle surface) and a larger degree of loss of tertiary
structure for binding to CL vesicles at high exposed LPR (uncrowded vesicle surface). By
contrast, the K72A, K73A and K72|73A variants all cause a smaller change in both the Soret CD
signal (Figures 4.4, 4.6 and 4.7) and a smaller increase in the Trp59 fluorescence (Figures 4.8,
4.9 and 4.11) compared to the binding of WT iso-1-Cytc to CL vesicles. Therefore, elimination
of the Lys72 and/or Lys73 charges leads to a smaller perturbation of the heme environment at
low exposed LPR (crowded vesicle surface) and a larger degree of loss of tertiary structure at
high exposed LPR (uncrowded vesicle surface).
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The shift in the emission maximum of Trp59 upon binding to CL vesicles (Figure 4.10) is
also consistent with the relative degree of unfolding indicated by the increase in Trp59
fluorescence observed for the different site A Lys→Ala variants (Figures 4.8, 4.9 and 4.11). For
WT iso-1-Cytc, the wavelength of maximum emission from the Trp59 shifts from ~330 nm for
the native state of iso-1-Cytc to near 340 nm when bound to CL vesicles through site A at high
exposed LPR.39 This shift in emission maximum indicates that Trp59 moves from a buried to a
surface-exposed site in contact with ordered water when bound to CL vesicles. 66 Exposure to
bulk water typically leads to an emission maximum near 350 nm for tryptophan. 66 For the K86A,
K87A and K86|87A variants the emission maximum shifts to ~342 nm indicating greater
exposure to bulk water for these variants when bound through site A to CL vesicles at high
exposed LPR (Figure 4.10). The greater exposure to bulk water for these variants relative to WT
iso-1-Cytc is consistent with the higher degree of unfolding relative to WT iso-1-Cytc indicated
by their higher emission intensity when bound to CL vesicles at high exposed LPR (Figures 4.8,
4.9 and 4.11). For the K72A, K73A and K72|73A variants the emission maximum shift is
smaller than for WT iso-1-Cytc, shifting only to ~335 nm for the K72|73A variant at high
exposed LPR (Figure 4.10). The smaller shift in emission maximum for these variants indicates
that Trp59 is more buried for these variants when bound through site A to CL vesicles at high
exposed LPR. A more buried Trp59 for these variants relative to WT iso-1-Cytc is consistent
with the lesser degree of unfolding relative to WT iso-1-Cytc indicated by their lower emission
intensity when bound to CL vesicles at high exposed LPR (Figures 4.8, 4.9 and 4.11).
These observations indicate that binding through the Lys72/Lys73 charge subcluster of site A
is necessary for larger conformational rearrangements both at low exposed LPR (crowded vesicle
surface) and high exposed LPR when bound to CL vesicles through site A. By contrast, the
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Lys86/Lys87 charge subcluster of site A appears to inhibit larger scale conformational
rearrangements at both at low exposed LPR (crowded vesicle surface) and high exposed LPR
when bound to CL vesicles through site A. When lysines 86 and 87 are substituted by alanine,
binding to CL vesicles through site A leads to larger conformational rearrangements. The
K72|73|86|87A variant, which eliminates both site A charge subclusters shows conformational
rearrangements upon binding to CL vesicles that are intermediate between the effects of the two
subclusters (Figures 4.6-4.9) indicating that the effects of the two charge subclusters on binding
to CL vesicles through site A are compensatory.

4.4.3. Effect of Lys→Ala Substitutions in Site A on Kd(app) and the cooperativity of binding
of Iso-1-Cytc to CL Vesicles.
In our comparative study on yeast iso-1-Cytc versus human Cytc binding to CL vesicles via
site A,39 we noted that our Kd(app) values are higher (weaker apparent binding) that in previous
studies carried out at pH 7 and 7.4.26, 28-30, 36, 67 This difference likely reflects the involvement of
site C and site L in these studies of binding at lower pH. Lys→Asn and Lys→Arg substitutions
in Ω-loop-D (residues 70 – 85) also indicated that Lys73 and Lys79 were critical for binding at
pH 7. We see no such specificity in our data at pH 8. This difference likely reflects participation
of site C and/or site L at pH 7. Site C is believed to involve direct insertion of one or more of the
hydrocarbon chains of CL into the hydrophobic core of Cytc.15, 35, 36 Insertion of a hydrocarbon
chain undoubtedly introduces restrictions not present for binding only through site A, the anionic
site.
As discussed above, our data for the binding of iso-1-Cytc variants to CL vesicles via site A
are consistent with the thermodynamic parameters in Table 4.2 reporting on conformational
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rearrangements of iso-1-Cytc already bound on the surface of the CL vesicles. That said, it is
evident for the K87A and K86|87A variants and most particularly the K72|73|86|87A variant
(Figure 4.6 and 4.7) that the isodichroic point for binding monitored by Soret CD does not form
until further into the binding titration. This observation suggests that these variants have
qualitatively weaker intermolecular association with CL vesicles than WT iso-1-Cytc. Because
of the low amplitude of this pre-isodichroic point phase, we were unable to fit the data for these
variants to a more complex model.
The most noteworthy observation in Table 4.2 is that Kd(app) is not strongly sensitive to the
site A Lys→Ala substitutions. Once bound to the membrane, two stages of conformational
rearrangement occur, a first phase under crowded conditions (low exposed LPR) involving
perturbation of the heme environment and a second phase involving partial unfolding of Cytc
that requires more space on the membrane surface (high exposed LPR). The relative insensitivity
of Kd(app) to site A Lys→Ala substitutions suggests that site A is fairly malleable, with the loss
of one or more lysines relatively easily replaced by nearby lysines. We were unable to obtain a
reliable fit of the Soret CD or the Trp59 emission versus exposed LPR data to the simple one site
cooperative binding model for the K72|73|86|87A variant which has all lysines commonly
attributed to site A replaced with alanine. It is evident that two separable conformational
rearrangements still occur (Figures 4.7, 4.11 and 4.13). Thus, in the absence of the “site A”
lysines other nearby positively charged groups, (Arg13, Arg91 and Lys88 for the Lys86/Lys87
charge subcluster and Lys54, Lys55 and Lys79 for the Lys72/Lys73 subcluster) appear to be able
to cause similar structural rearrangements at similar degrees of crowding (exposed LPR) on the
membrane surface.
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The Kd(app) for the first phase monitored by Soret CD is only modestly sensitive to exposed
LPR. The K73A and K86A variants yield Kd(app) within error of the WT value of 10.2 ± 0.2,
with maximal increases of 15 – 20% for the K72|73A and K86|87A variants. The cooperativity,
n, which provides an estimate of the number of CL involved in this phase, decreases for all
variants. Thus, elimination of lysines appears to decrease the number of lipids that interact with
iso-1-Cytc in the first conformational rearrangement. For the Lys72/Lys73 subcluster, Lys73 is
the dominant contributor to the cooperativity, whereas in the Lys86/Lys87 subcluster the two
lysines appear to contribute equally to the cooperativity of the conformational rearrangement
when the surface of the membrane is crowded.
The behavior of Kd(app) for the second phase monitored by Trp59 fluorescence depends
strongly on the subcluster of site A, which has had its charges neutralized. Substitution of either
Lys72 or Lys73 increases Kd(app) and the increase is roughly additive in the K72|73A variant
with the K72|73A variant showing a 45% increase in Kd(app). For the Lys86/Lys87 charge
subcluster, Lys→Ala substitutions do not affect Kd(app). The effect of substitutions in the
Lys86/Lys87 subcluster on the emission maximum and on the degree of increase in Trp59
emission intensity upon binding to CL vesicles suggest a higher degree of unfolding than for WT
iso-1-Cytc. More extensive unfolding might be expected to lead to a higher Kd(app) in terms of
exposed LPR (less crowded membrane surface needed). Based on the smaller red shift in the
Trp59 emission maximum and the decrease in Trp59 emission intensity for Lys→Ala
subsitutions in the Lys72/Lys73 charge subcluster, the space needed on the membrane is
expected to be less for these variants to partially unfold. Thus, changes in Kd(app) do not
correlate well with degree of unfolding assessed by Trp59 fluorescence (Trp59-heme distance).
It can be speculated that neutralization of the Lys86/87 charge subcluster shifts the site A
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interaction toward partial unfolding centered around Lys54/Lys55 and Lys72/Lys73, increasing
the Trp59-heme distance but not requiring a large increase in the space needed on the membrane
relative to WT iso-1-Cytc. In the absence of the Lys72/Lys73 charge subcluster, partial
unfolding may be dominated by the Lys86/Lys87 charge subcluster with concomitant unfolding
of the C-terminal helix. This possibility would require more space on the membrane, but might
lead to a smaller increase in the Trp59-heme distance for iso-1-Cytc bound to CL vesicles at high
exposed LPR if Ω-loop-C (residues 40 – 57) is less disrupted in the absence of Lys72/Lys73.
Fluorescence resonance energy transfer studies on horse Cytc binding to CL vesicles are
consistent with both the 60s helix and the C-terminal helix moving away from the heme.18
Substitutions in the Lys72/73 versus the Lys86/87 charge subcluster may shift the ensemble of
iso-1-Cytc structures on the membrane surface from ones involving partial unfolding near the
60s helix versus the C-terminal helix.
In all cases, the cooperativity, n, in Table 4.2 for the second phase of structural
rearrangement when iso-1-Cytc is bound to CL vesicles is near 2, indicating that no matter the
composition of site A interactions, direct interaction with ~2 CL lipids is needed for partial
unfolding of iso-1-Cytc. The cause of the increase in n for the K86|87A variant is unclear based
on the current data.

4.4.4. Implications for the Peroxidase Activity Signaling Switch in Apoptosis.
Studies on horse Cytc bound to CL vesicles indicate that the degree of structural
rearrangement that occurs on CL vesicles correlates with the peroxidase activity of the bound
Cytc.18 The effects of neutralizing the different subclusters of iso-1-Cytc show that the
distribution of positively charged amino acids on the surface of Cytc can be used to control the
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magnitude of the structural rearrangement that occurs when Cytc binds to CL on the inner
mitochondrial membrane. Thus, it is possible that the distribution of charges on the surface of
Cytc has evolved to maximize the increase in peroxidase activity of Cytc and thus the
effectiveness of the signaling switch when it is bound to CL in the early stages of apoptosis. Our
previous comparative study of the binding of yeast iso-1-Cytc and human Cytc to 100% CL
vesicles is consistent with the hypothesis. The magnitude of the enhancement in Trp59 emission
for WT human Cytc relative to WT iso-1-Cytc is similar to the effect of elimination of the
Lys86/Lys87 charge subcluster for iso-1-Cytc. Thus, the distribution of charges on the surface of
human Cytc (see Figure 2 in ref. 39) appears to have evolved to allow for a larger structural
rearrangement when human Cytc binds to CL. Recent studies on the G41S and Y48H diseasecausing variants of human Cytc indicate a linkage between increased dynamics at the interface of
Ω-loops C (residues 40 – 57) and D (residues 70 – 85) and enhanced peroxidase activity.68, 69 The
similarity of the behavior of the Lys86/87 iso-1-Cytc charge subcluster variants and human Cytc
may reflect evolution of Cytc toward a distribution of charges on the surface of human Cytc that
favors opening at the interface of Ω-loops C and D when bound to CL vesicles. Such evolution
of the charge distribution could optimize the peroxidase signaling switch in the early stages of
apoptosis.

4.5. CONCLUSIONS
We show that binding of iso-1-Cytc to 100% CL vesicles specifically through site A at pH 8,
is not strongly dependent on any one of the four lysines commonly attribute to site A. Our results
indicate that the specific complement of positively charged residues comprising site A is fairly
malleable. These results contrast with previous work at pH 7 which suggest that lysines 72 and
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79 are critical for binding to CL.29, 30 The difference is likely because binding at pH 7 includes
contributions from other binding sites such as site C. Our data also show that the details of both
the small structural rearrangement at low exposed LPR (crowded membrane surface) and the
larger structural rearrangement at high exposed LPR (uncrowded membrane surface) are
significantly dependent on the site A lysines available for interaction with CL. These results
suggest that site A may have evolved to optimize the structural switch that turns on peroxidase
activity in the early stages of apoptosis.
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V., Tomasina, F., Radi, R., and Murgida, D. H. (2017) Multifunctional cytochrome c:
learning new tricks from an old dog, Chem. Rev. 117, 13382−13460.
(9) Kagan, V. E., Bayir, H. A., Belikova, N. A., Kapralov, O., Tyurina, Y. Y., Tyurin, V. A.,
Jiang, J., Stoyanovsky, D. A., Wipf, P., Kochanek, P. M., Greenberger, J. S., Pitt, B.,
Shvedova, A. A., and Borisenko, G. (2009) Cytochrome c/cardiolipin relations in
mitochondria: a kiss of death, Free Radical Biol. Med. 46, 1439-1453.
(10) Kagan, V. E., Tyurin, V. A., Jiang, J., Tyurina, Y. Y., Ritov, V. B., Amoscato, A. A.,
Osipov, A. N., Belikova, N. A., Kapralov, A. A., Kini, V., Vlasova, I. I., Zhao, Q., Zou, M.,
Di, P., Svistunenko, D. A., Kurnikov, I. V., and Borisenko, G. G. (2005) Cytochrome c acts
as a cardiolipin oxygenase required for release of proapoptotic factors, Nat. Chem. Biol. 1,
223-232.
(11) Purring-Koch, C., and McLendon, G. (2000) Cytochrome c binding to Apaf-1: The effects
of dATP and ionic strength, Proc. Natl. Acad. Sci. U.S.A. 97, 11928-11931.
(12) Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996) Induction of apoptotic
program in cell-free extracts: requirement for dATP and cytochrome c, Cell 86, 147-157.
(13) Jiang, X., and Wang, X. (2004) Cytochrome c-mediated apoptosis, Annu. Rev. Biochem. 73,
87-106.
125

(14) Rytömaa, M., and Kinnunen, P. K. J. (1994) Evidence for two distinct acidic phospholipidbinding sites in cytochrome c, J. Biol. Chem. 269, 1770-1774.
(15) Rytömaa, M., and Kinnunen, P. K. J. (1995) Reversibility of the binding of cytochrome c to
liposomes, J. Biol. Chem. 270, 3197-3202.
(16) Tuominen, E. K. J., Zhu, K., Wallace, C. J. A., Clark-Lewis, I., Craig, D. B., Rytömaa, M.,
and Kinnunen, P. K. J. (2001) ATP Induces a conformational change in lipid-bound
cytochrome c, J. Biol. Chem. 276, 19356–19362.
(17) Muenzner, J., and Pletneva, E. V. (2014) Structural transformations of cytochrome c upon
interaction with cardiolipin, Chem. Phys. Lipids 179, 57-63.
(18) Hanske, J., Toffey, J. R., Morenz, A. M., Bonilla, A. J., Schiavoni, K. H., and Pletneva, E.
V. (2012) Conformational properties of cardiolipin-bound cytochrome c, Proc. Natl. Acad.
Sci. U.S.A. 109, 125-130.
(19) Hong, Y., Muenzner, J., Grimm, S. K., and Pletneva, E. V. (2012) Origin of the
conformational heterogeneity of cardiolipin-bound cytochrome c, J. Am. Chem. Soc. 134,
18713-18723.
(20) Amacher, J. F., Zhong, F., Lisi, G. P., Zhu, M. Q., Alden, S. L., Hoke, K. R., Madden, D.
R., and Pletneva, E. V. (2015) A compact structure of cytochrome c trapped in a lysineligated state: loop refolding and functional implications of a conformational switch, J. Am.
Chem. Soc. 137, 8435-8449.
(21) Muenzner, J., Toffey, J. R., Hong, Y., and Pletneva, E. V. (2013) Becoming a peroxidase:
cardiolipin-induced unfolding of cytochrome c, J. Phys. Chem. B 112, 12878-12886.
(22) Nantes, I. L., Zucchi, M. R., Nascimento, O. R., and Faljoni-Alario, A. (2001) Effect of
heme iron valence state on the conformation of cytochrome c and its association with
membrane interfaces - A CD and EPR investigation, J. Biol. Chem. 276, 153-158.
(23) Mandal, A., Hoop, C. L., DeLucia, M., Kodali, R., Kagan, V. E., Ahn, J., and van der Wel,
P. C. A. (2015) Structural changes and proapoptotic peroxidase activity of cardiolipin-bound
mitochondrial cytochrome c, Biophys. J. 109, 1873-1884.
(24) Heimburg, T., and Marsh, D. (1993) Investigation of secondary and tertiary structuralchanges of cytochrome-c in complexes with anionic lipids using amide hydrogen-exchange
measurements - an FTIR study, Biophys. J. 65, 2408-2417.
(25) Gorbenko, G. P., Molotkovsky, J. G., and Kinnunen, P. K. J. (2006) Cytochrome c
interaction with cardiolipin/phosphatidylcholine model membranes: effect of cardiolipin
protonation, Biophys. J. 90, 4093–4103.
(26) Pandiscia, L. A., and Schweitzer-Stenner, R. (2015) Coexistence of native-like and nonnative partially unfolded ferricytochrome c on the surface of cardiolipin-containing
liposomes, J. Phys. Chem. B 119, 1334-1349.
126

(27) Pandiscia, L. A., and Schweitzer-Stenner, R. (2015) Coexistence of native-like and nonnative cytochrome c on anionic liposomes with different cardiolipin content, J. Phys. Chem.
B 119, 12846-12859.
(28) Sinibaldi, F., Fiorucci, L., Patriarca, A., Lauceri, R., Ferri, T., Coletta, M., and Santucci, R.
(2008) Insights into the cytochrome c-cardiolipin interaction. Role played by ionic strength,
Biochemistry 47, 6928-6935.
(29) Sinibaldi, F., Howes, B. D., Droghetti, E., Polticelli, F., Piro, M. C., Di Pierro, D., Fiorucci,
L., Coletta, M., Smulevich, G., and Santucci, R. (2013) Role of lysines in cytochrome
c−cardiolipin interaction, Biochemistry 52, 4578−4588.
(30) Sinibaldi, F., Milazzo, L., Howes, B. D., Piro, M. C., Fiorucci, L., Polticelli, F., Ascenzi, P.,
Coletta, M., Smulevich, G., and Santucci, R. (2017) The key role played by charge in the
interaction of cytochrome c with cardiolipin, J. Biol. Inorg. Chem. 22, 19–29.
(31) Kostrzewa, A., Páli, T., Froncisz, W., and Marsh, D. (2000) Membrane location of spinlabeled cytochrome c determined by paramagnetic relaxation reagents, Biochemistry 39,
6066-6074.
(32) Kawai, C., Prado, F. M., Nunes, G. L. C., Di Mascio, P., Carmona-Ribeiro, A. M., and
Nantes, I. L. (2005) pH-dependent interaction of cytochrome c with mitochondrial mimetic
membranes: the role of an array of positively charges amino acids, J. Biol. Chem. 280,
34709-34717.
(33) O'Brien, E. S., Nucci, N. V., Fuglestad, B., Tommos, C., and Wand, A. J. (2015) Defining
the apoptotic trigger: the interaction of cytochrome c and cardiolipin, J. Biol. Chem. 290,
30879-30887.
(34) Rytömaa, M., Mustonen, P., and Kinnunen, P. K. J. (1992) Reversible, nonionic, and pHdependent association of cytochrome c with cardiolipin-phosphatidylcholine liposomes, J.
Biol. Chem. 267, 22243–22248.
(35) Tuominen, A. K. J., Wallace, C. J. A., and Kinnunen, P. K. J. (2002) Phospholipidcytochrome c interaction: evidence for the extended lipid anchorage, J. Biol. Chem. 277,
8822-8826.
(36) Sinibaldi, F., Howes, B. D., Piro, M. C., Polticelli, F., Bombelli, C., Ferri, T., Coletta, M.,
Smulevich, G., and Santucci, R. (2010) Extended cardiolipin anchorage to cytochrome c: a
model for protein-mitochondrial membrane binding, J. Biol. Inorg. Chem. 15, 689-700.
(37) Ascenzi, P., Polticelli, F., Marino, M., Santucci, R., and Coletta, M. (2011) Cardiolipin
drives cytochrome c proapoptotic and antiapoptotic actions, IUBMB Life 63, 160-165.
(38) McClelland, L. J., Steele, H. B. B., Whitby, F. G., Mou, T.-C., Holley, D., Ross, J. B. A.,
Sprang, S. R., and Bowler, B. E. (2016) Cytochrome c can form a well-defined binding
pocket for hydrocarbons, J. Am. Chem. Soc. 138, 16770–16778.

127

(39) Elmer-Dixon, M. M., and Bowler, B. E. (2017) Site A-mediated partial unfolding of
cytochrome c on cardiolipin vesicles is species-dependent and does not require Lys72,
Biochemistry 56, 4830−4839.
(40) Berghuis, A. M., and Brayer, G. D. (1992) Oxidation state-dependent conformational
changes in cytochrome c, J. Mol. Biol. 223, 959-976.
(41) Duncan, M. G., Williams, M. D., and Bowler, B. E. (2009) Compressing the free energy
range of substructure stabilities in iso-1-cytochrome c, Protein Science 18, 1155-1164.
(42) McClelland, L. J., Mou, T.-C., Jeakins-Cooley, M. E., Sprang, S. R., and Bowler, B. E.
(2014) Structure of a mitochondrial cytochrome c conformer competent for peroxidase
activity, Proc. Natl. Acad. Sci. U.S.A. 111, 6648-6653.
(43) McClelland, L. J., Seagraves, S. M., Khan, M. K. A., Cherney, M. M., Bandi, S.,
Culbertson, J. E., and Bowler, B. E. (2015) The response of Ω-loop D dynamics to truncation
of trimethyllysine 72 of yeast iso-1-cytochrome c depends on the nature of loop deformation,
J. Biol. Inorg. Chem. 20, 805-819.
(44) Cherney, M. M., Junior, C., and Bowler, B. E. (2013) Mutation of trimethyllysine-72 to
alanine enhances His79-heme mediated dynamics of iso-1-cytochrome c, Biochemistry 52,
837-846.
(45) Margoliash, E., and Frohwirt, N. (1959) Spectrum of horse-heart cytochrome c, Biochem. J.
71, 570-572.
(46) Moore, G. R., and Pettigrew, G. W. (1990) Cytochromes c: Evolutionary, Structural and
Physicochemical Aspects, Springer-Verlag, New York.
(47) Kristinsson, R., and Bowler, B. E. (2005) Communication of stabilizing energy between
substructures of a protein, Biochemistry 44, 2349-2359.
(48) Pace, C. N., and Vanderburg, K. E. (1979) Determining globular protein stability: guanidine
hydrochloride denaturation of myoglobin, Biochemistry 18, 288-292.
(49) McClelland, L. J., Seagraves, S. M., Khan, M. K. A., Cherney, M. M., Bandi, S.,
Culbertson, J. E., and Bowler, B. E. (2015) The response of Ω-loop D dynamics to truncation
of trimethyllysine 72 of yeast iso-1-cytochrome c depends on the nature of loop deformation,
JBIC Journal of Biological Inorganic Chemistry 20, 805-819.
(50) Cherney, M. M., Junior, C. C., Bergquist, B. B., and Bowler, B. E. (2013) Dynamics of the
His79- heme alkaline transition of yeast iso- 1- cytochrome c probed by conformationally
gated electron transfer with Co( II) bis( terpyridine), Journal of the American Chemical
Society 135, 12772.
(51) Elmer-Dixon, M. M., and Bowler, B. E. (2017) Rapid quantification of cardiolipin and
DOPC lipid and vesicle concentration, Anal. Biochem. 520, 58-61.

128

(52) Pollock, W. B., Rosell, F. I., Twitchett, M. B., Dumont, M. E., and Mauk, A. G. (1998)
Bacterial expression of a mitochondrial cytochrome c. Trimethylation of Lys72 in yeast iso1-cytochrome c and the alkaline conformational transition, Biochemistry 37, 6124-6131.
(53) Kostrzewa, A., Páli, T., Wojciech, F., and Marsh, D. (2000) Membrane location of spinlabeled cytochrome c determined by paramagnetic relaxation reagents, Biochemistry 39,
6066-6074.
(54) Rosell, F. I., Ferrer, J. C., and Mauk, A. G. (1998) Proton-linked protein conformational
switching: definition of the alkaline conformational transition of yeast iso-1-ferricytochrome
c, J. Am. Chem. Soc. 120, 11234-11245.
(55) Nelson, C. J., and Bowler, B. E. (2000) pH dependence of formation of a partially unfolded
state of a Lys 73 -> His variant of iso-1-cytochrome c: implications for the alkaline
conformational transition of cytochrome c, Biochemistry 39, 13584-13594.
(56) Rosell, F. I., Ferrer, J. C., and Mauk, A. G. (1998) Proton- linked protein conformational
switching: definition of the alkaline conformational transition of yeast iso- 1ferricytochrome c, Journal of the American Chemical Society 120, 11234.
(57) Santucci, R., Bongiovanni, C., Mei, G., Ferri, T., Polizio, F., and Desideri, A. (2000) Anion
size modulates the structure of the a state of cytochrome c, Biochemistry 39, 12632-12638.
(58) Soffer, J. B., Fradkin, E., Pandiscia, L. A., and Schweitzer-Stenner, R. (2013) The (not
completely irreversible) population of a misfolded state of cytochrome c under folding
conditions, Biochemistry 52, 1397.
(59) Pielak, G. J., Oikawa, K., Mauk, A. G., Smith, M., and Kay, C. M. (1986) Elimination of
the native Soret Cotton effect of cytochrome c by replacement of the invariant phenylalanine
using site-directed mutagenesis, J. Am. Chem. Soc. 108, 2724-2727.
(60) Dragomir, I., Hagarman, A., Wallace, C., and Schweitzer-Stenner, R. (2007) Optical band
splitting in cytochrome c at room temperature probed by visible electronic circular dichroism
spectroscopy, Biophys. J. 92, 989-998.
(61) Tsong, T. Y. (1974) The Trp-59 fluorescence of ferricytochrome c as a sensitive measure of
the over-all protein conformation, J. Biol. Chem. 249, 1988-1990.
(62) Pinheiro, T. J. T., Elöve, G. A., Watts, A., and Roder, H. (1997) Structural and kinetic
description of cytochrome c unfolding induced by the interaction with lipid vesicles,
Biochemistry 36, 13122-13132.
(63) Davies, A. M., Guillemette, J. G., Smith, M., Greenwood, C., Thurgood, A. G., Mauk, A.
G., and Moore, G. R. (1993) Redesign of the interior hydrophilic region of mitochondrial
cytochrome c by site-directed mutagenesis, Biochemistry 32, 5431-5435.
(64) Santucci, R., and Ascoli, F. (1997) The Soret circular dichroism spectrum as a probe for the
heme Fe(III)-Met(80) axial bond in horse cytochrome c, J. Inorg. Biochem. 68, 211–214.
129

(65) Hagarman, A., Duitch, L., and Schweitzer-Stenner, R. (2008) The conformational manifold
of ferricytochrome c explored by visible and far-UV electronic circular dichroism
spectroscopy, Biochemistry 47, 9667-9677.
(66) Burstein, E. A., Vedenkina, N. S., and Ivkova, M. N. (1973) Fluorescence and the location
of tryptophan residues in protein molecules, Photochem. Photobiol. 18, 263-279.
(67) Sinibaldi, F., Droghetti, E., Polticelli, F., Piro, M. C., Di Pierro, D., Ferri, T., Smulevich, G.,
and Santucci, R. (2011) The effects of ATP and sodium chloride on the cytochrome c–
cardiolipin interaction: The contrasting behavior of the horse heart and yeast proteins, J.
Inorg. Biochem. 105, 1365-1372.
(68) Karsisiotis, A. I., Deacon, O. M., Wilson, M. T., Macdonald, C., Blumenschein, T. M. A.,
Moore, G. R., and Worrall, J. A. R. (2016) Increased dynamics in the 40–57 Ω-loop of the
G41S variant of human cytochrome c promote its pro-apoptotic conformation, Sci. Rep. 6,
30447.
(69) Deacon, O. M., Karsisiotis, A. I., Moreno-Chicano, T., Hough, M. A., Macdonald, C.,
Blumenschein, T. M. A., Wilson, M. T., Moore, G. R., and Worrall, J. A. R. (2017)
Heightened dynamics of the oxidized Y48H variant of human cytochrome c increases its
peroxidatic activity, Biochemistry 56, 6111-6124.

130

CHAPTER 5: Consequences of Cardiolipin Lipid Partitioning in Mixed
Membrane Systems

5.1. INTRODUCTION
Lipid bilayers provide both a barrier for containment and exclusion of cellular components as
well as a platform for protein interactions required for cell signaling. Not all bilayers are created
equal and their composition varies greatly based on cellular location and functionality. 1
Membrane lipid composition is responsible for a host of lipid-protein interactions with both local
and far reaching consequences.2 Understanding the dynamics of mixed lipid bilayers and their
impact on lipid-protein binding is essential for understanding their role in regulatory processes.
Cardiolipin (CL) is a structurally unique phospholipid that plays a pivotal role in the initial
stages of apoptosis,3,4 CL’s structural characteristics could have a dramatic impact on its function
in the mitochondria with overarching consequences that affect the entire cell. Most studies on the
properties of CL and its interactions with proteins are carried out with 1’,3’-bis[1,2-dioleoyl-snglyvero-3-phospho]-sn-glycerol (TOCL). With four mono-unsaturated acyl chains and two
phosphate groups comprising its headgroup, TOCL has a classic inverted cone or type-2 lipid
structure typical for lipids that tend to pack on concave surfaces. 1
CL is synthesized in the matrix and is inserted into the concave surface of the inner leaflet of
the inner mitochondrial membrane.3,5,6 Here, it has many important roles from facilitating an ion
gradient and tethering electron transport constituents to functioning as an apoptotic trigger. 5
Recent work shows that the electron transport chain electron shuttle, cytochrome c (Cytc),
oxidizes CL, causing dissociation of the Cytc-CL complex, and thus facilitating the exit of Cytc
from mitochondria into the cytoplasm.6 In the cytoplasm, Cytc binds to apoptotic protease
activating factor 1 (Apaf-1) causing the formation of the apoptosome, which initiates
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apoptosis.3,6 Both before and since the discovery of the role of Cytc as a peroxidase that
oxygenates CL in the earliest stages of apoptosis, considerable efforts has been directed at
characterizing Cytc-CL binding. A vast array of techniques and mimetic membrane systems has
been employed to investigate Cytc-CL binding in vitro. Both pure CL7–9 and mixed lipid
systems6,10,19–22,11–18 modeling the content of CL in the IMM have been used extensively to
characterize how Cytc docks to CL producing a conformer of Cytc that can oxidize CL.
Four potential lipid binding sites on the surface of Cytc have been described in the literature,
the anionic (A-site),10,13,23 the hydrophobic cardiolipin binding site which may involve hydrogen
bonding to Asn52 (C-site),10,13 the histidine rich, hydrogen bonding L-site24 and the novel site (N
site).25 These four sites may work independently or in concert to dock CL and facilitate its
oxidation at the peroxidase active site of a non-native conformer of Cytc.3,4,26–32,6,7,9,11,12,14,18,20
Mixed lipid systems using liposomes comprised of 20-50% CL have often been employed to
study this interaction.6,10,33,11,14,16,18–22 Lipid binding in these experiments has been investigated
solely on the exterior of the liposomes. CL composition is generally offset with the neutral
cylindrically shaped lipid 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) in these systems.1
Given that the results of the various binding studies do not agree quantitatively, it is important to
understand if partitioning of CL to the inner versus the outer leaflet of liposomes could be
affecting the differing results observed with different model systems and different methods of
vesicle preparation.
This paper elucidates the nature of two mixed membrane systems commonly used to
characterize Cytc binding to membranes by (1) evaluating the leaflet-dependent distribution of
CL and DOPG in mixed lipid vesicles, (2) assessing potential anionic, headgroup-governed,
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partitioning and (3) applying our findings on inner versus out leaflet CL distribution to Cytc
binding studies to evaluate the effect of CL partitioning on Cytc-CL binding.

5.2. EXPERIMENTAL METHODS
5.2.1. Materials.
Cardiolipin (1’,3’-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol, TOCL), DOPC (1,2dioleoyl-sn-glycero-3-phosphocholine), and DOPG (1,2-dioleoyl-sn-glycero-3-phospho-(1’-racglycerol) were purchased from Avanti Polar Lipids, Inc., Alabaster AL and used in vesicle
formation without additional purification.

5.2.2. Preparation of 1,1,2,2,-tetrakis[4-(2trimethylammonioethoxy)phenyl]ethene (TTAPE-Me).
TTAPE-Me was synthesized following previously reported methods.34,35 Briefly, 3.0 g of
4,4’ dihydroxybenzophenone (Sigma Aldrich), 5.0 g potassium carbonate (Sigma Aldrich), 4 mL
1,2 dibromoethane and 50 mL acetone were combined in a round bottom flask and refluxed
overnight. Thin layer chromatography (TLC, 75% ethyl acetate in hexanes) was used to verify
quantitative conversion of benzophenone to 4,4′-bis(2-bromoethoxy) benzophenone (BBEBP).
The identity of BBEBP was verified via gas chromatography coupled to mass spectroscopy. 0.56
g of BBEBP, 28 ml of tetrahydrofuran, 0.146 mL of titanium tetrachloride (Sigma) and 0.168 g
of zinc dust were combined in a round bottom and refluxed overnight. Conversion of BBEBP to
1,1,2,2-tetrakis[4-(2-bromoethoxy)phenyl]ethene (TBEPE) was verified by thin layer
chromatography. The 1H NMR spectrum matched that reported previously for TBEPE.34 0.4 g
TBEPE, 10 mL of tetrahydrofuran and 2.25 mL dimethyl amine were mixed for 45 minutes at
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25˚C to form TTAPE-Me. Product was purified a silica gel column and then dried using rotovap.
Successful production of TTAPE-Me was verified by 1H and 13C NMR. Observed spectra were
consistent with previously reported NMR spectra.34

5.2.3. Vesicle Preparation.
Mixed lipid samples were prepared to the desired mole ratio by combining the appropriate
volume of each lipid, based on the reported lipid concentration provided by the manufacturer
(Avanti Polar Lipids, Inc, Alabaster AL), in a 1 dram vial, mixed and dried under nitrogen to
remove chloroform. Samples were reconstituted to desired total lipid concentration using 20 mM
TES buffer, 0.1 mM EDTA, pH 8. Lipids and buffer were gently mixed using a low speed
vortexer for 1 minute and set in a warm bath at approximately 40˚C for 9 minutes; this mixing
was repeated ten times. Samples were then subjected to a freeze/thaw/mixing (-60˚C/40˚C/25˚C )
cycle five times to form vesicles. Vesicles were then extruded to 100 nm using an Avanti mini
extruder outfitted with two 100 nm pore membranes. Samples were passed through the extruder
11 times to guarantee approximate vesicle size. Vesicle size was confirmed to be 100 ± 5 nm
using dynamic light scattering measurements carried out in triplicate with a Malvern Zetasizer.
When detecting-external lipid, TTAPE-Me was added to extruded vesicle samples in 40 – 80fold molar excess. When detecting total lipid distribution, vesicles were formed in presence of
fluorophore by reconstituting lipid with buffer containing 40 – 80-fold molar excess of TTAPEMe relative to total lipid concentration. CL/DOPC samples were prepared to a total lipid
concentration of 1.5 mM. DOPG/DOPC samples were prepared to a total lipid concentration of 3
mM. Mixed lipid samples at each mole fraction for both external TTAPE-Me exposure and total
(inner and outer leaflet) TTAPE-Me exposure were prepared independently in triplicate.
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5.2.4. TTAPE-Me Fluorescence Measurements.
A Perkin-Elmer LS55 Fluorescence Spectrometer was used to acquire fluorescence spectra.
Samples were excited at 350 nm in a 4 mm x 4 mm Hellma fluorescence cuvette. Emitted light
was passed through a 350 nm cutoff filter to eliminate excitation breakthrough. Sample emission
was acquired from 370-600 nm with a 2.5 nm bandwidth and a scan rate of 100 nm/min.

5.2.5. TTAPE-Me and Vesicle Concentration Determination.
Using a Beckman-Coulter DU800 Spectrophotometer, UV-Visible spectra were acquired in
triplicate from 300-450 nm for samples in a Hellma 10 mm microcuvette. TTAPE-Me
concentration was approximated using absorbance at 350 nm (due to no reported extinction
coefficient) to ensure that all samples had the same excess of fluorophore. Measurements at 400,
425, and 450 nm were used to evaluate lipid concentration by Mie scattering as TTAPE-Me has
no appreciable absorbance in this region. DLS measurements (Malvern Zetasizer) and the UVVisible measurements at 400, 425 and 450 nm were used to calculate the total lipid and vesicle
concentration as well as the concentration of each constituent in the mixed lipid vesicle using
previously reported methods based on Mie scattering.36,37

5.2.6. Protein Purification.
Wild type (WT) yeast iso-1-cytochrome c (iso-1-Cytc) was expressed and purified from
Escherichia coli BL21-DE3 cells following previously reported procedures38,39. Unlike, WT
iso1-Cytc expressed from its native host, Saccharomyces cerevisiae, the Lys72 of WT iso-1-Cytc
expressed from E. coli is not trimethylated.40
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5.2.7. Cytochrome c cardiolipin/DOPC and DOPC vesicle titrations.
Cardiolipin/DOPC and DOPC binding titrations of WT iso-1-Cytc were performed by a
batch procedure. Vesicle samples were prepared and quantified immediately prior to the
experiment, as described above. WT iso-1-Cytc purified as described above was adjusted to
twice the desired concentration. A set of vesicle samples was prepared at twice the desired lipid
concentration for each step of the titration. WT iso-1-Cytc and vesicle samples were mixed in 1:1
volume ratios generating a set of samples at the desired experimental concentration of protein
and lipid for each step of the titration. Samples were gently mixed and incubated at room
temperature for 30 minutes before spectroscopic measurements at 25 oC. Measurements at each
lipid concentration were performed in triplicate with independently prepared samples.

5.2.8. Circular Dichroism Spectroscopy.
An Applied Photophysics Chirascan CD Spectrophotometer was used to acquire Soret CD
measurements of iso-1-Cytc/vesicle titration samples. The spectral region 450-350 nm was
probed with samples in a Hellma 4x10mm Quartz cuvette, utilizing the 4 mm pathlength. Spectra
were acquired at 25 oC in 1 nm step increments, with a 1.8 nm bandwidth, and a 3 s sampling
time at each wavelength. Each spectrum was smoothed using a 6th order Savitsky-Golay filter
smoothing technique. Spectra from three independent trials were averaged at each lipid
concentration.

5.2.9. Cytochrome c Fluorescence Spectroscopy.
An Applied Photophysics Chirascan CD Spectrophotometer was adapted for scanning
fluorescence measurements using a scanning emission monochromator (Applied Photophysics).
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Samples were placed in a 5x5 mm Hellma fluorescence cuvette. Trp59 of iso-1-Cytc was excited
at 295 nm with a 5 nm bandwidth. Excitation bleed through was filtered out using a 305 nm
cutoff filter (Newport Co.) placed in front of the detector. Emission spectra were acquired from
320-500 nm at 25 C with 1 nm step, a 2.5 nm bandwidth and a 0.5 sec acquisition time per step.
Emission spectra from three independent trials were averaged at each lipid concentration.

5.2.10. Cytochrome c Absorbance Spectroscopy.
A Beckman-Coulter DU800 UV-Visible Spectrophotometer was used to acquire iso-1-Cytc
spectra in the presence of varying concentrations of lipid vesicles. Samples were placed in a 10
mm pathlength Hellma microcuvette and scanned from 200-800 nm with a 1 nm step, a 5 nm
bandwidth and a scan rate of 400 nm/min.

5.2.11. Data Fitting.
Fits of CD and fluorescence data as a function of exposed (outer leaflet) lipid to protein ratio
(LPR) were attempted using a one-site cooperative Langmuir-type equation (eqn. 5.1) where s(x)
is the reported spectroscopic value at a given exposed (outer leaflet) LPR and

𝑠(𝑥) =

𝑥

𝑠𝑜 +𝑠1 (𝐾 (app))
𝑑
1+(

𝑥
)
𝐾𝑑 (app)

𝑛

𝑛

(eqn. 5.1.)

so and s1, represent the value of s(x) in the initial (no lipid) and final (lipid bound) states,
respectively. The apparent dissociation constant Kd(app) corresponds to the requisite lipid to
protein ratio to produce 50% bound protein and n is the corresponding Hill coefficient.
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5.3. RESULTS AND DISCUSSION
5.3.1. TTAPE-Me Fluoresces in the Presence of both CL and DOPG.
To determine the role of the inverted cone structure of CL in mediating partitioning of CL to
the inner versus the outer leaflet of vesicles studies, an important control is to evaluate whether
DOPG, a negatively-charged cylindrical lipid, behaves differently. It is preferable to measure
partitioning of the two lipids using the same method. In previous work, TTAPE-Me was shown
to fluoresce strongly in the presence of CL-containing vesicles.33 It was also shown that DOPC
vesicles containing phosphatidylserine at levels found in the mitochondria (1%) did not produce
a significant fluorescence in the presence of TTAPE-Me.33 To be able to compare the
partitioning of CL versus DOPG to the inner versus the outer leaflet of an extruded vesicle, we
initially compared the relative enhancement of emission from TTAPE-Me in the presence of CL
versus DOPG. As a control, we compared the effects of DOPC vesicles (headgroup has no net
charge) on the fluorescence of TTAPE-Me. Because CL has approximately twice the headgroup
surface area of DOPG, we carried out studies with DOPG (and DOPC) vesicles at twice the lipid
concentration as for the CL vesicles to keep the available surface area of CL and DOPG
available for TTAPE-Me binding the same as a function of mole fraction. Pure lipid vesicles at
lipid concentrations of 1.5 mM for CL, 3 mM for DOPC and 3 mM for DOPG (Figure 5.1) were
exposed to excess TTAPE-Me. With excitation at 350 nm, TTAPE-Me has minimal fluorescence
in the absence of lipid (Figure 5.1). In the presence of DOPC, no appreciable enhancement of
fluorescence is detected (Figure 5.1). TTAPE-Me, therefore, does not report on the presence of
DOPC. When exposed to pure CL vesicles, the fluorescence emission of TTAPE-Me is strongly
enhanced with peak fluorescence at approximately 468 nm and a slight shoulder between 370-
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400 nm (Figure 1). These findings are congruent with Leung et. al34 who reported on TTAPE-Me
as a probe for detecting CL. A similar enhancement in emission is observed for TTAPE-Me in
the presence of pure DOPG vesicles with peak fluorescence at approximately 472 nm and a less
prominent shoulder appearing between 370-400 nm compared to pure CL vesicles. Thus,
TTAPE-Me exhibits enhanced fluorescence of similar magnitude in the presence of the anionic
lipids CL and DOPG, with only minor differences in the emission spectra. These findings show
that TTAPE-Me is capable of detecting the presence of anionic lipid but not does distinguish
appreciably between different anionic lipid headgroups, at least for CL and DOPG.

Figure 5.1. Emission spectra for free TTAPE-Me (black) added externally at 40 mM excess to
vesicles in the presence of 100 nm pure vesicles of either 1.5 mM CL (red), 3 mM DOPC (green)
and 3 mM DOPG (cyan) in 20 mM TES buffer, 0.1 mM EDTA at pH 8 and 25 C. Samples were
excited at 350 nm with a bandwidth of 5 nm and emission was detected at 90o after passage
through a 350 nm cutoff filter.
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5.3.2. TTAPE-Me Detects DOPG on the Inner and Outer Leaflet of Vesicles.
The outer leaflets of vesicles at a constant concentration, but composed of varying mole
fractions of DOPG and DOPC were exposed to excess TTAPE-Me and the fluorescence
associated with the presence of DOPG was measured (Figure 5.2). Both the intensity at the peak
of fluorescence and total fluorescence (area under the emission spectrum) increase linearly with
respect to an increase in the mole fraction of DOPG (Figure 5.3,Left) demonstrating the ability
of TTAPE-Me to quantitatively report the presence of DOPG. When DOPG/DOPC vesicles were
formed in the presence of TTAPE-Me, exposing both leaflets to the fluorophore, the
fluorescence also scaled linearly with the mole fraction of DOPG. However, the fluorescence
was double that observed when only the outer leaflet was exposed to TTAPE-Me. This finding
verifies that TTAPE-Me acts as a quantitative anionic lipid reporter for anionic lipid residing on
both surfaces. Furthermore, this verifies that vesicle formation in the presence of TTAPE-Me
permits detection of anionic lipid inside the vesicle. Black and gray trend lines have been added
to figure 5.3 to demonstrate the approximate fluorescence reporter response expected for
homogeneous lipid mixing with no preferential lipid partitioning to either the inner or outer
leaflet of the vesicle. DOPG fluorescence reported using both peak fluorescence intensity at 460
nm and total fluorescence follow this trend closely strongly suggesting that DOPG has no
preferential partitioning on the vesicle surface. This observation is congruent with the expected
behavior of DOPG, which is a cylindrical lipid with no preference for leaflet curvature. These
findings also suggest that there is no headgroup governed partitioning to a preferred curved
surface for this system.
When reported fluorescence from outer leaflet exposure is compared to reported fluorescence
for total vesicle exposure for each mole fraction of DOPG, it is evident that approximately 50%
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of the total fluorescence is generated by the outer leaflet throughout the titration (Figure 5.3,
Right). Half of the DOPG population is consistently reported on the outer leaflet leading to the
conclusion that there is no preferential localization of DOPG on one specific leaflet.

Figure 5.2. Raw TTAPE-Me fluorescence data corresponding to exposure to 100 nm
DOPG/DOPC vesicles at 3 mM total lipid concentration composed of varying mole percent of
DOPG (10%(Black), 20%(Dark Blue), 40%(Teal), 50%(Cyan), 70%(Yellow), 80%(Orange), and
100% (Red)). Data were acquired in 20 mM TES, 0.1 mM EDTA, at pH 8 and 25 oC. Left panel:
only outer leaflet is exposed to excess TTAPE-Me. Right panel: both leaflets are exposed to
excess TTAPE-Me.
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Figure 5.3. LEFT: Fraction of total DOPG reported by TTAPE-Me fluorescence at various
mole fractions of DOPG, using the pure DOPG vesicles exposed to TTAPE-Me on both leaflets
as the reference state. For samples exposed to TTAPE-Me on the outer leaflet, fluorescence peak
intensity is shown with solid green circles and total integrated fluorescence emission with solid
red circles. For samples exposed to TTAPE-Me on both the inner and outer leaflets, fluorescence
peak intensity is shown with solid black squares and total integrated fluorescence emission with
solid cyan squares. The solid black line shows the predicted linear dependence of fluorescence of
homogeneously mixed DOPG/DOPC vesicles as a function of DOPG mole fraction when
exposed to TTAPE-Me on both the inner and outer leaflets. The dashed gray line shows the
predicted linear dependence of fluorescence of homogeneously mixed DOPG/DOPC vesicle as a
function of DOPG mole fraction when exposed to TTAPE-Me on outer leaflet only. Error bars
are the standard deviation derived from data for peak intensity or total fluorescence from 3
independent trials. RIGHT: Fraction of DOPG detected on the outer leaflet with respect to total
DOPG detected on both the inner and outer leaflets by TTAPE-Me fluorescence as a function of
DOPG mole fraction for DOPG/DOPC vesicles. Solid red squares use peak fluorescence
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intensity of TTAPE-Me and empty black squares use total fluorescence emission of TTAPE-Me.
The solid black line represents the ratio of 0.5 expected at all mole fractions for homogeneously
mixed DOPG/DOPC vesicles with no preferential partitioning of the DOPG. Error bars are the
standard deviation derived from data for peak intensity or total fluorescence from 3 independent
trials.

143

5.3.3. TTAPE-Me Detects Cardiolipin on the Inner and Outer Leaflet of Vesicles.
The inner and outer leaflets of vesicles composed of varying mole fractions of CL and DOPC
were exposed to excess TTAPE-Me and fluorescence associated with the presence of CL was
measured (Figure 5.4). Both peak fluorescence intensity and total fluorescence increase linearly
with respect to an increase in the mole fraction of CL in the vesicles when excess TTAPE-Me is
present both inside and outside the vesicles (Figure 5.5, Left). A solid black line illustrates the
expected linear dependence of fluorescence on the mole fraction of CL in the CL/DOPC
vesicles. The close adherence of the observed data to the expected linear dependence on mole
fraction of CL illustrates the ability of TTAPE-Me to report on total CL concentration, similar to
its ability to quantify mitochondria based on its binding to CL. 33 By contrast, the fluorescence
corresponding to external CL (Figure 5.5,Left) systematically falls below the theoretical trend
line (gray dashed line) representing predicted external fluorescence for a homogeneously mixed
lipid with no preferential partitioning to the inner concave surface of the vesicle. This
observation is more clearly illustrated when the fluorescence of CL/DOPC vesicles only exposed
to TTAPE-Me on the outer leaflet is compared to the fluorescence of CL/DOPC vesicle with
excess TTAPE-Me available both inside and outside the vesicles (Figure 5.5, Right). When
TTAPE-Me is only available on the outer leaflet of the vesicles, the amount of CL reported by
TTAPE-Me is always considerably less than 50% of the TTAPE-Me fluorescence when TTAPEMe is available to both the inner and outer leaflets of the vesicles, except when the mole fraction
of CL is 1. Such deviations could result if the CL containing vesicles are not unilamellar.
Transmission electron microscopy confirms that CL vesicles prepared by extrusion are
unilamellar (Figure 5.6). Thus, our data show that for mixed lipid systems when CL is doped into
DOPC bilayers, CL preferentially localizes on the concave inner leaflet of the vesicles. For
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mixed CL/DOPC vesicles with a CL mole fraction of 0.5 or less, the fraction of the total CL that
partition to the outer leaflet is ~0.2 (Figure 5.5, Right). This fractional partitioning indicates a 5:1
preference for the concave inner leaflet because of the inverted conical structure of CL.

Figure 5.4. Raw TTAPE-Me fluorescence corresponding to exposure to 100 nm CL/DPOPC
vesicles at 1.5 mM total lipid concentration composed of varying mole percent of CL (0%
(Blue), 12%(Green), 34%(Yellow), 50%(Orange), 75%(Red), and 100%(Maroon)). Data were
acquired in 20 mM TES, 0.1 mM EDTA, at pH 8 and 25 oC. Left panel: only outer leaflet is
exposed to excess TTAPE-Me. Right panel: both leaflets are exposed to excess TTAPE-Me.

145

Figure 5.5. LEFT: Fraction of total CL reported at various mole fractions of CL by TTAPE-Me
fluorescence, using the pure CL vesicles exposed to TTAPE-Me on both leaflets as the reference
state. For samples exposed to TTAPE-Me on the outer leaflet, data fluorescence peak intensity
are shown with solid green circles and data for total integrated fluorescence emission with solid
red circles. For samples exposed to TTAPE-Me on both the inner and outer leaflets, fluorescence
peak intensity data are shown with solid black circles and total integrated fluorescence emission
data with solid cyan circles. The solid black line shows the predicted linear dependence of
fluorescence of homogeneously mixed CL/DOPC vesicles as a function of CL mole fraction
when exposed to TTAPE-Me on both the inner and outer leaflets. The dashed gray line shows
the predicted linear dependence of fluorescence of homogeneously mixed CL/DOPC vesicle as a
function of CL mole fraction when exposed to TTAPE-Me on the outer leaflet only. Error bars
are the standard deviation derived from data for peak intensity or total fluorescence from 3
independent trials. RIGHT: Fraction of CL detected on the outer leaflet with respect to total CL
detected on both the inner and outer leaflets by TTAPE-Me fluorescence as a function of CL
mole fraction for CL/DOPC vesicles. Solid red squares use peak fluorescence intensity of
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TTAPE-Me and empty black circles use total fluorescence emission of TTAPE-Me. The solid
black line represents the ratio of 0.5 expected at all mole fractions for homogeneously mixed
CL/DOPC vesicles with no preferential partitioning of the CL. Error bars are the standard
deviation derived from data for peak intensity or total fluorescence from 3 independent trials.

Figure 5.6. Transmission electron microscopy image of 100% Cardiolipin vesicles extruded to
100 nm.
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5.3.4. Cardiolipin Addition to DOPC Vesicles Induces Asymmetric Lipid Distribution but
DOPG Does Not.
Measurement of TTAPE-Me fluorescence induced by DOPG in mixed DOPG/DOPC
vesicles demonstrates that headgroup charge interactions per se do not cause asymmetric
distribution of DOPG to the inner versus the outer leaflet when it is mixed with another
cylindrically-shaped lipid. Roke and colleagues showed that vesicles containing
phosphatidylserine and DOPC also do not generate asymmetric distributions of lipids between
leaflets.41 DOPG and DOPC have been shown to form charged domains laterally in a leaflet 42 but
not between leaflets. Further, Tian and Baumgart showed that sorting of cylindrically-shaped
lipids as a function of membrane curvature does not occur. 43 We also find no evidence of lipid
partitioning between leaflets in our samples containing varying mole fractions of DOPG mixed
with DOPC. DOPC appears to have no preferential localization, nor does it drive asymmetric
lipid distribution. This is to be expected based on the findings of Roke and colleagues and Tian
and Baumgart. Techniques employed here could not resolve phase separation in each leaflet.
Our studies on CL/DOPC show that CL preferentially partitions to the inner leaflet of a
mixed lipid membrane. Neglecting potential headgroup interactions, CL’s inverted cone shape
alone predicts a preferred asymmetric distribution to concave surfaces. 44 Sorre et. al showed that
DOPC can be sorted into a preferred bilayer as needed based on local environmental criteria. 45
Here, the structure of CL provides the needed packing instability required to drive DOPC to the
outer leaflet while CL sorts preferentially onto the concave interior surface of the vesicle.
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5.3.5. External Cytochrome c Binding to 100% DOPC Vesicles Demonstrates No
Significant Protein-Lipid Binding.
Vesicles and liposomes are often prepared with varying concentrations of neutral DOPC
when investigating Cytc binding to CL.6,10,20,22,11–14,16–19 To fully understand the role of lipid
partitioning to binding of Cytc in mixed lipid systems, wild type (WT) yeast iso-1-cytochrome c
(iso-1-Cytc) binding to DOPC was investigated. Because the headgroup of DOPC is neutral and
the headgroup of CL carries two negative charge we use solution conditions that select for
electrostatic binding to the A-site, namely a pH 8 buffer that suppresses binding at the L- and Csites.7 Specifically, electrostatic binding at the A-site of iso-1-Cytc was investigated by titrating
in varying concentrations of 100 nm pure DOPC vesicles in 20 mM TES buffer, 0.1 mM EDTA
at pH 8. Binding was investigated using both the Soret CD and Trp59 fluorescence signals of
iso-1-Cytc during a DOPC vesicle titration (Figure 5.7). The Soret CD signal monitors the heme
environment of iso-1-Cytc. The heme is the known site of peroxidase activity in the protein and
interactions at the heme have been directly linked to cardiolipin binding. 7,16,46 The Soret CD
showed no appreciable change over the course of the titration implying that the structural
rearrangement around the heme of iso-1-Cytc that normally occurs when Cytc binds to CL
membranes does not occurs for extruded 20% CL/80% DOPC vesicles. A plot of the difference
in the intensity of the positive maximum and negative minimum of the Soret CD spectrum,

,

also shows no significant change over the course of the titration further verifying a lack of lipidinduced heme rearrangement and thus binding of Cytc to the DOPC vesicles (Figure 5.7).
Trp59 fluorescence has been used to investigate partial unfolding of the protein upon lipid
interaction.7,33 Lipid induced protein unfolding typically leads to an increase in Trp59
fluorescence. However, fluorescence did not increase when Cytc was exposed to 100% DOPC
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vesicles over a large range of exposed (outer leaflet) lipid to protein ration (LPR) (Figure 5.7).
An analysis of the intensity of the peak of fluorescence over the range of the titration shows no
significant change due to exposure to DOPC vesicles. Thus, DOPC vesicles do not induce partial
unfolding of Cytc, as detected by Trp59 fluorescence, a signature for binding of Cytc to
membrane surfaces. This finding is in accordance with previous studies that demonstrate Cytc’s
preferential binding to anionic lipid headgroups.16

150

Figure 5.7. Titration of yeast iso-1-Cytc with 100 nm 100% DOPC vesicles in 20 mM TES, 0.1
mM EDTA at pH 8 and 25 ˚C monitored by Soret CD (top left) and Trp59 fluorescence (top
right). Soret CD amplitude (∆∆𝜀 = ∆𝜀 max – ∆𝜀 min) plotted as a function of exposed lipid to
protein ratio (LPR, bottom left). Trp59 fluorescence intensity at 331 nm plotted as a function of
exposed LPR (bottom right).
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5.3.6. Titration of Cytc with 20% CL/80% DOPC Vesicles Demonstrates Minimal ProteinLipid Binding.
20% CL:80% DOPC vesicles are commonly used to investigate CL binding to Cytc
12,14,16,21,47

because CL represents 20% of the lipid content of mitochondria. 48 Both Soret CD and

Trp59 fluorescence have been used in these studies to monitor binding of mixed lipid vesicles to
Cytc. Previous studies have been carried out at lower pH where the C- and L-sites also contribute
to binding. At pH 8, where binding of iso-1-Cytc is limited to the A-site,7 a plot of the difference
in the intensity of the positive maximum and negative minimum of the Soret CD spectrum,

,

does not change over the course of the titration of WT yeast iso-1-Cytc with 20% CL/80%
DOPC vesicles (Figure 5.8). Likewise, Trp59 fluorescence does not show the increase in
intensity normally observed for partial unfolding of iso-1-Cytc typically associated with binding
of iso-1-Cytc to CL-containing vesicles (Figure 5.8). Tracking the fluorescence intensity over the
course of the titration at the emission maximum confirms the lack of a significant interaction of
iso-1-Cytc with 20% CL/80% DOPG via the A-site at pH 8 (Figure 5.8). Thus, neither local
structural rearrangement around the heme (Soret CD), nor partial unfolding of iso-1-Cytc (Trp59
fluorescence) occur when iso-1-Cytc is titrated with 20% CL/80% DOPC vesicles at pH 8.
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Figure 5.8. Titration of iso-1-Cytc with 100 nm 20% CL/80% DOPC vesicles in 20 mM TES,
0.1 mM EDTA at pH 8 and 25 ˚C monitored using Soret CD (top left) and Trp59 fluorescence
(top right). CD amplitude (∆∆𝜀 = ∆𝜀 max – ∆𝜀 min) plotted as a function of exposed LPR (bottom
left). Fluorescence intensity at 331 nm plotted as a function of exposed LPR (bottom right).
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5.3.7. 100% DOPC and 20% CL/80% DOPC Do Not Illicit Electrostatic Cytochrome c
Binding at pH 8 via the A-site.
Previous work investigating binding binding to 100% CL vesicles the A-site of Cytc did
showed a significant change in both the Soret CD and Trp59 fluorescence for yeast iso-1-Cytc7
(see Figure 5.8, lower panel). Using a one-site cooperative binding model (eq 5.1), Soret CD
reported a Kd(app) of 10.2 in terms of exposed LPR and a cooperativity, n, of 2.27 and Trp59
fluorescence reported Kd(app) of 23.4 in terms of exposed LPR and n of 2.37 (solid curves in
Figure 5.8, bottom panels). Attempts to fit the Soret CD and Trp59 fluorescence amplitudes to eq
5.1 failed for both 100% DOPC and 20% CL/80% DOPC vesicle binding at pH 8 in Figures 5.7
and 5.8. Thus, 100% DOPC and 20% CL/80% DOPC vesicles fail to induce electrostatic binding
to the A-site of Cytc at pH 8.
TTAPE-Me fluorescence studies show that CL/DOPC vesicles had approximately 20% of the
total CL on the outside of the vesicle for CL mole fractions of 0.5 and below (Figure 3B). In the
case of 20% CL/80% DOPC vesicles, 20% of the total concentration of CL on the outside
corresponds to the mole fraction of only 0.04 CL on the outer leaflet. Thus, the range of exposed
LPR in terms of CL concentration effectively covers the range 0 – 4 rather than 0 – 100 (0 – 20
in terms of CL concentration) for the Soret CD-monitored titrations (Figure 4) and 0 – 8 rather
than 0 – 200 (0 – 40 in terms of CL concentration) in the case of the Trp59 fluorescencemonitored titrations (Figure 5.8). Given that the Kd(app) for Soret CD is ~10 in terms of exposed
LPR and Trp59 fluorescence is ~23 in terms of exposed LPR for 100% CL vesicles it is not
surprising that no significant binding is observed. As there will be an entropic penalty for
demixing in the mixed lipid system,49 the necessary Kd(app) is probably even higher than those
observed for pure CL vesicles. Thus, it is not surprising that no binding is observed under our
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conditions because of the preferential partitioning of CL to the inner leaflet of extruded vesicles.
To elucidate the apparent dissociation constant corresponding to electrostatic binding it would be
necessary to go to much higher exposed LPR, which would be impractical in our system.
Because of this, a mixed lipid system where CL may not distribute evenly on both leaflets, may
not be ideal for investigating quantitative Cytc binding.

5.3.8. 100% DOPC Vesicles Do Not Illicit Electrostatic Cytochrome c Binding at pH 7 but
20% CL/80% DOPC Vesicles Do Facilitate Binding.
Previous work showed that 100% CL vesicles induce scattering in the presence of WT iso-1Cytc at pH 7.7 This scattering was attributed to CL binding to multiple binding sites on Cytc,
notably the electrostatic A-site, and hydrogen bonding L-site.24 Binding of vesicles to multiple
sites on Cytc induces large supramolecular structures of vesicles crosslinked by Cytc that
enhance scattering in the UV-Visible spectral region. DOPC and 20% CL/80% DOPC vesicle
binding to Cytc was evaluated at pH 7 using UV-Visible spectroscopy to determine if enhanced
scattering due to formation of supramolecular structures occurs over the course of vesicle
titrations of iso-1-Cytc (Figure 5.9). No appreciable scattering off of DOPC and 20% CL/80%
DOPC vesicles beyond the expected concentration-dependent scattering off the vesicles
themselves36,37 occurs during vesicles titrations of WT iso-1-Cytc. The lack of scattering off of
DOPC vesicles at pH 7 verifies the lack of affinity Cytc has for DOPC. This finding is consistent
with the lack of binding detected for DOPC vesicles at pH 8 (Figure 5.7). The lack of scattering
off of 20% CL/80% DOPC vesicles (Figure 5.9) suggests CL may not be sufficiently present in
the outer leaflet to induce crosslinking of vesicles. This finding is congruent with TTAPE-Me
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detecting less CL on the outer leaflet of CL/DOPC vesicles than expected for unbiased
partitioning of CL to the inner versus the outer leaflet of 100 nm vesicles.

Figure 5.9. UV-Visible spectra of 100 nm DOPC (Left) and 20% CL/80% DOPC (Right)
vesicles as a function of total lipid concentration in the presence of 10 µM yeast iso-1-Cytc in 20
mM TES, 0.1 mM EDTA, at pH 7 and 25 oC.

Stronger binding of Cytc to cardiolipin binding has been detected using mixed lipid systems
at pH 76,10,13,17,19,21,23,30 and 7.4.11,12,14,16,18,20,22 Under these conditions binding appears to be
stronger because of the availability of sites A and L.7 Thus, lipid binding to WT iso-1-Cytc with
20% CL/80% DOPC vesicles at pH 7 was evaluated using Soret CD and Trp59 fluorescence.
DOPC binding studies demonstrated no significant lipid binding to Cytc at pH 7 (Figure 5.10).
Neither Soret CD nor Trp59 fluorescence deviated significantly from the unbound spectral
signature throughout each titration.
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When WT iso-1-Cytc was exposed to 20% CL/80% DOPC vesicles, the Soret CD spectra is
affected as the titration progresses (Figure 5.11). The observed

is indicative of CL binding

however an upper limit to the binding curve could not be resolved because sufficiently high
concentrations of vesicles could not be achieved. Thus, it was not impossible to evaluate Kd(app)
and n for extruded 20% CL/80%DOPC vesicles using Soret CD alone. Trp59 fluorescence also
showed evidence of Cytc-CL binding for extruded 20% CL/80% DOPC vesicles at pH 7 (Figure
5.11). The increase in Trp59 fluorescence intensity at 331 nm shows that exposure of iso-1-Cytc
to extruded 20% CL/80% DOPC vesicles at pH 7 leads to movement of Trp59 away from the
heme and thus partial unfolding of the protein. However, with 100% CL vesicles the emission
maximum red shifts from ~330 nm to ~ 340 nm, whereas a minimal red shift is apparent for the
interaction of iso-1-Cytc with extruded 20% CL/80% DOPC vesicles at pH 7. Thus, the nature of
the interaction appears to be qualitatively different. Sufficiently high exposed LPR could not be
achieved to allow the Trp59 intensity versus exposed LPR data to be fit to eq 5.1. This finding is
in accordance with TTAPE-Me findings suggesting that some CL resides on the outer leaflet but
much less than expected if partitioning of CL was unbiased for extruded vesicles. Thus, even
though binding is stronger at pH 7, the low content of CL in the outer leaflet of extruded mixed
CL/DOPC vesicles precludes quantitative assessment of binding even at pH 7. It is possible that
preparation of vesicles by other methods such as sonication may affect the degree of partitioning
to the inner leaflet, possibly accounting for the stronger apparent binding observed at pH 7 – 7.4
in previous studies with mixed lipid CL/DOPC vesicles.
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Figure 5.10. Titration of Iso-1-Cytc with 100 nm 100% DOPC vesicles in 20 mM TES, 0.1 mM
EDTA at pH 7 and 25 ˚C monitored using Soret CD (top left) and Trp59 fluorescence (top right).
Soret CD amplitude (

=

max

–

min)

as a function of exposed lipid to protein ratio (LPR)

(bottom left). Trp59 fluorescence intensity at 331 nm as a function of exposed LPR (bottom
right).
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Figure 5.11. Titration of iso-1-Cytc with 100 nm 20% CL/80% DOPC vesicles in 20 mM TES,
0.1 mM EDTA at pH 7 and 25 ˚C monitored using Soret CD (top left) and Trp59 fluorescence
(top right). Soret CD amplitude (

=

max

–

min)

plotted as a function of exposed LPR

(bottom left). Trp59 fluorescence intensity at 331 nm plotted at as a function of exposed LPR
(bottom right).
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5.4. CONCLUSION
Using the fluorophore TTAPE-Me which binds specifically to lipids with anionic
headgroups, we have shown that for CL/DOPC mixed lipid vesicles prepared by freeze/thaw
methods followed by extrusion, the inverted cone lipid CL shows a 5:1 to preference for the
concave surface of the inner leaflet of the vesicle over the convex outer leaflet at CL mole
fractions less than or equal to 0.5. DOPG, a cylindrically-shaped vesicle, shows the expected 1:1
partitioning between the inner and outer leaflet, for mixed DOPG/DOPC vesicles at all mixing
ratios. Thus, for extruded vesicles, lipid structure can impact the characteristics of the vesicles
produced with potential impacts for studies on protein lipid interactions. We show for the
interaction of iso-1-Cytc with extruded 20% CL/80% DOPC vesicles at both pH 7 and 8 that the
binding is much weaker than expected based on previous work with pure CL vesicles. The
weaker than expected interaction of iso-1-Cytc with 20% CL/80% DOPC vesicles results from
the ~4% CL content in the outer leaflet caused by the 5:1 preference of CL for the inner leaflet of
mixed CL/DOPC vesicles prepared by extrusion. It is possible that preparation of vesicles by
other methods such as sonication may affect the degree of partitioning to the inner leaflet.
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Chapter 6: Curvature Dependent Binding of Cytochrome c to Cardiolipin

6.1. INTRODUCTION
Cytochrome c (Cytc) resides at low millimolar concentrations (0.5 – 1 mM) in the intracristal compartments and the intermembrane space.1 The primary functions of Cytc are as an
intermediary in the electron transport chain and as a signaling agent in the intrinsic pathway of
apoptosis. The earliest signal in the intrinsic pathway of apoptosis involves oxidation of the
cone-shaped, non-bilayer forming lipid, cardiolipin (CL) by Cytc on the inner mitochondrial
membrane (IMM) of the intermembrane space (IMS).2,3 The IMM, particularly in the intra-cristal
compartments, contains many concave surfaces.4 After oxidation of CL, Cytc is released from
the IMM, exits the mitochondria and forms part of the apoptosome in the cytosol, initiating
apoptosis.3,5 Because Cytc-CL binding is a preemptive step to apoptosis, work has been
performed in an effort to elucidate the nature and extent of this interaction. Studies have
investigated the role of lipid composition in protein binding but have only minimally addressed
the role membrane curvature plays in the interaction. 6–9 Here, we investigate protein binding to
the concave inner surface of pure (100%) CL vesicles to assess the role of membrane curvature
in Cytc binding to CL.

6.2. MATERIALS AND METHODS
6.2.1. Sample Preparation.
Wild-type yeast iso-1-cytochrome c (iso-1-Cytc) was expressed from Escherichia coli BL21
DE3 cells (BioRad, Phage T1-resistant strain) and purified following previously reported
methods.10 Protein was concentrated to concentrations between 0.5 and 5 mM in 20 mM TES,
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0.1 mM EDTA, 0.1 mM NaCl, pH 8. For each titration point, three aliquots of 100% cardiolipin
(Avanti Polar Lipids, Inc) (CL) (minimally 5 mg each) were mixed with the ionophore Nonactin
in a 1:100 ratio of Nonactin:CL, and the mixtures were dried individually under compressed
nitrogen for approximately 2 hours to remove chloroform. The lipid/nonactin mixture was then
combined with the concentrated protein solutions to form vesicles. Mixing was performed at low
speeds on a vortexer. Vortexing was sufficiently vigorous to thoroughly mix the protein with the
CL/nonactin but not so vigorous that formation of bubbles occurred. Protein/lipid/nonactin
mixtures were extruded to 100 nm using an Avanti Mini Extruder where two 100 nm membrane
supports were used for extrusion and samples were passed through the extruder 11 times. After
extrusion, samples were loaded onto a washed (20 mM TES buffer, 0.1 mM EDTA, pH 8) CM
Sepharose Fast Flow column (GE Healthcare Life Sciences) and run down the column in the
mobile phase. Cytc external to the vesicles bound to the CM-sepharose cation-exchange resin
while the negatively-charged vesicles filled with Cytc eluted off the column. Eluent containing
Cytc filled vesicles was collected and concentrated to <1 mL using Amicon Ultra-15 Centrifugal
Filter Units with 50k MWCO (EMD Millipore, Sigma). Samples were diluted to 15 mL in 20
mM TES Buffer, 0.1 mM EDTA, pH 8 and set to equilibrate on an orbital shaker for 8 hours at 4
°C. Conductivity was periodically measured to follow the flow of NaCl from inside the vesicles
via the nonactin channels. When conductivity stabilized, indicating that the flow of NaCl out of
the interior of the samples was complete, the CL vesicles loaded with iso-1-Cytc were again run
down a CM Sepharose column in 20 mM TES Buffer, 0.1 mM EDTA, pH 8, collected and
concentrated using the same 50k MWCO ultrafiltration devices. Conductivity at equilibrium was
approximately the conductivity of 20 mM TES, 0.1 mM EDTA buffer at pH 8. The concentration
of iso-1-Cytc was measured with a Beckman Coulter DU800 using previously reported
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extinction coefficients,11 and taking into account scattering off of the vesicles. A Malvern
Zetasizer was used to perform Dynamic Light Scattering on all samples to determine vesicle
size. Vesicle size was measured to be 100 nm ± 5 nm for all replicates at all titration points.
Vesicle size was later used to calculate lipid concentration and determine exposed lipid to protein
ratio (LPR) for each protein concentration point. Samples were then diluted or concentrated as
needed to either 5 µM or 10 µM iso-1-Cytc concentration, as appropriate, for spectroscopic
measurements.

6.2.2. Circular Dichroism Spectroscopy.
Soret CD spectra were measured using previously reported methods.10 Briefly, CD data were
acquired using an Applied Photophysics Chirascan Spectrophotometer to measure the spectral
region from 350 nm – 450 nm, scanning in 1 nm steps with a 3 second/nm scan rate and 1.8 nm
bandwidth. Samples were contained in a 4 mm by 10 mm Hellma cuvette (Hellma Analytics)
utilizing the 4 mm pathlength. Spectra were smoothed with a 6-point Savitsky-Golay smoothing
function and data were analyzed using the difference between the positive maximum near 405
nm and negative minimum near 420 nm as the signal amplitude, as previously described.

6.2.3. Tryptophan Fluorescence Spectroscopy.
Trp59 fluorescence measurements were performed using previously reported methods.10
Briefly, fluorescence data were acquired using an Applied Photophysics Chirascan
Spectrophotometer modified for fluorescence data acquisition using a scanning emission
monochromator (Applied Photophysics). Samples were excited at 295 nm (5 nm bandwidth) and
fluorescence was measured at 90o with a 305 nm cutoff filter (Newport Corp) in-line to limit
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excitation bleed through. Emission was measured from 320 nm to 500 nm in 1 nm steps, with 0.5
sec per step and a 2.5 nm bandwidth. A 5 mm by 5 mm Hellma fluorescence cuvette was used
for measurements. Spectra were smoothed a 6-point Savitsky-Golay smoothing function and data
were analyzed to extract fluorescence peak emission intensity as previously reported.

6.2.4. Data Fitting.
A one site cooperative Langmuir-type equation (eq 6.1) was used to fit CD and fluorescence
data, where the spectroscopic value, s(x)

𝑠(𝑥) =

𝑥

𝑠𝑜 +𝑠1 (𝐾 (app))
𝑑
𝑥

1+(𝐾 (app))
𝑑

𝑛

𝑛

(eq 6.1)

corresponds to the amplitude measured at the exposed lipid to protein ratio (LPR), x, in the
titration and s0 and s1 are the amplitudes of the initial (free protein) and final (lipid bound
protein) states, respectively. Here, Kd(app) is the apparent dissociation constant corresponding to
the exposed LPR required to induce half occupancy of the conformation associated with site A
binding to CL and n is the associated Hill coefficient.

6.2.5. Lipid to Protein Ratio Calculations.
Lipid to protein ratio was calculated for concave binding using the initial protein
concentration (protein concentration during vesicle formation) and the lipid concentration on the
vesicle inner leaflet associated with vesicle size measured using DLS. After vesicle formation
and removal of excess protein from the exterior of vesicles, DLS was run to measure vesicle size.
Using bilayer thickness of CL(3.67 nm)12, average surface area of an inner leaflet was calculated.
Headgroup surface area of CL (1.298 nm2)12 was then used to determine the number of lipids on
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the concave surface of the vesicle. Taking into account bilayer thickness, the average inner
volume of a vesicle was calculated and the initial protein concentration was used to find the total
number of proteins present on the interior of a vesicle. The LPR was calculated using both
populations for each sample at each concentration point for each trial.

6.3. RESULTS AND ANALYSIS
In previous work, we showed that yeast iso-1-Cytc binds to the convex surface of 100 nm,
pure CL vesicles and reported the associated binding parameters for cooperative, one-site,
Langmuir-type binding (Eq. 6.1, Table 6.1)10. These studies were carried out at pH 8, conditions
selective for binding to the anionic site, A-site,10 which has long been attributed to electrostatic
binding to lysines 72 and 73,13,14 and possibly lysines 86 and 87 (See Figure 6.1, top).13–15 We
assigned the two distinct apparent dissociation constants, Kd(app), found using Soret circular
dichroism (CD) and fluorescence spectroscopy, to a two-step conformational rearrangement on
the surface of the pure CL vesicles. If we interpret the Kd(app) in terms of exposed lipid to
protein ratio (LPR) as reflecting the space required on the membrane surface, the first step
requires the surface area of ~10 CL headgroups (~13 nm2; CL headgroup surface is 1.298
nm2,12). This surface area requirement is only slightly larger than the 9.1 nm2 of membrane
surface area the native state of Cytc is expected to require,16,17 suggesting only a modest
structural rearrangement in the first step.
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Figure 6.1. TOP: Yeast iso-1-Cytc (PDB entry 2YCC) showing lysines 72, 73, 86 and 87, which
are commonly assigned as constituents of the A-site (top panel, prepared using MacPymol)
Neighboring lysines 54, 55 and 89 are also shown. Trp59 is shown in green behind the heme.
The heme and its ligands, Met80 and His18, are also shown. BOTTOM: Schematic
representation of spatial constraints on binding iso-1-Cytc to the convex outer surface versus the
concave inner surface of a pure CL vesicle.
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The second step requires ~23 CL headgroups (~30 nm2) indicative of a more significant
conformational rearrangement. Fluorescence resonance energy transfer studies of partial
unfolding on the surface of 1:1 CL:DOPC vesicles, which show that the C-terminal helix moves
away from the heme at high LPR,18 are qualitatively consistent with the additional membrane
surface area indicated by the Kd(app) of the second conformational rearrangement we observe on
pure CL vesicles. The associated Hill coefficient for each step (n ~2) suggests that the iso-1Cytc interacts directly with 2 lipid headgroups (4 negatively charged phosphates) as part of each
step of the conformational rearrangement.

Table 6.1. Thermodynamic parameters for iso-1-Cytc binding to
100% CL vesicles.
CD

Fluorescence

Membrane
Curvature
Concave

Kd(app),
Exposed
LPR
54.8 ± 3.3

4.4 ± 1.0

58.2 ± 4.2

4.7 ± 1.2

Convex10

10.2 ± 0.2

2.2 ± 0.1

23.4 ± 0.8

2.3 ± 0.2

n

Kd(app),
Exposed
LPR

n

Reported in exposed (leaflet) lipid to protein ratio (LPR). Error
corresponds to the standard error in the fit of the parameter
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We have recently shown that CL partitions preferentially to the inner leaflet of CL-containing
DOPC vesicles (See Chapter 5). This preferential localization suggests a variation in CL packing
on concave and convex surfaces with a strong favorability for CL to pack well in vesicle inner
leaflets. Conformational rearrangements of proteins on a concave membrane surface differ in two
respects relative to those on a convex surface. The concave surface will cause globular proteins
on the surface to tilt toward each other, rather than away from each other as on a convex surface
(Figure 6.1, bottom). Thus, more surface area is expected to be necessary for protein binding to a
concave membrane surface. The concave membrane surface will also better match the curvature
of a globular protein, so, one might expect that more of the protein could interact with the
membrane perhaps increasing the number of lipids which directly bind to the protein and thus the
cooperativity of binding and/or structural rearrangements on the membrane surface.
To examine protein binding to concave membrane surfaces, we performed CL-binding
titrations for iso-1-Cytc encapsulated within 100 nm, pure CL vesicles, so, that they only see the
concave surface of the bilayer (For preparation of vesicle with iso-1-Cytc trapped inside, see
Supporting Information). Vesicle titrations of Cytc binding to the concave exterior surface of CLcontaining vesicles are typically done at a constant protein concentrations between 5 and 10
M10,19–21 in the presence of increasing amounts of vesicles. Our previous work on iso-1-Cytc
indicates that at this protein concentration, both Soret CD and Trp59 fluorescence monitor
conformational rearrangements of iso-1-Cytc already bound to pure CL vesicles.10 Thus,
titrations are best evaluated as a function of exposed LPR (available membrane surface area). For
titrations as a function of exposed LPR for iso-1-Cytc trapped inside vesicles, iso-1-Cytc
concentration must be changed to vary exposed LPR. To achieve exposed LPR across the same
range as for titrations with iso-1-Cytc to the convex outer surface of vesicles, the vesicles must
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be formed in the presence of iso-1-Cytc at concentrations ranging from 0.5 – 5 mM. Thus, the
concentration of iso-1-Cytc in the lumen of the pure CL vesicles in this study is similar to that
observed physiologically in the IMS of mitochondria.
To monitor local and global structural rearrangement as a function of exposed LPR, Soret CD
and Trp59 fluorescence spectroscopy, respectively, were used (see Supplementary Information
for sample preparation and experimental methods). Soret CD is sensitive to the local heme
environment, particularly heme-Met80 ligation19 and the proximity of Phe82 to the heme.22
Trp59 fluorescence depends on the Trp59-heme distance and is used to monitor changes in
tertiary structure of Cytc.23 For binding titrations followed by Soret CD, the CL vesicle titration
evaluated iso-1-Cytc binding from a low exposed LPR (high iso-1-Cytc concentration, Figure
6.2, top, blue spectrum) to a high exposed LPR (low protein concentration, Figure 6.2, top left,
red spectrum) to assess the effect of the binding density of iso-1-Cytc on the concave CL surface
on the local heme environment. The amplitude of the CD signal (

=

406

–

420)

was

plotted versus exposed LPR and fit to a one-site cooperative Langmuir binding model (Eq. S1) to
determine Kd(app) and n (Figure 6.2, bottom left panel, Table 6.1). Compared to binding
titrations on the external convex surface of pure 100 nm CL vesicles, Kd(app) obtained from
Soret CD measurements on the concave inner surface of pure CL vesicles is much higher (Table
6.1), indicating that more space is required for the Soret CD-monitored conformational change
on a concave versus a convex surface. The associated Hill coefficient, n, is also twice the value
reported for binding on a convex membrane surface. Trp59 fluorescence as a function of exposed
LPR on the concave inner surface of the pure CL vesicle also is shown in Figure 6.2 (top right).
The increase in Trp59 fluorescence intensity at the emission maximum (341 nm) was plotted
versus exposed LPR and fit to Eq. 6.1 to obtain Kd(app) and n (Figure 6.2, bottom right, Table
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6.2). The Kd(app) and n values obtained for binding on the concave inner surface of pure CL
vesicles from Trp59 fluorescence data are approximately double the magnitude of the values
obtained for Cytc-CL binding on the convex exterior surface of pure 100 nm CL vesicles (Table
6.2). Whereas the Kd(app) and n parameters obtained from Soret CD versus Trp59 fluroescence
data are significantly different for binding to convex membrane surfaces, they are essentially
identical for binding to concave surfaces. Thus, conformational rearrangement of iso-1-Cytc is
concerted on the concave inner surface and stepwise on the convex outer surface of 100 nm pure
CL vesicles (Figure 6.3).
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Figure 6.2. Soret CD spectra of 10 M iso-1-Cytc (top left panel) prepared from low exposed
LPR (high iso-1-Cytc concentration in vesicle lumen; blue spectrum is iso-1-Cytc in the absence
of vesicles) to a high exposed LPR (Red, low iso-1-Cytc concentration in vesicle lumen) inside
100 nm, 100% CL vesicles formed in 20 mM TES buffer, 0.1 mM EDTA at pH 8. Vesicle
concentration was adjusted, so that iso-1-Cytc concentration was 10 M in all samples. Average
Soret CD amplitude (

=

406

–

420,

solid black circles) as a function of exposed LPR

(bottom left panel) fit to eq 6.1 (solid red curve). Trp59 fluorescence signal of 5 M iso-1-Cytc
prepared at lipid concentrations ranging from a low exposed LPR (Blue) to a high exposed LPR
(Red) inside 100 nm, 100% CL vesicles formed in 20 mM TES buffer, 0.1 mM EDTA at pH 8.
Average Trp59 fluorescence peak signal at 441 nm as a function of exposed LPR (solid black
circles) fit to Eq. 6.1 (solid red curve). Error bars of data points in the bottom panels are the
standard deviation from three independent trials.
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Figure 6.3. Overlay of the titration curves for WT iso-1-Cytc obtained by Soret CD (blue
circles) and Trp59 fluorescence (red squares) for binding to the interior concave surface of pure
CL vesicles showing that binding as monitored by both spectroscopic probes is concerted.

The amplitude of the CD signal (

=

406

–

420 )

was plotted versus exposed LPR and fit

to a one-site cooperative Langmuir binding model (Eq. 6.1) to determine Kd(app) and n (Figure
6.2, bottom left panel, Table 6.1). Compared to binding titrations on the external convex surface
of pure 100 nm CL vesicles, Kd(app) obtained from Soret CD measurements on the concave
inner surface of pure CL vesicles is much higher (Table 6.1), indicating that more space is
required for the Soret CD-monitored conformational change on a concave versus a convex
surface. The associated Hill coefficient, n, is also twice the value reported for binding on a
convex membrane surface. Trp59 fluorescence as a function of exposed LPR on the concave
inner surface of the pure CL vesicle also is shown in Figure 6.2 (top right). The increase in Trp59
fluorescence intensity at the emission maximum (341 nm) was plotted versus exposed LPR and
fit to Eq. 6.1 to obtain Kd(app) and n (Figure 6.2, bottom right, Table 6.1). The Kd(app) and n
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values obtained for binding on the concave inner surface of pure CL vesicles from Trp59
fluorescence data are approximately double the magnitude of the values obtained for Cytc-CL
binding on the convex exterior surface of pure 100 nm CL vesicles (Table 6.1). Whereas the
Kd(app) and n parameters obtained from Soret CD versus Trp59 fluorescence data are
significantly different for binding to convex membrane surfaces, they are essentially identical for
binding to concave surfaces. Thus, conformational rearrangement of iso-1-Cytc is concerted on
the concave inner surface and stepwise on the convex outer surface of 100 nm pure CL vesicles
(Figure 6.3).
The lowest exposed LPR in the titration followed by Soret CD in Figure 6.2 gives a spectrum
similar to the spectrum of iso-1-Cytc free in solution at pH 8 (Figure 6.4). At pH 8 when not
bound to vesicles, wild type (WT) iso-1-Cytc expressed from Escherichia coli (unlike protein
expressed from the native host, Saccharomyces cerevisiae, Lys72 is not trimethylated causing the
pKapp of the alkaline transition of iso-1-Cytc to decrease to 8)24 gives a Soret CD spectrum
consistent with significant population of the alkaline conformer of iso-1-Cytc. By contrast at an
exposed LPR near 13, the negative band of the Soret CD of iso-1-Cytc near 420 nm, typical of
the native conformer free in solution, reappears when WT iso-1-Cytc is bound to the convex
exterior surface of pure CL vesicles (Figure 6.4). Thus, initial structural rearrangement that
occurs on the outer surface of pure CL vesicles, which appears to make the structure of iso-1Cytc more nativelike, does not occur on the concave inner surface of pure CL vesicles. Instead,
the protein appears to maintain a heme environment that is more similar to that of the protein
free in solution up to an exposed LPR of almost 40.
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Figure 6.4. Soret CD signal corresponding to 10 µM unbound Cytc in the concave (Black) and
convex (Red) systems as well as signals corresponding to 10 µM bound Cytc in the concave (--)
and convex (--) systems.

The concerted partial unfolding on the concave inner surface occurs at about twice the
exposed LPR (Kd(app) of ~56.5, Table 6.1) of the second conformational rearrangement (partial
unfolding) on the convex outer surface of pure CL vesicles. This Kd(app) corresponds to a
surface area of ~73 nm2 for partial unfolding on the concave inner surface of pure CL vesicles,
more than twice the surface area needed for this conformational rearrangement on the convex
outer surface of pure CL vesicles. The Hill coefficient, n, is approximately the sum of the
individual steps observed for binding to a convex membrane surface indicating that a similar
total number of lipids (~4.5) interact with iso-1-Cytc when it unfolds on the concave inner
surface of pure CL vesicles. One factor that may lead to the concerted (concave surfaces) versus
the stepwise (convex surfaces) mechanism for structural rearrangement of iso-1-Cytc on
membrane surfaces is that the concave surface is more stable because the cone-shape of CL is
better adapted to a concave surface. Our recent studies showing that CL preferentially partitions
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to the inner leaflet of 100 nm vesicles supports this contention. A more stable surface would be
less prone to deformation and thus require more points of contact to initiate structural
rearrangement of iso-1-Cytc. The larger surface area (Kd(app)) needed for partial unfolding of
iso-1-Cytc on a concave versus a convex membrane surface likely has a number of contributing
factors. One factor, as illustrated in Figure 6.1, is that proteins on a concave surface effectively
tilt toward each other leading to more excluded volume on a concave surface and thus a
requirement for more lipid surface area to allow structural rearrangements. The concave
curvature may also facilitate simultaneous contact with lysine residues in or near the A site
because the curvature on the surface allows for closer contact with more of the surface of iso-1Cytc. The convex exterior surface of a vesicle, by contrast, curves away from the surface of the
protein. Thus, the concave surface may facilitate interaction with a broader group of lysines, in
or near the A-site, permitting a more extensive concerted partial unfolding of the protein that
occurs at a higher Kd(app) (larger membrane surface area).
Our recent work on the effect of Lys→Ala variants of iso-1-Cytc on binding to the convex
outer surface of pure CL vesicles shows that at least four lysines govern binding at the A site
(Lys72, Lys73, Lys86, and Lys87). The results also indicate that neighboring lysines (Lys54,
Lys55 and Lys89) also could be involved in A site binding. Thus, a large surface of lysines likely
contributes to electrostatic binding via site A. The better shape complementarity between the
concave inner surface of a CL vesicle and the surface of iso-1-Cytc may facilitate contact with a
larger group of these lysines and the negatively-charged CL headgroups leading to a larger
structural rearrangement on a concave versus a convex membrane surface. Further investigation
of which lysines contribute to A-site binding will be important, as will determination of whether
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the relative importance of each lysine contributing to the A-site is the same on convex versus
concave surfaces.
Through their work on binding of horse Cytc to the concave surface of reverse micelles
titrated with CL, Wand and colleagues found no evidence of partial unfolding of Cytc. This
conclusion was based on the observation that there are only small changes in the 1H-15N HSQC
of horse Cytc during the CL titration.7 The diameter of the reverse micelles in this study was
about 4 nm. If the entire surface area of the reverse micelle was replaced by CL during the
titration, maximally 35 – 40 CL could be accommodated on the available surface area. At the 7
mM concentration of horse Cytc used in these experiments, each reversed micelle would contain
no more than one Cytc molecule. Thus, the maximal value for the exposed LPR would be 35 –
40 and is probably less. Our data (Figure 6.2, bottom panels) also shows minimal structural
perturbation to iso-1-Cytc at exposed LPR values less than 40. For mitochondria in the orthodox
state, the diameter of the cristae and the cristae junctions are near 30 nm.4,25,26 The intra-cristal
regions make up most of the surface area of the IMM available to Cytc, providing substantial
surface area with negative curvature.26 The negative curvature of the cristae fall in between that
of the 4 nm reversed micelles used by Wand and colleagues and the 100 nm CL vesicles used
here. Both experiments indicate that at exposed LPR below 40 partial unfolding does not occur
on concave CL-containing membrane surfaces. However, our data show that at physiological
concentrations of Cytc (0.5 – 1.0 mM, high exposed LPR in our study), it is possible that partial
unfolding could occur on the concave surfaces in the intra-cristal compartments of the IMM.
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6.4. CONCLUSION
Our findings indicate that, Cytc partially unfolds on both convex and concave surfaces of
pure CL vesicles. However, the membrane surface area required for partial unfolding is larger on
concave than on convex membrane surfaces. The unfolding process is also more cooperative on a
concave versus a convex membrane surface. The larger surface area required on the concave
versus the convex surface suggests that the extent of protein unfolding on concave surfaces may
be more extensive than for convex surface binding. Our results suggest that the concave
curvature of the IMM will have an important impact on the conformational rearrangements of
Cytc on CL-containing membranes and thus in controlling the peroxidase activity of Cytc in the
early stages of apoptosis.
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CHAPTER 7: Summary

7.1. Quantification of Lipids Enables Analytical Protein-Lipid Binding Analysis
A tool to rapidly quantify lipid concentration is required to approach protein-lipid binding
quantitatively. With the intent of performing an in-depth analysis of both variant dependent and
amino acid dependent lipid binding, we created a calculator that uses absorbance measurements
acquired from a UV-Visible spectrophotometer and first calculates the number of vesicles in
solution, then employs a lipid density measurement to approximate the total lipid concentration
of the system of interest. This technique was first developed for pure lipid systems. 1 With the
intent of expanding protein-lipid analysis to mixed lipid systems like those commonly employed
to study the Cytc-CL interaction, we modified our lipid calculator technique to make accessible
lipid concentration measurements of varying compositions and concentrations of lipids. 2 Both
the pure and mixed lipid calculators enable rapid quantification of lipids essential for analytical
analysis of protein-lipid binding.

7.2. Evolutionary Comparison of Cytochrome c Variants Demonstrates Divergence of
Protein Function.
Recent work has extended the role of Cytc from an electron shuttle in the electron transport
chain to a constituent in the pre-apoptotic pathway specifically in mammals.3,4 In both cellular
roles, Cytc associates with CL on the outer leaflet of the inner mitochondrial membrane. In this
work, we investigated the electrostatic protein-lipid interaction of both yeast and human Cytc to
determine if differing binding mechanisms exist that may explain the development of apoptotic
precursor for human Cytc. Our findings show that both protein variants initially dock on the
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membrane and remain in a folded state at low lipid to protein ratios (when space is population
limited) and display a biphasic response to binding. This biphasic response arises as the lipid to
protein ratio increases, freeing up space on the membrane. Our variant dependent analysis
showed that human Cytc had an attenuated dissociation constant consistent with more lipid
required to generate unfolding on the membrane surface than its yeast homologue. Further, we
showed that the amino acid generally assumed to be responsible for this interaction (Lys72) did
not contribute substantially to lipid binding, suggesting a complete characterization of
electrostatic binding constituents on Cytc is required to further understand the interaction being
investigated.

7.3. Alanine Screening Characterizes Anionic Binding Site Constituents and Shows
Concentration Charge Dependence of Lysines on Cardiolipin Binding.
As evidenced from variant dependent analysis of CL binding in chapter 3, an investigation
into the constituents of the anionic site A was needed to fully understand the electrostatic
interaction between Cytc and CL during protein-lipid docking. To determine amino acid
contribution, alanine screening was performed in and around the A site (Figure 1.2) of Cytc and
CL binding studies were used to assess the contribution of each substituted lysine of interest.
Through these studies, we found that several lysines in the region of the A site (Lys72, Lys73,
Lys86 and Lys87) had varying contributions to binding. Interestingly, complete removal of all
four lysines did not completely terminate electrostatic binding suggesting that these four lysines
do not completely account for electrostatic binding in this region of the protein.
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7.4. Cardiolipin Membrane Distribution Demonstrates Preference of the Lipid for Concave
Surfaces.
A concern in designing protein-lipid binding experiments is what exactly is being
investigated especially in more complex systems where different mixtures of lipids are used.
Specifically, CL is known to reside on concave surfaces but when used in binding experiments, it
is assumed that the lipid homogeneously distributes itself between the concave and convex
surfaces of vesicles. Further, most published work studying the Cytc-CL interaction study the
interaction on the convex outer leaflet of vesicles, ignoring any potential lipid driven distribution
inhomogeneity. In chapter 4, we assessed the distribution of anionic lipids in mixed lipid systems
comprised of the neutral lipid DOPC. To do this, we used the anionic lipid detecting fluorophore
TTAPE-Me and found that CL prefers the concave interior of vesicles generated an
inhomogeneity of lipid composition between vesicle membrane leaflets. This preferential
localization is directly due to CL’s structure, specifically it’s four acyl chains. In comparison,
when we assessed lipid distribution of DOPG (structurally similar to CL but possessing half the
number of hydrophobic tails), we found that no preferential distribution of the anionic lipid
exists. Using these findings, we then analyzed Cytc-CL binding to both 100% DOPC and 20%
CL/80%DOPC systems and found that protein-lipid binding was extensively attenuated. Binding
did not occur appreciably in pure DOPC titrations and only modest binding was detected in the
mixed lipid system. These findings further suggest that CL prefers the concave interior of
vesicles, giving rise to the possibility that binding of Cytc to CL on the outside of a vesicle may
be intrinsically different that binding to CL on the interior of the vesicle.
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7.5. Curvature Dependent Binding Analysis Demonstrates the Role of Membrane Structure
in Cytochrome c-Cardiolipin Binding.
Because Cytc-CL binding is known to occur on concave membrane surfaces, our last point of
analysis of this binding interaction was to elucidate the role of membrane curvature in the
protein-lipid interaction. In chapter 3, we demonstrated that a concentration dependent biphasic
response to lipid exposure occurred in both yeast and human mutants exposed to convex
surfaces. In comparing these findings with yeast Cytc exposed to concave membrane surfaces,
we have been able to show that the biphasic nature of the binding event is wholly conditional,
dependent on membrane structure. This loss of biphasic binding strongly suggests that the
membrane’s curvature plays a direct role in the facilitation of protein docking and concerted
unfolding.

7.6. Future Directions
Our findings presented in this work provide impetus for several future directions of
investigation. Current work hypothesizes four potential binding sites on Cytc. Given the
relatively small size of the protein and in coordination with our findings that a biphasic binding
event is observed under certain conditions, it is probably more likely that the four hypothesized
binding sites are actually different aspects of a smaller number of binding domains. Experimental
design and environmental conditions may be such that different aspects of each domain are
intermittently probed but the physiological behavior of the entire domain is not seen using
current methods. Alanine screening would provide insight into population of amino acids
involved in lipid docking and binding. Further, a repetition of concave binding analysis using
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alanine mutants would aid in elucidating the role of each amino acid involved in either docking
or unfolding the protein.
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Appendix I.1: INSTRUCTIONS FOR USING THE MVCC
Below is the MVCC.m file for vesicle and lipid quantification for TOCL. To use file, copy from
top green ‘%’ line to bottom ‘%’ line into blank .m file in Matlab and save as MVCC.m in the
Matlab directory.
To run MVCC file in Matlab, open Matlab and in command line, type ‘MVCC’ and press enter.
An ‘options’ window will appear allowing you to choose the lipid of interest (TOCL, DOPC,
POPC or POPG) if file has been copied and saved correctly. Select the lipid you wish to
measure. Next a popup window will appear. Input wavelength in nanometers and absorbance in
A.U. For spectrophotometer pathlengths not equal to 1 cm, scale absorbance accordingly. Input
vesicle diameter in nanometers. Press enter. Calculation output will appear in command window.
Output specifies first, vesicle concentration in mol/L and secondly, TOCL lipid concentration in
mol/L.
Modifying Calculator for different lipids:
This calculator can be modified to calculate lipid concentration for other lipids as well. To
modify the MVCC to measure a different lipid, change the following parameters: HDSA, BT and
RI. These correspond to headgroup surface area (HDSA), bilayer thickness (BT) and refractive
index (RI) and can be found in lines 31-33 once the code is copied into the .m file.
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%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
%
MVCC.m (Matlab Vesicle Concentration Calculator)
%
%
Written by: Margaret Elmer-Dixon
%
Last Editted: 9/19/2016
%
%
The MVCC Calculates concentration of TOCL lipid using data input taken
%
from a UVVis spectrophotometer at a known wavelength. Vesicle diameter
%
must be specified. To calculate lipid concentration from vesicle
%
scattering, follow dialog box prompts. Output is in command window.
%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

clear all
% Construct a questdlg with three options
choice = menu('Select Lipid Composition', ...
'TOCL','DOPC','POPC','POPG');
% Handle response
switch choice
case 1 %'TOCL'
lipidchoice = 'TOCL'
HDSA = 1.298; % nm^2 (Pan, Soft Matter, 2015)
BT = 3.67;% nm (Pan, Soft Matter, 2015)
RI = 1.46; %(Maniti, Biochimica et Biophysica Acta, Biomembranes,
%1808(4):1129-1139, 2011)
case 2 %'DOPC'
lipidchoice = 'DOPC'
HDSA = .674; % nm^2 (Pan, Soft Matter, 2015)
BT = 3.87;% nm (Pan, Soft Matter, 2015)
RI = 1.375;%1.375;% (JF Popplewell, Biochemicia et Biophysicia Acta
%1768 (2007) 13-20)
case 3 %'POPC'
lipidchoice = 'POPC'
HDSA = .627; % nm^2 @20C (Kucerka, Biochemia et Biophysicia Acta
% 1808(2011) 2761-2771)
BT = 3.98; % nm (Kucerka, Biochemia et Biophysicia Acta 1808(2011)
% 2761-2771)
RI = 1.376; % 1.376(JF Popplewell, Biochemicia et Biophysicia Acta 1768
% (2007) 13-20)
case 4 %'POPG'
lipidchoice = 'POPG'
BT = 3.73;% nm @20C (Pan, Biochemicia et Biophysicia Acta 2012,
% 1818(9):2135-2148)
HDSA = .644;% nm^2 @20C (Pan, Biochemicia et Biophysicia Acta 2012,
% 1818(9):2135-2148)
RI = 1.45;% (Murray. J Struct. Bio. 2009, 168(1):183-189)
end
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prompt = {'Wavelength of Absorbance','Absorbance Measurement (A.U.)',…
'Vesicle Diameter (nm)'};
dlg_title = 'MVCC Input';
num_lines = 1;
defaultans={'300','1.08','100'};
answer = inputdlg(prompt,dlg_title,num_lines,defaultans);
Wavelength = str2num(answer{1,1});
AbsorbanceMeasured = str2num(answer{2,1});
diameter = str2num(answer{3,1}); %nm
radius = diameter/2; %nm
radiusM= radius/10^9; %radius in meters

%calculate lipid specific vesicle characteristics
radiusInner = radius-BT; %using bilayer thickness, calculate
%inner radius
SAvesicle=4*pi*(radius^2+(radiusInner)^2); %SA of Outer and Inner
%bilayer in nm^2
LipidDensity = SAvesicle/HDSA; %lipids per vesicle
%calculate refractive index for each wavelength
m1 = 1.31848+6.662./(Wavelength-129.2); % equation from 'Water
%refractive index in dependence on temperature and wavelngth: a
%simple approximation' Bashkatov and Genina, Optics Department
%Saratoc state university
m = RI+i.*1.1*10^-7;%1.45 taken from sucrose index matching
%(Ardhammar,2002)
%calculate x parameter fommo equation 4
k = 2.*pi./Wavelength; %convert to angular wave number
xx = 2*pi*radius*m1./Wavelength;%defines size parameter
%calculate extinction efficiencies for each wavelength based on Bohren 1983.
x=xx;
if x==0 % To avoid a singularity at x=0
Eff=[real(m) imag(m) 0 0];
elseif x>0 % This is the normal situation
nmax=round(2+x+4*x^(1/3));
n1=nmax-1;
n=(1:nmax);cn=2*n+1; c1n=n.*(n+2)./(n+1); c2n=cn./n./(n+1);
x2=x*x;

%finding ABCD
nu=(n+.5);
z=m.*x;
m2=m.*m;
sqx=sqrt(0.5*pi./x);
sqz=sqrt(0.5*pi./z);
bx=besselj(nu,x).*sqx;
bz=besselj(nu,z).*sqz;
yx=bessely(nu,x).*sqx;
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hx=bx+i*yx;
b1x=[sin(x)/x,bx(1:nmax-1)];
b1z=[sin(z)/z,bz(1:nmax-1)];
y1x=[-cos(x)/x,yx(1:nmax-1)];
h1x=b1x+i*y1x;
ax=x.*b1x-n.*bx;
az=z.*b1z-n.*bz;
ahx=x.*h1x-n.*hx;
anABCD=(m2.*bz.*ax-bx.*az)./(m2.*bz.*ahx-hx.*az); % this
%corresponds to an in Eqn 3a
bnABCD=(bz.*ax-bx.*az)./(bz.*ahx-hx.*az); %this corresponds to bn
%in Eqn 3b
cnABCD=(bx.*ahx-hx.*ax)./(bz.*ahx-hx.*az);
dnABCD=m.*(bx.*ahx-hx.*ax)./(m2.*bz.*ahx-hx.*az);

f =[anABCD;bnABCD;cnABCD;dnABCD];%ABCD Values required for Qext
%calculation
anp=(real(f(1,:))); anpp=(imag(f(1,:)));
bnp=(real(f(2,:))); bnpp=(imag(f(2,:)));
g1(1:4,nmax)=[0; 0; 0; 0]; % displaced numbers used for
g1(1,1:n1)=anp(2:nmax); % asymmetry parameter, p. 120, Bohren
g1(2,1:n1)=anpp(2:nmax);
g1(3,1:n1)=bnp(2:nmax);
g1(4,1:n1)=bnpp(2:nmax);
dn=cn.*(anp+bnp);
q=sum(dn);
Qext=2*q/x2;% this corresponds to Cext in eqn 2
Eff=[real(m) imag(m) x Qext];
end

area= pi*radiusM^2; %area of scattering centers in m^2
pathlength=.01; %pathlength in meters
N = AbsorbanceMeasured./Qext./area./pathlength; %finds
%N=2.303*A/Q/area/d and converts to Mol
Nmol=N/6.022e23 %convert N avg to moles
fprintf('this is the vesicle concentration in M/L');
lipid=Nmol*LipidDensity %lipids total
fprintf('this is the lipid concentration in M/L');
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
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Appendix I.2: INSTRUCTIONS FOR USING THE MLC
MATLAB CODE Installation and User Instructions:
1) In matlab, copy and paste the following page of code (starting with the Green commented
region ‘%’) into a .m file and save it as ‘MLC.m’ in the Matlab directory.
2) To run:
a. Type ‘MLC’ into the command line and press ‘Enter’
b. Open MLC.m and press ‘Run’ at the top of the page view window.
3) The running program initiates with the following pop-up window, where the mole
fraction/fraction of DOPG, DOPC and Cardiolipin (TOCL) can be specified. Note that
three component systems may be calculated but have not been validated. Further, any
number of absorbances and their corresponding wavelengths can be specified provided
they are space separated.

4) The output after pressing ‘OK’, will show up in the command window in table format.
Standard deviations will be output for total lipid concentration and vesicle concentration
if more than one absorbance is provided.
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%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
%
Mixed Lipid Calculator
%
%
Written by: Margaret Elmer-Dixon
%
Last Edited: 3.14.2018
%
%
The Mixed Lipid Calculator calculates concentration of lipid using data input taken
%
from a UV-Vis spectrophotometer at a known wavelength. Vesicle diameter
%
must be specified. To calculate lipid concentration from vesicle
%
scattering, follow dialog box prompts. Lipid Mixture Concentrations must be specified.
%
Output is in command window.
%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
clear all
prompt={'Mole % DOPC','Mole % TOCL','Mole % DOPG','Absorbance wavelengths','Associated Absorbance
Scattering','Vesicle Diameter (nm)'};
dlg_title='Mixed Lipid Calculator';
num_lines = 1;
defaultans = {'80','20','0','400 425 450','.5124 .3894 .2911','100'};
answer=inputdlg(prompt,dlg_title,num_lines,defaultans);
A=str2num(answer{1,1});
B=str2num(answer{2,1});
C=str2num(answer{3,1});
nm=str2num(answer{4,1});
Absorbance=str2num(answer{5,1});
Diameter=str2num(answer{6,1});
XA=A./(A+B+C);
XB=B./(A+B+C);
XC=C./(A+B+C);
%DOPC
HDSAa = .674; % nm^2 (Pan, Soft Matter, 2015)
BTa = 3.87;% nm (Pan, Soft Matter, 2015)
RIa = 1.375;%1.375;% (JF Popplewell, Biochemicia et Biophysicia Acta 1768 (2007) 13-20)
Va =HDSAa*BTa; %nm^3
%Cardiolipin
BTb= 3.67;% nm (Pan, Soft Matter, 2015)
HDSAb= 1.298; % nm^2 (Pan, Soft Matter, 2015)
RIb= 1.46; %(Maniti, Biochimica et Biophysica Acta, Biomembranes, 1808(4):1129-1139, 2011)
Vb=HDSAb*BTb;
%DOPG
HDSAc = .694; %nm^2 @20C (Pan, Biochemicia et Biophysicia Acta 2012, 1818(9):2135-2148)
BTc = 3.63; %nm @20C (Pan, Biochemicia et Biophysicia Acta 2012, 1818(9):2135-2148)
RIc = 1.359; %(JF Popplewell, Biochemicia et Biophysicia Acta 1768 (2007) 13-20) THIS IS FOR PG
Vc = HDSAc*BTc;
%SA Percent HD (surface area percent by headgroup)
%Average HDSA (headgroup surface area) taking into account mole fraction
HDSA = (XA*HDSAa+XB*HDSAb+XC*HDSAc);
%Percent surface area covered by each molecule
PA = XA*HDSAa/HDSA; %percent surface area comprised of DOPC
PB = XB*HDSAb/HDSA; %percent surface area comprised of CL
PC = XC*HDSAc/HDSA; %percent surface area comprised of DOPG
%Refractive index based on the surface area occupation of each lipid
RI = RIa*PA+RIb*PB+RIc*PC;
% Bilayer thickness based on the weighted surface area occupation of
% each lipid
BT = BTa*PA+BTb*PB+BTc*PC;
%calculate lipid specific vesicle characteristics
diameter = Diameter;%%nm
radius = diameter/2; %nm
radiusM= radius/10^9; %radius in meters
radiusInner = radius-BT; %using bilayer thickness, calculate inner radius
SAvesicle=4*pi*(radius^2+(radiusInner)^2); %SA of Outer and Inner bilayer in nm^2
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LipidDensity = SAvesicle/HDSA; %lipids per vesicle
for ii = 1:length(nm)
RIi(ii) = RI;
%set indep vars
Wavelength = nm(ii);%nm
AbsorbanceMeasured = Absorbance(ii);%arbitrary units
%calculate refractive index for each wavelength
m1 = 1.31848+6.662./(Wavelength-129.2); % equation from 'Water refractive index in
%dependence on temperature and wavelngth: a simple approximation' Bashkatov and Genina, Optics
%Department Saratoc state university
m = RI+i.*1.1*10^-7;%1.45 taken from sucrose index matching (Ardhammar,2002)
%calculate x parameter from equation 4 from Elmer-Dixon and Bowler 2017
k = 2.*pi./Wavelength; %convert to angular wave number
xx = 2*pi*radius*m1./Wavelength;%defines size parameter
%calculate extinction efficiencies for each wavelength based on Bohren 1998.
x=xx;
X(ii)=x;
if x==0 % To avoid a singularity at x=0
Eff=[real(m) imag(m) 0 0];
elseif x>0 % This is the normal situation
nmax=round(2+x+4*x^(1/3));
n1=nmax-1;
n=(1:nmax);cn=2*n+1; c1n=n.*(n+2)./(n+1); c2n=cn./n./(n+1);
x2=x*x;
%finding ABCD
nu=(n+.5);
z=m.*x;
m2=m.*m;
sqx=sqrt(0.5*pi./x);
sqz=sqrt(0.5*pi./z);
bx=besselj(nu,x).*sqx;
bz=besselj(nu,z).*sqz;
yx=bessely(nu,x).*sqx;
hx=bx+i*yx;
b1x=[sin(x)/x,bx(1:nmax-1)];
b1z=[sin(z)/z,bz(1:nmax-1)];
y1x=[-cos(x)/x,yx(1:nmax-1)];
h1x=b1x+i*y1x;
ax=x.*b1x-n.*bx;
az=z.*b1z-n.*bz;
ahx=x.*h1x-n.*hx;
anABCD=(m2.*bz.*ax-bx.*az)./(m2.*bz.*ahx-hx.*az); % this corresponds to an in Eqn 3a from
%Elmer-Dixon and Bowler 2017
bnABCD=(bz.*ax-bx.*az)./(bz.*ahx-hx.*az); %this corresponds to bn in Eqn 3b from Elmer
%Dixon and Bowler 2017
cnABCD=(bx.*ahx-hx.*ax)./(bz.*ahx-hx.*az);
dnABCD=m.*(bx.*ahx-hx.*ax)./(m2.*bz.*ahx-hx.*az);
f =[anABCD;bnABCD;cnABCD;dnABCD];%ABCD Values required for Qext calculation using Eqn 2
%from Elmer-Dixon and Bowler 2017
anp=(real(f(1,:))); anpp=(imag(f(1,:)));
bnp=(real(f(2,:))); bnpp=(imag(f(2,:)));
g1(1:4,nmax)=[0; 0; 0; 0]; % displaced numbers used for
g1(1,1:n1)=anp(2:nmax); % asymmetry parameter, p. 120, Bohren 1983
g1(2,1:n1)=anpp(2:nmax);
g1(3,1:n1)=bnp(2:nmax);
g1(4,1:n1)=bnpp(2:nmax);
dn=cn.*(anp+bnp);
q=sum(dn);
Qext=2*q/x2;% this corresponds to Cext in eqn 2 from Elmer-Dixon and Bowler 2017
Eff=[real(m) imag(m) x Qext];
end
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Qx(ii)=Qext;
area= pi*radiusM^2; %area of scattering centers in m^2
pathlength=.01; %pathlength in cm
N = AbsorbanceMeasured./Qext./area./pathlength; %finds N=2.303*A/Q/area/d and converts to
%Mol
Nmol(ii)=N/6.022e23; %convert N avg to moles
% fprintf('this is the vesicle concentration in M/L');
lipid(ii)=Nmol(ii)*LipidDensity; %lipids total
% fprintf('this is the lipid concentration in M/L');
end
lmean = mean(lipid)*10^3;%convert from M to mMol
lstd = std(lipid)*10^3;
Nmean = mean(Nmol)*10^9;%convert from M to nMol
Nstd = std(Nmol)*10^9;
DOPCcon=XA*lmean;
CLcon=XB*lmean;
DOPGcon=XC*lmean;
DataName = {'Mole Fraction DOPC','Mole Fraction CL','Mole Fraction DOPG','mM DOPC Lipid',...
'mM CL Lipid','mM DOPG Lipid','mM Total Lipid','nM Vesicles'};
Mean = [XA; XB; XC; DOPCcon; CLcon; DOPGcon; lmean; Nmean];
STD = [0; 0; 0; 0; 0; 0; lstd; Nstd];
T= table(Mean,STD,'RowNames',DataName)
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Appendix II: Tables
Table A.1.
Comparison of Cardiolipin and DOPC content in vesicles from phosphorous analysis versus
Mie scattering analysis.
Vesicle
Lipid
Content

Phosphorous,†

2/27/15

TOCL

5/14/15

Lipid
Concentration,†
mM,

Calculated
Lipid
Concentration,‡
mM

% error

59.7

0.995

0.957

4.0

TOCL

201

3.35

3.20

4.7

4/8/16

TOCL

32.2

0.537

0.515

4.3

4/8/16

TOCL

60.5

1.01

1.01

0.0

4/8/16

TOCL

112

1.87

1.87

0.0

10/27/16

DOPC

53.4

1.72

1.73

0.6

11/4/16

DOPC

48.4

1.56

1.59

1.9

11/6/16

DOPC

50.6

1.63

1.68

3.0

Date

†Based

mg/L

on phosphorous content obtained from ICP measurements after phosphorous digest.
using Matlab vesicle concentration calculator.

‡ Calculated
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Table A.2.
Comparison of DOPC content in vesicles from phosphorous analysis versus concentration
calculation using initial manufacturer specified concentration

Date

Vesicle
Lipid
Content

Volume
Lipid
Dried
(µl)

Phosphorous,†
mg/L

2/27/15

TOCL*

160

59.7

0.957

1.07

12

5/14/15

TOCL*

1000

201

3.20

3.3

3.1

10/27/16

DOPC§

160

53.4

1.72

2.00

16

11/4/16

DOPC§

160

48.4

1.56

2.00

28

11/6/16

DOPC§

160

50.6

1.63

2.00

23

†Based

Cardiolipin,† Cardiolipin,‡
mM,
mM

% error

on phosphorous content obtained from ICP measurements after phosphorous digest.
Based on Manufacturer specified concentration. Samples were prepared with the intended
concentration based on manufacturer labeling (Cardiolipin: 5 mg/ml, DOPC: 10 mg/ml)
‡
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Table A.3.
Wavelength Ranges for testing Various Vesicle Sizes
Wavelength Range for Testing (nm)
Vesicle Size
(nm)
Cardiolipin
DOPC
POPC
POPG
50
200 - 350
200 - 325
200 - 325
200 - 350
100
200 - 690
200 - 650
200 - 650
200 - 690
200
200 - 1000
200 - 1000
200 - 1000
200 - 1000
400
275 - 1000
260 - 1000
260 - 1000
275 - 1000
1000
690 - 1000
650 - 1000
650 - 1000
690 - 1000
Calculations based on reported Index of refractions using Eqn. 4 from the main text.
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Table A.4.
Comparison of lipid concentration in pure DOPG vesicles from lipid mass versus phosphorous
and Mie scattering analyses
Expected lipid
concentration
based on lipid
mass, mM*

Expected
Phosphorous
Total Lipid
Calculated DOPG % Error
phosphorus
content from ICP, Concentration
Concentration
lipid mass
content based on
mg/L†
from ICP, mM†
(MVCC), mM‡
versus
lipid mass,
ICP§
*
mg/mL
1.48
45.9
36.0
1.16
1.14 ± 0.02
27.5
1.00
30.6
29.2
0.94
0.89 ± 0.05
6.38
0.25
7.65
6.16
0.20
0.21 ± 0.01
25.0
*
Based on manufacturer reported lipid mass.
†
Based on phosphorous content obtained from ICP measurements after a cold digest to release phosphorous (see ref.
[1]).
‡
Calculated using Matlab Vesicle Concentration Calculator (MVCC). Error is the standard deviation from
scattering data at multiple wavelengths.
§
% Error for manufacturer reported lipid mass relative to ICP.
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Table A.5.
Comparison of mixed lipid content in vesicles from phosphorous analysis versus Mie
scattering analysis
Vesicle
Mixed
Lipid
Content*

Expected lipid
concentration
based on lipid
mass†, mM

Expected
phosphorus
content based
on lipid mass,
mg/L†

Phosphorous
content from
ICP, mg/L‡

Total lipid
concentration
from ICP,
mM‡

Calculated
total lipid
concentration
(MLC), mM§

% Error
lipid mass
versus
ICP‖

20% CL
1.00
37.2
34.6
0.93
0.95 ± 0.03
7.64
20% CL
1.50
55.8
46.8
1.26
1.37 ± 0.04
19.2
20% CL
3.36
104
85.0
2.28
2.47 ± 0.08
22.5
50% CL
0.66
31.0
27.0
0.58
0.54 ± 0.03
15.0
50% CL
0.45
21.0
16.4
0.35
0.35± 0.03
28.2
20%
1.12
34.7
33.1
1.07
1.09± 0.01
4.83
DOPG
20%
0.37
11.5
11.8
0.38
0.37± 0.01
3.13
DOPG
20%
0.75
23.3
23.4
0.75
0.79± 0.03
0.47
DOPG
50%
1.12
34.7
32.7
1.06
1.08± 0.02
6.11
DOPG
*
Mole percent, the remainder being DOPC.
†
Based on manufacturer reported lipid mass.
‡
Based on phosphorous content obtained from ICP measurements after a cold digest to release phosphorous (see
ref. [1]).
§
Calculated using the Mixed Lipid Calculator (MLC) using Mie scattering data. Error is the standard deviation
from scattering data at multiple wavelengths.
‖
% Error for manufacturer reported lipid mass relative to ICP.
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Table A.6. Sense primer sequences for preparation of iso-1-Cytc variants.
Variant
Primer sequence
K73A TCAGAGTACTTGACTAACCCAAAAGCCTATATTCCTGGTACCAAGATGGCC
K72|73A
GAGTACTTGACTAACCCAGCCGCATATATTCCTGGTACCAAGAT
K86A
GATGGCCTTTGGTGGGTTGGCGAAGGAAAAAGACAGAAAC
K87A
GGCCTTTGGTGGGTTGAAGGCGGAAAAAGACAGAAACGAC
K86|87A
TCGTTTCTGTCTTTTTCCGCCGCCAACCCACCAAAGGC
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